<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>2.675e-19</TD><TD>-42.77</TD><TD>cytokine activity</TD><TD>molecular function</TD><TD>GO:0005125</TD><TD>218</TD><TD>13</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>3.817e-18</TD><TD>-40.11</TD><TD>KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION</TD><TD>MSigDB lists</TD><TD>KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION</TD><TD>256</TD><TD>13</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>4.081e-18</TD><TD>-40.04</TD><TD>cytokine receptor binding</TD><TD>molecular function</TD><TD>GO:0005126</TD><TD>268</TD><TD>13</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>1.209e-17</TD><TD>-38.95</TD><TD>HALLMARK_TNFA_SIGNALING_VIA_NFKB</TD><TD>MSigDB lists</TD><TD>HALLMARK_TNFA_SIGNALING_VIA_NFKB</TD><TD>198</TD><TD>12</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CCL20,CXCL3,IL6,G0S2,CXCL6,CXCL1,CXCL2,CCL5,CSF2,CD83</TD></TR>
<TR><TD>7.567e-17</TD><TD>-37.12</TD><TD>GHANDHI_DIRECT_IRRADIATION_UP</TD><TD>MSigDB lists</TD><TD>GHANDHI_DIRECT_IRRADIATION_UP</TD><TD>102</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,MMP3,CXCL3,IL6,G0S2,CXCL1,NFKBIZ,CXCL2,DKK1</TD></TR>
<TR><TD>1.341e-16</TD><TD>-36.55</TD><TD>NABA_SECRETED_FACTORS</TD><TD>MSigDB lists</TD><TD>NABA_SECRETED_FACTORS</TD><TD>336</TD><TD>13</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>1.506e-16</TD><TD>-36.43</TD><TD>CYTOKINE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>CYTOKINE_ACTIVITY</TD><TD>109</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,CCL20,CCL8,CXCL3,CXCL6,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>1.987e-16</TD><TD>-36.15</TD><TD>GAURNIER_PSMD4_TARGETS</TD><TD>MSigDB lists</TD><TD>GAURNIER_PSMD4_TARGETS</TD><TD>68</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>3.158e-16</TD><TD>-35.69</TD><TD>GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN</TD><TD>179</TD><TD>11</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,CXCL3,IL6,G0S2,CXCL1,NFKBIZ,PIM2,CXCL2,CD83</TD></TR>
<TR><TD>4.103e-16</TD><TD>-35.43</TD><TD>CHEMOKINE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>CHEMOKINE_ACTIVITY</TD><TD>41</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>5.064e-16</TD><TD>-35.22</TD><TD>CHEMOKINE_RECEPTOR_BINDING</TD><TD>MSigDB lists</TD><TD>CHEMOKINE_RECEPTOR_BINDING</TD><TD>42</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>7.282e-16</TD><TD>-34.86</TD><TD>Chemokine_IL8-like_dom</TD><TD>interpro domains</TD><TD>IPR001811</TD><TD>45</TD><TD>8</TD><TD>18293</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.103e-15</TD><TD>-34.44</TD><TD>chemokine activity</TD><TD>molecular function</TD><TD>GO:0008009</TD><TD>47</TD><TD>8</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.557e-15</TD><TD>-34.10</TD><TD>IL8</TD><TD>pfam domains</TD><TD>PF00048</TD><TD>45</TD><TD>8</TD><TD>16629</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>3.767e-15</TD><TD>-33.21</TD><TD>G_PROTEIN_COUPLED_RECEPTOR_BINDING</TD><TD>MSigDB lists</TD><TD>G_PROTEIN_COUPLED_RECEPTOR_BINDING</TD><TD>53</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>3.800e-15</TD><TD>-33.20</TD><TD>TIAN_TNF_SIGNALING_VIA_NFKB</TD><TD>MSigDB lists</TD><TD>TIAN_TNF_SIGNALING_VIA_NFKB</TD><TD>27</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CCL20,CXCL3,IL6,CD83</TD></TR>
<TR><TD>5.132e-15</TD><TD>-32.90</TD><TD>SCY</TD><TD>smart domains</TD><TD>SM00199</TD><TD>43</TD><TD>8</TD><TD>9131</TD><TD>18</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>5.628e-15</TD><TD>-32.81</TD><TD>WINZEN_DEGRADED_VIA_KHSRP</TD><TD>MSigDB lists</TD><TD>WINZEN_DEGRADED_VIA_KHSRP</TD><TD>97</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CCL20,CXCL3,IL6,NFKBIZ,CXCL2,CSF2,DKK1</TD></TR>
<TR><TD>5.750e-15</TD><TD>-32.79</TD><TD>chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0042379</TD><TD>57</TD><TD>8</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>6.419e-15</TD><TD>-32.68</TD><TD>env (gp160; envelope glycoprotein)</TD><TD>protein interactions</TD><TD>155971</TD><TD>1401</TD><TD>18</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,CD83,ELF3,DKK1,PTGS2,MMP3,IL6,CCL8,G0S2,CXCL1</TD></TR>
<TR><TD>1.193e-14</TD><TD>-32.06</TD><TD>GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN</TD><TD>167</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,G0S2,CXCL3,IL6,NFKBIZ,CXCL2,CSF2,CD83</TD></TR>
<TR><TD>1.376e-14</TD><TD>-31.92</TD><TD>positive regulation of leukocyte migration</TD><TD>biological process</TD><TD>GO:0002687</TD><TD>104</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.426e-14</TD><TD>-31.88</TD><TD>PHONG_TNF_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>PHONG_TNF_TARGETS_UP</TD><TD>62</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CXCL2,CSF2,CCL20,CXCL3,IL6,CD83</TD></TR>
<TR><TD>1.517e-14</TD><TD>-31.82</TD><TD>GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP</TD><TD>171</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,G0S2,CXCL3,IL6,CXCL1,NFKBIZ,PIM2,CXCL2,CD83</TD></TR>
<TR><TD>1.707e-14</TD><TD>-31.70</TD><TD>GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP</TD><TD>173</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,CXCL3,IL6,G0S2,CXCL1,NFKBIZ,CXCL2,CD83</TD></TR>
<TR><TD>1.779e-14</TD><TD>-31.66</TD><TD>Cytokine-cytokine receptor interaction</TD><TD>KEGG pathways</TD><TD>ko04060</TD><TD>265</TD><TD>13</TD><TD>6908</TD><TD>20</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,TNFSF13B,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>1.779e-14</TD><TD>-31.66</TD><TD>Cytokine-cytokine receptor interaction</TD><TD>KEGG pathways</TD><TD>hsa04060</TD><TD>265</TD><TD>13</TD><TD>6908</TD><TD>20</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,TNFSF13B,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>3.229e-14</TD><TD>-31.06</TD><TD>HINATA_NFKB_IMMU_INF</TD><TD>MSigDB lists</TD><TD>HINATA_NFKB_IMMU_INF</TD><TD>16</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CCL20,CXCL3,IL6,CD83,CXCL6</TD></TR>
<TR><TD>5.438e-14</TD><TD>-30.54</TD><TD>GSE8515_IL1_VS_IL6_4H_STIM_)MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE8515_IL1_VS_IL6_4H_STIM_)MAC_UP</TD><TD>194</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,G0S2,CXCL3,IL6,CXCL6,CXCL1,CXCL2,PIM2,CD83</TD></TR>
<TR><TD>5.994e-14</TD><TD>-30.45</TD><TD>CHICAS_RB1_TARGETS_SENESCENT</TD><TD>MSigDB lists</TD><TD>CHICAS_RB1_TARGETS_SENESCENT</TD><TD>539</TD><TD>13</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,IL11,CCL20,C15orf48,G0S2,CXCL3,IL6,CXCL6,CXCL1,NFKBIZ,CXCL2,CSF2</TD></TR>
<TR><TD>6.300e-14</TD><TD>-30.40</TD><TD>chemokine-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0070098</TD><TD>72</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.204e-13</TD><TD>-29.75</TD><TD>MAHAJAN_RESPONSE_TO_IL1A_UP</TD><TD>MSigDB lists</TD><TD>MAHAJAN_RESPONSE_TO_IL1A_UP</TD><TD>80</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CCL8,CXCL3,IL6,CXCL2,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>1.206e-13</TD><TD>-29.75</TD><TD>NABA_MATRISOME_ASSOCIATED</TD><TD>MSigDB lists</TD><TD>NABA_MATRISOME_ASSOCIATED</TD><TD>739</TD><TD>14</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>1.531e-13</TD><TD>-29.51</TD><TD>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP</TD><TD>215</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,C15orf48,G0S2,CXCL3,CXCL1,IL4I1,NFKBIZ,CXCL2,CCL5,CD83</TD></TR>
<TR><TD>2.017e-13</TD><TD>-29.23</TD><TD>SOUCEK_MYC_TARGETS</TD><TD>MSigDB lists</TD><TD>SOUCEK_MYC_TARGETS</TD><TD>8</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CXCL6</TD></TR>
<TR><TD>2.992e-13</TD><TD>-28.84</TD><TD>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP</TD><TD>22</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>3.070e-13</TD><TD>-28.81</TD><TD>inflammatory response</TD><TD>biological process</TD><TD>GO:0006954</TD><TD>450</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,NFKBIZ,CXCL2,CCL5,ELF3</TD></TR>
<TR><TD>3.539e-13</TD><TD>-28.67</TD><TD>regulation of leukocyte migration</TD><TD>biological process</TD><TD>GO:0002685</TD><TD>148</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>4.188e-13</TD><TD>-28.50</TD><TD>REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES</TD><TD>MSigDB lists</TD><TD>REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES</TD><TD>50</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>5.599e-13</TD><TD>-28.21</TD><TD>LIANG_SILENCED_BY_METHYLATION_2</TD><TD>MSigDB lists</TD><TD>LIANG_SILENCED_BY_METHYLATION_2</TD><TD>52</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL5,CSF2,CCL20,IL6,CXCL6</TD></TR>
<TR><TD>7.624e-13</TD><TD>-27.90</TD><TD>cell chemotaxis</TD><TD>biological process</TD><TD>GO:0060326</TD><TD>161</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>8.780e-13</TD><TD>-27.76</TD><TD>GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP</TD><TD>168</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CXCL3,IL6,G0S2,CXCL1,NFKBIZ,CXCL2,CD83</TD></TR>
<TR><TD>9.239e-13</TD><TD>-27.71</TD><TD>RECEPTOR_BINDING</TD><TD>MSigDB lists</TD><TD>RECEPTOR_BINDING</TD><TD>369</TD><TD>11</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,CCL20,CCL8,CXCL3,CXCL6,CXCL1,CXCL2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>9.686e-13</TD><TD>-27.66</TD><TD>Rheumatoid arthritis</TD><TD>KEGG pathways</TD><TD>hsa05323</TD><TD>89</TD><TD>9</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,IL11,CSF2,MMP3,CCL5,CCL20,IL6,CXCL6,TNFSF13B</TD></TR>
<TR><TD>9.686e-13</TD><TD>-27.66</TD><TD>Rheumatoid arthritis</TD><TD>KEGG pathways</TD><TD>ko05323</TD><TD>89</TD><TD>9</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,IL11,CSF2,MMP3,CCL5,CCL20,IL6,CXCL6,TNFSF13B</TD></TR>
<TR><TD>1.031e-12</TD><TD>-27.60</TD><TD>GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP</TD><TD>171</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,CXCL3,G0S2,CXCL1,NFKBIZ,PIM2,CXCL2,CD83</TD></TR>
<TR><TD>1.287e-12</TD><TD>-27.38</TD><TD>positive regulation of response to stimulus</TD><TD>biological process</TD><TD>GO:0048584</TD><TD>1946</TD><TD>18</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,PIM2</TD></TR>
<TR><TD>1.594e-12</TD><TD>-27.16</TD><TD>MODULE_46</TD><TD>MSigDB lists</TD><TD>MODULE_46</TD><TD>388</TD><TD>11</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,IL11,CSF3,CCL20,CCL8,IL6,CXCL6,CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>1.642e-12</TD><TD>-27.14</TD><TD>GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN</TD><TD>180</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,IL6,G0S2,CXCL1,NFKBIZ,CXCL2,CD83</TD></TR>
<TR><TD>1.884e-12</TD><TD>-27.00</TD><TD>MODULE_75</TD><TD>MSigDB lists</TD><TD>MODULE_75</TD><TD>394</TD><TD>11</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,IL11,CSF3,CCL20,CCL8,IL6,CXCL6,CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>2.896e-12</TD><TD>-26.57</TD><TD>Chemokine receptors bind chemokines</TD><TD>REACTOME pathways</TD><TD>R-HSA-380108</TD><TD>56</TD><TD>7</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>2.928e-12</TD><TD>-26.56</TD><TD>GNF2_MMP1</TD><TD>MSigDB lists</TD><TD>GNF2_MMP1</TD><TD>31</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CSF3,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>3.219e-12</TD><TD>-26.46</TD><TD>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</TD><TD>MSigDB lists</TD><TD>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</TD><TD>66</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CSF2,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>3.677e-12</TD><TD>-26.33</TD><TD>response to lipopolysaccharide</TD><TD>biological process</TD><TD>GO:0032496</TD><TD>288</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CCL5,CSF2,CCL20,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>4.225e-12</TD><TD>-26.19</TD><TD>tat (p14)</TD><TD>protein interactions</TD><TD>155871</TD><TD>1701</TD><TD>17</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,CD83,PTGS2,MMP3,IL6,CCL8,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>5.016e-12</TD><TD>-26.02</TD><TD>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</TD><TD>MSigDB lists</TD><TD>ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION</TD><TD>126</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL1,NFKBIZ,CXCL2,CSF2,CCL20,IL6,CXCL6</TD></TR>
<TR><TD>5.515e-12</TD><TD>-25.92</TD><TD>response to molecule of bacterial origin</TD><TD>biological process</TD><TD>GO:0002237</TD><TD>300</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CCL5,CSF2,CCL20,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>6.863e-12</TD><TD>-25.70</TD><TD>TNF signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04668</TD><TD>110</TD><TD>9</TD><TD>6908</TD><TD>20</TD>
<TD>PTGS2,MMP3,CCL20,CXCL3,IL6,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>6.863e-12</TD><TD>-25.70</TD><TD>TNF signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04668</TD><TD>110</TD><TD>9</TD><TD>6908</TD><TD>20</TD>
<TD>PTGS2,MMP3,CCL20,CXCL3,IL6,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>7.316e-12</TD><TD>-25.64</TD><TD>KRAS.LUNG.BREAST_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.LUNG.BREAST_UP.V1_UP</TD><TD>132</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CSF2,CCL20,CXCL3,G0S2</TD></TR>
<TR><TD>8.398e-12</TD><TD>-25.50</TD><TD>NABA_MATRISOME</TD><TD>MSigDB lists</TD><TD>NABA_MATRISOME</TD><TD>1010</TD><TD>14</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>1.184e-11</TD><TD>-25.16</TD><TD>MODULE_76</TD><TD>MSigDB lists</TD><TD>MODULE_76</TD><TD>79</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,PTGS2,CXCL2,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>1.184e-11</TD><TD>-25.16</TD><TD>GHANDHI_BYSTANDER_IRRADIATION_UP</TD><TD>MSigDB lists</TD><TD>GHANDHI_BYSTANDER_IRRADIATION_UP</TD><TD>79</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,PTGS2,CXCL2,MMP3,CXCL3,G0S2</TD></TR>
<TR><TD>1.297e-11</TD><TD>-25.07</TD><TD>SANA_TNF_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>SANA_TNF_SIGNALING_UP</TD><TD>80</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL2,MMP3,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.526e-11</TD><TD>-24.91</TD><TD>BIERIE_INFLAMMATORY_RESPONSE_TGFB1</TD><TD>MSigDB lists</TD><TD>BIERIE_INFLAMMATORY_RESPONSE_TGFB1</TD><TD>5</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CCL20,CXCL6</TD></TR>
<TR><TD>1.690e-11</TD><TD>-24.80</TD><TD>HINATA_NFKB_TARGETS_FIBROBLAST_UP</TD><TD>MSigDB lists</TD><TD>HINATA_NFKB_TARGETS_FIBROBLAST_UP</TD><TD>83</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,CXCL3,IL6,G0S2,CD83,CXCL6</TD></TR>
<TR><TD>1.749e-11</TD><TD>-24.77</TD><TD>positive regulation of leukocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0002690</TD><TD>81</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>2.774e-11</TD><TD>-24.31</TD><TD>MODULE_263</TD><TD>MSigDB lists</TD><TD>MODULE_263</TD><TD>44</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>2.790e-11</TD><TD>-24.30</TD><TD>LOCOMOTORY_BEHAVIOR</TD><TD>MSigDB lists</TD><TD>LOCOMOTORY_BEHAVIOR</TD><TD>89</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>2.790e-11</TD><TD>-24.30</TD><TD>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</TD><TD>MSigDB lists</TD><TD>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</TD><TD>89</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CCL5,CCL20,CXCL3,IL6,CD83,CXCL6</TD></TR>
<TR><TD>3.198e-11</TD><TD>-24.17</TD><TD>positive regulation of immune system process</TD><TD>biological process</TD><TD>GO:0002684</TD><TD>866</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CD83</TD></TR>
<TR><TD>3.200e-11</TD><TD>-24.17</TD><TD>extracellular space</TD><TD>cellular component</TD><TD>GO:0005615</TD><TD>1363</TD><TD>15</TD><TD>17570</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2,DKK1</TD></TR>
<TR><TD>3.566e-11</TD><TD>-24.06</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>MSigDB lists</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>372</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,G0S2,CXCL1,CXCL2,ELF3</TD></TR>
<TR><TD>4.260e-11</TD><TD>-23.88</TD><TD>positive regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030335</TD><TD>369</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>4.333e-11</TD><TD>-23.86</TD><TD>cytokine-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0019221</TD><TD>514</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>5.540e-11</TD><TD>-23.62</TD><TD>positive regulation of cell motility</TD><TD>biological process</TD><TD>GO:2000147</TD><TD>379</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>6.211e-11</TD><TD>-23.50</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>50</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL5,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>6.784e-11</TD><TD>-23.41</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN</TD><TD>174</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CXCL3,IL6,C15orf48,CXCL1,NFKBIZ,CXCL2</TD></TR>
<TR><TD>6.801e-11</TD><TD>-23.41</TD><TD>positive regulation of cellular component movement</TD><TD>biological process</TD><TD>GO:0051272</TD><TD>387</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>7.366e-11</TD><TD>-23.33</TD><TD>regulation of leukocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0002688</TD><TD>99</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>7.780e-11</TD><TD>-23.28</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_R848_DC_DN</TD><TD>177</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL3,IL6,C15orf48,CXCL1,NFKBIZ,CXCL2,CCL5</TD></TR>
<TR><TD>8.521e-11</TD><TD>-23.19</TD><TD>positive regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040017</TD><TD>396</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>8.948e-11</TD><TD>-23.14</TD><TD>MODULE_108</TD><TD>MSigDB lists</TD><TD>MODULE_108</TD><TD>53</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>1.006e-10</TD><TD>-23.02</TD><TD>ONDER_CDH1_TARGETS_3_DN</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_TARGETS_3_DN</TD><TD>54</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CSF2,CXCL3</TD></TR>
<TR><TD>1.108e-10</TD><TD>-22.92</TD><TD>KEGG_CHEMOKINE_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_CHEMOKINE_SIGNALING_PATHWAY</TD><TD>185</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.353e-10</TD><TD>-22.72</TD><TD>response to cytokine</TD><TD>biological process</TD><TD>GO:0034097</TD><TD>757</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.843e-10</TD><TD>-22.41</TD><TD>DAZARD_RESPONSE_TO_UV_SCC_UP</TD><TD>MSigDB lists</TD><TD>DAZARD_RESPONSE_TO_UV_SCC_UP</TD><TD>116</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CSF2,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>2.148e-10</TD><TD>-22.26</TD><TD>KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>61</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL8,IL6</TD></TR>
<TR><TD>2.414e-10</TD><TD>-22.14</TD><TD>positive regulation of chemotaxis</TD><TD>biological process</TD><TD>GO:0050921</TD><TD>117</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>2.690e-10</TD><TD>-22.04</TD><TD>ACKR1 (atypical chemokine receptor 1 (Duffy blood group))</TD><TD>protein interactions</TD><TD>2532</TD><TD>8</TD><TD>4</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CXCL1,CCL5,CCL8</TD></TR>
<TR><TD>3.353e-10</TD><TD>-21.82</TD><TD>response to other organism</TD><TD>biological process</TD><TD>GO:0051707</TD><TD>819</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>3.353e-10</TD><TD>-21.82</TD><TD>response to external biotic stimulus</TD><TD>biological process</TD><TD>GO:0043207</TD><TD>819</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>3.801e-10</TD><TD>-21.69</TD><TD>regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030334</TD><TD>630</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>4.896e-10</TD><TD>-21.44</TD><TD>receptor binding</TD><TD>molecular function</TD><TD>GO:0005102</TD><TD>1429</TD><TD>14</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2,DKK1</TD></TR>
<TR><TD>5.069e-10</TD><TD>-21.40</TD><TD>response to biotic stimulus</TD><TD>biological process</TD><TD>GO:0009607</TD><TD>849</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>5.087e-10</TD><TD>-21.40</TD><TD>MCLACHLAN_DENTAL_CARIES_DN</TD><TD>MSigDB lists</TD><TD>MCLACHLAN_DENTAL_CARIES_DN</TD><TD>224</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,IL11,PIM2,CCL5,G0S2,CCL8,IL6</TD></TR>
<TR><TD>6.126e-10</TD><TD>-21.21</TD><TD>cellular response to cytokine stimulus</TD><TD>biological process</TD><TD>GO:0071345</TD><TD>659</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>6.719e-10</TD><TD>-21.12</TD><TD>MCLACHLAN_DENTAL_CARIES_UP</TD><TD>MSigDB lists</TD><TD>MCLACHLAN_DENTAL_CARIES_UP</TD><TD>232</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CCL8,IL6,G0S2,CXCL1,PIM2,CCL5</TD></TR>
<TR><TD>6.851e-10</TD><TD>-21.10</TD><TD>regulation of cell motility</TD><TD>biological process</TD><TD>GO:2000145</TD><TD>666</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>6.940e-10</TD><TD>-21.09</TD><TD>response to bacterium</TD><TD>biological process</TD><TD>GO:0009617</TD><TD>491</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CCL5,CSF2,CCL20,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>7.738e-10</TD><TD>-20.98</TD><TD>positive regulation of behavior</TD><TD>biological process</TD><TD>GO:0048520</TD><TD>138</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>7.760e-10</TD><TD>-20.98</TD><TD>MODULE_64</TD><TD>MSigDB lists</TD><TD>MODULE_64</TD><TD>510</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,IL11,CSF3,CCL20,CCL8,IL6,CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>8.224e-10</TD><TD>-20.92</TD><TD>EXTRACELLULAR_SPACE</TD><TD>MSigDB lists</TD><TD>EXTRACELLULAR_SPACE</TD><TD>238</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CSF3,CXCL2,MMP3,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>8.343e-10</TD><TD>-20.90</TD><TD>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>MSigDB lists</TD><TD>SEKI_INFLAMMATORY_RESPONSE_LPS_UP</TD><TD>76</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,NFKBIZ,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>9.081e-10</TD><TD>-20.82</TD><TD>BILD_HRAS_ONCOGENIC_SIGNATURE</TD><TD>MSigDB lists</TD><TD>BILD_HRAS_ONCOGENIC_SIGNATURE</TD><TD>241</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,NFKBIZ,PTGS2,CXCL2,CCL20,CXCL3,G0S2</TD></TR>
<TR><TD>9.332e-10</TD><TD>-20.79</TD><TD>BEHAVIOR</TD><TD>MSigDB lists</TD><TD>BEHAVIOR</TD><TD>146</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>9.790e-10</TD><TD>-20.74</TD><TD>MODULE_92</TD><TD>MSigDB lists</TD><TD>MODULE_92</TD><TD>147</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,CCL20,CCL8,IL6,CXCL6</TD></TR>
<TR><TD>1.009e-09</TD><TD>-20.71</TD><TD>SMID_BREAST_CANCER_LUMINAL_B_DN</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_LUMINAL_B_DN</TD><TD>524</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,MMP3,CCL20,IL6,CXCL1,CXCL2,CCL5,MT1F,DKK1</TD></TR>
<TR><TD>1.070e-09</TD><TD>-20.66</TD><TD>G-protein coupled receptor binding</TD><TD>molecular function</TD><TD>GO:0001664</TD><TD>252</TD><TD>8</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>1.268e-09</TD><TD>-20.49</TD><TD>immune response</TD><TD>biological process</TD><TD>GO:0006955</TD><TD>1442</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CSF2,CCL5,CD83</TD></TR>
<TR><TD>1.679e-09</TD><TD>-20.21</TD><TD>regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040012</TD><TD>725</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.770e-09</TD><TD>-20.15</TD><TD>regulation of cell proliferation</TD><TD>biological process</TD><TD>GO:0042127</TD><TD>1479</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,PTGS2,CSF3,IL11,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,PIM2,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>1.851e-09</TD><TD>-20.11</TD><TD>ONDER_CDH1_TARGETS_1_DN</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_TARGETS_1_DN</TD><TD>161</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CSF2,CXCL3,DKK1</TD></TR>
<TR><TD>1.856e-09</TD><TD>-20.10</TD><TD>positive regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048522</TD><TD>4598</TD><TD>21</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,PIM2</TD></TR>
<TR><TD>1.923e-09</TD><TD>-20.07</TD><TD>Chemokine_CXC</TD><TD>interpro domains</TD><TD>IPR001089</TD><TD>13</TD><TD>4</TD><TD>18293</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>1.923e-09</TD><TD>-20.07</TD><TD>Chemokine_CXC_CS</TD><TD>interpro domains</TD><TD>IPR018048</TD><TD>13</TD><TD>4</TD><TD>18293</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>1.980e-09</TD><TD>-20.04</TD><TD>KRAS.600.LUNG.BREAST_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.600.LUNG.BREAST_UP.V1_UP</TD><TD>266</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,CSF2,CCL20,CXCL3,G0S2</TD></TR>
<TR><TD>1.995e-09</TD><TD>-20.03</TD><TD>regulation of cellular component movement</TD><TD>biological process</TD><TD>GO:0051270</TD><TD>737</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>2.205e-09</TD><TD>-19.93</TD><TD>positive regulation of response to external stimulus</TD><TD>biological process</TD><TD>GO:0032103</TD><TD>262</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,PTGS2,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>2.304e-09</TD><TD>-19.89</TD><TD>regulation of immune system process</TD><TD>biological process</TD><TD>GO:0002682</TD><TD>1509</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CSF2,CCL5,CD83</TD></TR>
<TR><TD>2.968e-09</TD><TD>-19.64</TD><TD>ZUCCHI_METASTASIS_DN</TD><TD>MSigDB lists</TD><TD>ZUCCHI_METASTASIS_DN</TD><TD>42</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>3.028e-09</TD><TD>-19.62</TD><TD>BIOCARTA_STEM_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_STEM_PATHWAY</TD><TD>14</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,CSF2,IL6</TD></TR>
<TR><TD>3.075e-09</TD><TD>-19.60</TD><TD>monocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0002548</TD><TD>41</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>3.183e-09</TD><TD>-19.57</TD><TD>REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS</TD><TD>MSigDB lists</TD><TD>REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS</TD><TD>174</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>3.183e-09</TD><TD>-19.57</TD><TD>regulation of response to stimulus</TD><TD>biological process</TD><TD>GO:0048583</TD><TD>3566</TD><TD>19</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,PIM2</TD></TR>
<TR><TD>3.313e-09</TD><TD>-19.53</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_2H_LPS_DC_DN</TD><TD>175</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,NFKBIZ,CXCL2,CXCL3,IL6,C15orf48</TD></TR>
<TR><TD>3.374e-09</TD><TD>-19.51</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</TD><TD>MSigDB lists</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</TD><TD>424</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,CXCL3,IL6,G0S2,CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>3.782e-09</TD><TD>-19.39</TD><TD>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</TD><TD>MSigDB lists</TD><TD>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</TD><TD>44</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CXCL2,CCL5,CCL20</TD></TR>
<TR><TD>3.870e-09</TD><TD>-19.37</TD><TD>response to lipid</TD><TD>biological process</TD><TD>GO:0033993</TD><TD>785</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL20,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>4.126e-09</TD><TD>-19.31</TD><TD>BIOCARTA_ERYTH_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_ERYTH_PATHWAY</TD><TD>15</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,CSF2,IL6</TD></TR>
<TR><TD>4.155e-09</TD><TD>-19.30</TD><TD>SMALL_CYTOKINES_CXC</TD><TD>prosite domains</TD><TD>PS00471</TD><TD>13</TD><TD>4</TD><TD>11866</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>4.455e-09</TD><TD>-19.23</TD><TD>myeloid leukocyte migration</TD><TD>biological process</TD><TD>GO:0097529</TD><TD>97</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3,IL6</TD></TR>
<TR><TD>4.773e-09</TD><TD>-19.16</TD><TD>regulation of chemotaxis</TD><TD>biological process</TD><TD>GO:0050920</TD><TD>179</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>5.144e-09</TD><TD>-19.09</TD><TD>ONDER_CDH1_TARGETS_2_DN</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_TARGETS_2_DN</TD><TD>445</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,G0S2,CXCL3,CXCL1,CXCL2,CSF2,CD83</TD></TR>
<TR><TD>5.209e-09</TD><TD>-19.07</TD><TD>defense response</TD><TD>biological process</TD><TD>GO:0006952</TD><TD>1606</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,NFKBIZ,CXCL2,CSF2,CCL5,CD83,ELF3</TD></TR>
<TR><TD>5.651e-09</TD><TD>-18.99</TD><TD>RESPONSE_TO_EXTERNAL_STIMULUS</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_EXTERNAL_STIMULUS</TD><TD>304</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL6,ELF3</TD></TR>
<TR><TD>6.312e-09</TD><TD>-18.88</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>192</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CCL5,CCL20,CCL8,CXCL3,IL6</TD></TR>
<TR><TD>6.760e-09</TD><TD>-18.81</TD><TD>CXCR chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0045236</TD><TD>17</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>7.544e-09</TD><TD>-18.70</TD><TD>HALLMARK_INFLAMMATORY_RESPONSE</TD><TD>MSigDB lists</TD><TD>HALLMARK_INFLAMMATORY_RESPONSE</TD><TD>197</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,CSF3,CCL5,CCL20,IL6,CXCL6</TD></TR>
<TR><TD>8.432e-09</TD><TD>-18.59</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</TD><TD>MSigDB lists</TD><TD>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</TD><TD>471</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,G0S2,CXCL3,IL6,CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>9.064e-09</TD><TD>-18.52</TD><TD>CXCR1 (chemokine (C-X-C motif) receptor 1)</TD><TD>protein interactions</TD><TD>3577</TD><TD>17</TD><TD>4</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>9.222e-09</TD><TD>-18.50</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>MSigDB lists</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>18</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5,CXCL3,CXCL6</TD></TR>
<TR><TD>9.222e-09</TD><TD>-18.50</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G28</TD><TD>MSigDB lists</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G28</TD><TD>18</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL20,CXCL3</TD></TR>
<TR><TD>9.909e-09</TD><TD>-18.43</TD><TD>WORSCHECH_TUMOR_REJECTION_UP</TD><TD>MSigDB lists</TD><TD>WORSCHECH_TUMOR_REJECTION_UP</TD><TD>53</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL1,NFKBIZ,CXCL2,CCL5</TD></TR>
<TR><TD>1.073e-08</TD><TD>-18.35</TD><TD>EXTRACELLULAR_REGION_PART</TD><TD>MSigDB lists</TD><TD>EXTRACELLULAR_REGION_PART</TD><TD>330</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CSF3,CXCL2,MMP3,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>1.174e-08</TD><TD>-18.26</TD><TD>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>MSigDB lists</TD><TD>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</TD><TD>210</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,NFKBIZ,CXCL2,CCL20,IL6,ELF3</TD></TR>
<TR><TD>1.370e-08</TD><TD>-18.11</TD><TD>Cytokines and Inflammatory Response</TD><TD>WikiPathways</TD><TD>WP530</TD><TD>23</TD><TD>5</TD><TD>4455</TD><TD>17</TD>
<TD>CXCL1,CSF3,CXCL2,CSF2,IL6</TD></TR>
<TR><TD>1.456e-08</TD><TD>-18.04</TD><TD>leukocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0030595</TD><TD>118</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3,IL6</TD></TR>
<TR><TD>1.575e-08</TD><TD>-17.97</TD><TD>CROONQUIST_STROMAL_STIMULATION_UP</TD><TD>MSigDB lists</TD><TD>CROONQUIST_STROMAL_STIMULATION_UP</TD><TD>58</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PIM2,CXCL2,CXCL3,IL6</TD></TR>
<TR><TD>1.723e-08</TD><TD>-17.88</TD><TD>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</TD><TD>222</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,NFKBIZ,CSF2,CCL20,G0S2,CXCL3,DKK1</TD></TR>
<TR><TD>1.723e-08</TD><TD>-17.88</TD><TD>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</TD><TD>MSigDB lists</TD><TD>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</TD><TD>222</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,PTGS2,CXCL2,CXCL3,IL6,CD83</TD></TR>
<TR><TD>1.799e-08</TD><TD>-17.83</TD><TD>WANG_TNF_TARGETS</TD><TD>MSigDB lists</TD><TD>WANG_TNF_TARGETS</TD><TD>21</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2,MMP3,IL6</TD></TR>
<TR><TD>1.799e-08</TD><TD>-17.83</TD><TD>FERRARI_RESPONSE_TO_FENRETINIDE_UP</TD><TD>MSigDB lists</TD><TD>FERRARI_RESPONSE_TO_FENRETINIDE_UP</TD><TD>21</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL20,CXCL3</TD></TR>
<TR><TD>1.874e-08</TD><TD>-17.79</TD><TD>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP</TD><TD>MSigDB lists</TD><TD>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP</TD><TD>60</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CXCL3,G0S2</TD></TR>
<TR><TD>1.874e-08</TD><TD>-17.79</TD><TD>MODULE_433</TD><TD>MSigDB lists</TD><TD>MODULE_433</TD><TD>60</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CSF3,IL6,DKK1</TD></TR>
<TR><TD>1.882e-08</TD><TD>-17.79</TD><TD>INFLAMMATORY_RESPONSE</TD><TD>MSigDB lists</TD><TD>INFLAMMATORY_RESPONSE</TD><TD>127</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL6,ELF3</TD></TR>
<TR><TD>1.966e-08</TD><TD>-17.74</TD><TD>Peptide ligand-binding receptors</TD><TD>REACTOME pathways</TD><TD>R-HSA-375276</TD><TD>193</TD><TD>7</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>2.040e-08</TD><TD>-17.71</TD><TD>response to oxygen-containing compound</TD><TD>biological process</TD><TD>GO:1901700</TD><TD>1463</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,MMP3,CCL20,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>2.356e-08</TD><TD>-17.56</TD><TD>immune system process</TD><TD>biological process</TD><TD>GO:0002376</TD><TD>2162</TD><TD>15</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2,CD83</TD></TR>
<TR><TD>2.360e-08</TD><TD>-17.56</TD><TD>Chemokine_CC_CS</TD><TD>interpro domains</TD><TD>IPR000827</TD><TD>23</TD><TD>4</TD><TD>18293</TD><TD>25</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>2.369e-08</TD><TD>-17.56</TD><TD>Chemokine signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04062</TD><TD>187</TD><TD>8</TD><TD>6908</TD><TD>20</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>2.369e-08</TD><TD>-17.56</TD><TD>Chemokine signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04062</TD><TD>187</TD><TD>8</TD><TD>6908</TD><TD>20</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL3,CXCL6</TD></TR>
<TR><TD>2.404e-08</TD><TD>-17.54</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>63</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>2.656e-08</TD><TD>-17.44</TD><TD>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</TD><TD>MSigDB lists</TD><TD>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</TD><TD>23</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL11,CCL5,IL6</TD></TR>
<TR><TD>3.143e-08</TD><TD>-17.28</TD><TD>NUYTTEN_EZH2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NUYTTEN_EZH2_TARGETS_UP</TD><TD>985</TD><TD>11</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,MMP3,CCL20,IL6,C15orf48,G0S2,CXCL1,IL4I1,CXCL2,CSF2,CD83</TD></TR>
<TR><TD>3.228e-08</TD><TD>-17.25</TD><TD>positive regulation of biological process</TD><TD>biological process</TD><TD>GO:0048518</TD><TD>5310</TD><TD>21</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,PIM2</TD></TR>
<TR><TD>3.230e-08</TD><TD>-17.25</TD><TD>regulation of behavior</TD><TD>biological process</TD><TD>GO:0050795</TD><TD>236</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>3.312e-08</TD><TD>-17.22</TD><TD>neutrophil chemotaxis</TD><TD>biological process</TD><TD>GO:0030593</TD><TD>65</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3</TD></TR>
<TR><TD>3.352e-08</TD><TD>-17.21</TD><TD>CXCR2 (chemokine (C-X-C motif) receptor 2)</TD><TD>protein interactions</TD><TD>3579</TD><TD>23</TD><TD>4</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>3.609e-08</TD><TD>-17.14</TD><TD>positive regulation of intracellular signal transduction</TD><TD>biological process</TD><TD>GO:1902533</TD><TD>973</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,IL6,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>4.114e-08</TD><TD>-17.01</TD><TD>response to organic substance</TD><TD>biological process</TD><TD>GO:0010033</TD><TD>2656</TD><TD>16</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CSF2,CCL5,DKK1,CD83,CSF3,PTGS2,MMP3,IL6,CCL8,CXCL1</TD></TR>
<TR><TD>4.163e-08</TD><TD>-16.99</TD><TD>P53_DN.V2_UP</TD><TD>MSigDB lists</TD><TD>P53_DN.V2_UP</TD><TD>145</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,MMP3,CCL20,CD83,CXCL6</TD></TR>
<TR><TD>4.168e-08</TD><TD>-16.99</TD><TD>neutrophil migration</TD><TD>biological process</TD><TD>GO:1990266</TD><TD>68</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3</TD></TR>
<TR><TD>4.348e-08</TD><TD>-16.95</TD><TD>positive regulation of signaling</TD><TD>biological process</TD><TD>GO:0023056</TD><TD>1558</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>4.497e-08</TD><TD>-16.92</TD><TD>SMALLCYTKCXC</TD><TD>prints domains</TD><TD>PR00437</TD><TD>13</TD><TD>4</TD><TD>4759</TD><TD>15</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>4.829e-08</TD><TD>-16.85</TD><TD>granulocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0071621</TD><TD>70</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3</TD></TR>
<TR><TD>4.843e-08</TD><TD>-16.84</TD><TD>DEFENSE_RESPONSE</TD><TD>MSigDB lists</TD><TD>DEFENSE_RESPONSE</TD><TD>258</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CD83,CXCL6,ELF3</TD></TR>
<TR><TD>4.915e-08</TD><TD>-16.83</TD><TD>positive regulation of cell communication</TD><TD>biological process</TD><TD>GO:0010647</TD><TD>1574</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>5.091e-08</TD><TD>-16.79</TD><TD>SMALL_CYTOKINES_CC</TD><TD>prosite domains</TD><TD>PS00472</TD><TD>23</TD><TD>4</TD><TD>11866</TD><TD>20</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>5.303e-08</TD><TD>-16.75</TD><TD>GROSS_HYPOXIA_VIA_ELK3_DN</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_DN</TD><TD>151</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF3,CXCL2,IL6,CXCL6</TD></TR>
<TR><TD>5.349e-08</TD><TD>-16.74</TD><TD>response to tumor necrosis factor</TD><TD>biological process</TD><TD>GO:0034612</TD><TD>254</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL5,CCL20,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>6.403e-08</TD><TD>-16.56</TD><TD>granulocyte migration</TD><TD>biological process</TD><TD>GO:0097530</TD><TD>74</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3</TD></TR>
<TR><TD>6.439e-08</TD><TD>-16.56</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</TD><TD>MSigDB lists</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</TD><TD>156</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL20,CXCL3,IL6,DKK1</TD></TR>
<TR><TD>6.502e-08</TD><TD>-16.55</TD><TD>chemotaxis</TD><TD>biological process</TD><TD>GO:0006935</TD><TD>789</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>6.502e-08</TD><TD>-16.55</TD><TD>taxis</TD><TD>biological process</TD><TD>GO:0042330</TD><TD>789</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>6.940e-08</TD><TD>-16.48</TD><TD>growth factor activity</TD><TD>molecular function</TD><TD>GO:0008083</TD><TD>161</TD><TD>6</TD><TD>16491</TD><TD>23</TD>
<TD>CXCL1,CSF3,IL11,CSF2,IL6,DKK1</TD></TR>
<TR><TD>7.084e-08</TD><TD>-16.46</TD><TD>BIOCARTA_INFLAM_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_INFLAM_PATHWAY</TD><TD>29</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,CSF2,IL6</TD></TR>
<TR><TD>8.988e-08</TD><TD>-16.22</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP</TD><TD>165</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,PTGS2,CXCL2,CCL20,CXCL3</TD></TR>
<TR><TD>8.988e-08</TD><TD>-16.22</TD><TD>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</TD><TD>MSigDB lists</TD><TD>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP</TD><TD>165</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>9.004e-08</TD><TD>-16.22</TD><TD>positive regulation of ERK1 and ERK2 cascade</TD><TD>biological process</TD><TD>GO:0070374</TD><TD>160</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>9.285e-08</TD><TD>-16.19</TD><TD>EXTRACELLULAR_REGION</TD><TD>MSigDB lists</TD><TD>EXTRACELLULAR_REGION</TD><TD>436</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CSF3,CXCL2,MMP3,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>9.501e-08</TD><TD>-16.17</TD><TD>cellular response to interleukin-1</TD><TD>biological process</TD><TD>GO:0071347</TD><TD>80</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>9.747e-08</TD><TD>-16.14</TD><TD>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</TD><TD>MSigDB lists</TD><TD>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</TD><TD>83</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CXCL2,CCL5,CD83</TD></TR>
<TR><TD>9.794e-08</TD><TD>-16.14</TD><TD>REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS</TD><TD>MSigDB lists</TD><TD>REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS</TD><TD>286</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>1.013e-07</TD><TD>-16.10</TD><TD>cellular response to organic substance</TD><TD>biological process</TD><TD>GO:0071310</TD><TD>2021</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>1.190e-07</TD><TD>-15.94</TD><TD>GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP</TD><TD>173</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,PTGS2,CXCL2,CCL20,CXCL3,MT1F</TD></TR>
<TR><TD>1.236e-07</TD><TD>-15.91</TD><TD>HALLMARK_IL6_JAK_STAT3_SIGNALING</TD><TD>MSigDB lists</TD><TD>HALLMARK_IL6_JAK_STAT3_SIGNALING</TD><TD>87</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CSF2,CXCL3,IL6</TD></TR>
<TR><TD>1.297e-07</TD><TD>-15.86</TD><TD>CCR chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0048020</TD><TD>34</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>1.374e-07</TD><TD>-15.80</TD><TD>SIMBULAN_UV_RESPONSE_NORMAL_UP</TD><TD>MSigDB lists</TD><TD>SIMBULAN_UV_RESPONSE_NORMAL_UP</TD><TD>8</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3,IL6</TD></TR>
<TR><TD>1.380e-07</TD><TD>-15.80</TD><TD>cellular response to chemical stimulus</TD><TD>biological process</TD><TD>GO:0070887</TD><TD>2460</TD><TD>15</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CSF2,CCL5,MT1F</TD></TR>
<TR><TD>1.556e-07</TD><TD>-15.68</TD><TD>GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>MSigDB lists</TD><TD>GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>181</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CXCL2,CCL20,G0S2,CD83</TD></TR>
<TR><TD>1.640e-07</TD><TD>-15.62</TD><TD>positive regulation of signal transduction</TD><TD>biological process</TD><TD>GO:0009967</TD><TD>1418</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>1.695e-07</TD><TD>-15.59</TD><TD>RESPONSE_TO_CHEMICAL_STIMULUS</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_CHEMICAL_STIMULUS</TD><TD>310</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>1.828e-07</TD><TD>-15.51</TD><TD>GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN</TD><TD>186</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL20,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>1.887e-07</TD><TD>-15.48</TD><TD>RESPONSE_TO_WOUNDING</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_WOUNDING</TD><TD>187</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL6,ELF3</TD></TR>
<TR><TD>1.947e-07</TD><TD>-15.45</TD><TD>GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>188</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CCL5,CCL20,IL6</TD></TR>
<TR><TD>1.947e-07</TD><TD>-15.45</TD><TD>REACTOME_G_ALPHA_I_SIGNALLING_EVENTS</TD><TD>MSigDB lists</TD><TD>REACTOME_G_ALPHA_I_SIGNALLING_EVENTS</TD><TD>188</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>2.073e-07</TD><TD>-15.39</TD><TD>GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP</TD><TD>190</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,PIM2,CCL5,CCL20,IL6,MT1F</TD></TR>
<TR><TD>2.138e-07</TD><TD>-15.36</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN</TD><TD>191</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CCL20,CCL8,MT1F</TD></TR>
<TR><TD>2.274e-07</TD><TD>-15.30</TD><TD>GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN</TD><TD>193</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,PIM2,CXCL3,IL6</TD></TR>
<TR><TD>3.171e-07</TD><TD>-14.96</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NUYTTEN_NIPP1_TARGETS_UP</TD><TD>719</TD><TD>9</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CCL20,CXCL3,G0S2,CXCL6,CXCL1,CXCL2,CSF2</TD></TR>
<TR><TD>3.906e-07</TD><TD>-14.76</TD><TD>response to interleukin-1</TD><TD>biological process</TD><TD>GO:0070555</TD><TD>106</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>4.107e-07</TD><TD>-14.71</TD><TD>cell surface receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007166</TD><TD>2257</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CSF3,CCL20,G0S2,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2,DKK1</TD></TR>
<TR><TD>4.822e-07</TD><TD>-14.54</TD><TD>ACKR4 (atypical chemokine receptor 4)</TD><TD>protein interactions</TD><TD>51554</TD><TD>11</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>5.377e-07</TD><TD>-14.44</TD><TD>RAY_ALZHEIMERS_DISEASE</TD><TD>MSigDB lists</TD><TD>RAY_ALZHEIMERS_DISEASE</TD><TD>12</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CCL5</TD></TR>
<TR><TD>5.700e-07</TD><TD>-14.38</TD><TD>ZHU_CMV_8_HR_UP</TD><TD>MSigDB lists</TD><TD>ZHU_CMV_8_HR_UP</TD><TD>48</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CCL5,IL6</TD></TR>
<TR><TD>5.867e-07</TD><TD>-14.35</TD><TD>regulation of localization</TD><TD>biological process</TD><TD>GO:0032879</TD><TD>2322</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,IL11,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5,DKK1</TD></TR>
<TR><TD>6.070e-07</TD><TD>-14.31</TD><TD>Class A/1 (Rhodopsin-like receptors)</TD><TD>REACTOME pathways</TD><TD>R-HSA-373076</TD><TD>318</TD><TD>7</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>6.201e-07</TD><TD>-14.29</TD><TD>HALMOS_CEBPA_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HALMOS_CEBPA_TARGETS_UP</TD><TD>49</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL20,CXCL3</TD></TR>
<TR><TD>6.731e-07</TD><TD>-14.21</TD><TD>regulation of ERK1 and ERK2 cascade</TD><TD>biological process</TD><TD>GO:0070372</TD><TD>225</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>7.051e-07</TD><TD>-14.16</TD><TD>DAZARD_RESPONSE_TO_UV_NHEK_UP</TD><TD>MSigDB lists</TD><TD>DAZARD_RESPONSE_TO_UV_NHEK_UP</TD><TD>234</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>7.066e-07</TD><TD>-14.16</TD><TD>REACTOME_GPCR_LIGAND_BINDING</TD><TD>MSigDB lists</TD><TD>REACTOME_GPCR_LIGAND_BINDING</TD><TD>383</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>7.248e-07</TD><TD>-14.14</TD><TD>cell migration</TD><TD>biological process</TD><TD>GO:0016477</TD><TD>771</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>7.320e-07</TD><TD>-14.13</TD><TD>human chr4q21</TD><TD>chromosome location</TD><TD>human chr4q21</TD><TD>19</TD><TD>3</TD><TD>26250</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3</TD></TR>
<TR><TD>8.053e-07</TD><TD>-14.03</TD><TD>cellular response to tumor necrosis factor</TD><TD>biological process</TD><TD>GO:0071356</TD><TD>232</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>8.192e-07</TD><TD>-14.01</TD><TD>4_helix_cytokine-like_core</TD><TD>interpro domains</TD><TD>IPR009079</TD><TD>54</TD><TD>4</TD><TD>18293</TD><TD>25</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>8.513e-07</TD><TD>-13.98</TD><TD>SABATES_COLORECTAL_ADENOMA_UP</TD><TD>MSigDB lists</TD><TD>SABATES_COLORECTAL_ADENOMA_UP</TD><TD>128</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,MMP3,CCL20,CXCL3</TD></TR>
<TR><TD>9.601e-07</TD><TD>-13.86</TD><TD>cellular response to lipopolysaccharide</TD><TD>biological process</TD><TD>GO:0071222</TD><TD>127</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,CSF2,CCL20,IL6</TD></TR>
<TR><TD>9.670e-07</TD><TD>-13.85</TD><TD>V$NFKB_Q6</TD><TD>MSigDB lists</TD><TD>V$NFKB_Q6</TD><TD>247</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,PTGS2,CXCL2,CSF2,CCL5,CD83</TD></TR>
<TR><TD>1.251e-06</TD><TD>-13.59</TD><TD>positive regulation of MAPK cascade</TD><TD>biological process</TD><TD>GO:0043410</TD><TD>596</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>1.252e-06</TD><TD>-13.59</TD><TD>cellular response to molecule of bacterial origin</TD><TD>biological process</TD><TD>GO:0071219</TD><TD>134</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,CSF2,CCL20,IL6</TD></TR>
<TR><TD>1.280e-06</TD><TD>-13.57</TD><TD>BMI1_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>BMI1_DN.V1_UP</TD><TD>139</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF2,MMP3,CCL20,DKK1</TD></TR>
<TR><TD>1.319e-06</TD><TD>-13.54</TD><TD>CROMER_TUMORIGENESIS_UP</TD><TD>MSigDB lists</TD><TD>CROMER_TUMORIGENESIS_UP</TD><TD>59</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MMP3,G0S2,IL6</TD></TR>
<TR><TD>1.398e-06</TD><TD>-13.48</TD><TD>leukocyte migration</TD><TD>biological process</TD><TD>GO:0050900</TD><TD>255</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,CXCL3,IL6</TD></TR>
<TR><TD>1.589e-06</TD><TD>-13.35</TD><TD>STK33_NOMO_UP</TD><TD>MSigDB lists</TD><TD>STK33_NOMO_UP</TD><TD>269</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL20,C15orf48,CXCL3,CXCL6</TD></TR>
<TR><TD>1.623e-06</TD><TD>-13.33</TD><TD>response to external stimulus</TD><TD>biological process</TD><TD>GO:0009605</TD><TD>2118</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,PIM2,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>1.629e-06</TD><TD>-13.33</TD><TD>ACKR2 (atypical chemokine receptor 2)</TD><TD>protein interactions</TD><TD>1238</TD><TD>16</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>1.686e-06</TD><TD>-13.29</TD><TD>localization of cell</TD><TD>biological process</TD><TD>GO:0051674</TD><TD>853</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.686e-06</TD><TD>-13.29</TD><TD>cell motility</TD><TD>biological process</TD><TD>GO:0048870</TD><TD>853</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.793e-06</TD><TD>-13.23</TD><TD>IL-6/GCSF/MGF</TD><TD>interpro domains</TD><TD>IPR030474</TD><TD>2</TD><TD>2</TD><TD>18293</TD><TD>25</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.793e-06</TD><TD>-13.23</TD><TD>IL6/GCSF/MGF_CS</TD><TD>interpro domains</TD><TD>IPR030473</TD><TD>2</TD><TD>2</TD><TD>18293</TD><TD>25</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.806e-06</TD><TD>-13.22</TD><TD>response to chemical</TD><TD>biological process</TD><TD>GO:0042221</TD><TD>3971</TD><TD>17</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CSF2,CCL5,DKK1,CD83,CSF3,PTGS2,MMP3,IL6,CCL8,CXCL1,MT1F</TD></TR>
<TR><TD>1.952e-06</TD><TD>-13.15</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>MSigDB lists</TD><TD>TENEDINI_MEGAKARYOCYTE_MARKERS</TD><TD>65</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CCL5,IL6</TD></TR>
<TR><TD>1.983e-06</TD><TD>-13.13</TD><TD>CHEN_ETV5_TARGETS_SERTOLI</TD><TD>MSigDB lists</TD><TD>CHEN_ETV5_TARGETS_SERTOLI</TD><TD>18</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL6,CXCL6</TD></TR>
<TR><TD>2.144e-06</TD><TD>-13.05</TD><TD>G alpha (i) signalling events</TD><TD>REACTOME pathways</TD><TD>R-HSA-418594</TD><TD>236</TD><TD>6</TD><TD>8202</TD><TD>15</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>2.258e-06</TD><TD>-13.00</TD><TD>cellular response to biotic stimulus</TD><TD>biological process</TD><TD>GO:0071216</TD><TD>151</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,CSF2,CCL20,IL6</TD></TR>
<TR><TD>2.409e-06</TD><TD>-12.94</TD><TD>positive regulation of peptidyl-tyrosine phosphorylation</TD><TD>biological process</TD><TD>GO:0050731</TD><TD>153</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,CCL5,CSF2,IL6</TD></TR>
<TR><TD>2.699e-06</TD><TD>-12.82</TD><TD>INTERLEUKIN_6</TD><TD>prosite domains</TD><TD>PS00254</TD><TD>2</TD><TD>2</TD><TD>11866</TD><TD>20</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>3.157e-06</TD><TD>-12.67</TD><TD>movement of cell or subcellular component</TD><TD>biological process</TD><TD>GO:0006928</TD><TD>1515</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5,CSF2</TD></TR>
<TR><TD>3.302e-06</TD><TD>-12.62</TD><TD>CCR3 (chemokine (C-C motif) receptor 3)</TD><TD>protein interactions</TD><TD>1232</TD><TD>20</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>3.326e-06</TD><TD>-12.61</TD><TD>response to stimulus</TD><TD>biological process</TD><TD>GO:0050896</TD><TD>7571</TD><TD>22</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>3.350e-06</TD><TD>-12.61</TD><TD>GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN</TD><TD>169</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL5,CCL20,CXCL3</TD></TR>
<TR><TD>3.359e-06</TD><TD>-12.60</TD><TD>Salmonella infection</TD><TD>KEGG pathways</TD><TD>ko05132</TD><TD>85</TD><TD>5</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CSF2,CXCL3,IL6</TD></TR>
<TR><TD>3.359e-06</TD><TD>-12.60</TD><TD>Salmonella infection</TD><TD>KEGG pathways</TD><TD>hsa05132</TD><TD>85</TD><TD>5</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CSF2,CXCL3,IL6</TD></TR>
<TR><TD>3.449e-06</TD><TD>-12.58</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP</TD><TD>170</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,NFKBIZ,CXCL2,IL6</TD></TR>
<TR><TD>3.671e-06</TD><TD>-12.52</TD><TD>IL6</TD><TD>smart domains</TD><TD>SM00126</TD><TD>2</TD><TD>2</TD><TD>9131</TD><TD>18</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>4.062e-06</TD><TD>-12.41</TD><TD>chr4q21</TD><TD>MSigDB lists</TD><TD>chr4q21</TD><TD>78</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>4.133e-06</TD><TD>-12.40</TD><TD>eosinophil chemotaxis</TD><TD>biological process</TD><TD>GO:0048245</TD><TD>22</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.319e-06</TD><TD>-12.35</TD><TD>VERHAAK_AML_WITH_NPM1_MUTATED_UP</TD><TD>MSigDB lists</TD><TD>VERHAAK_AML_WITH_NPM1_MUTATED_UP</TD><TD>178</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CCL20,G0S2,CXCL3,IL6</TD></TR>
<TR><TD>4.371e-06</TD><TD>-12.34</TD><TD>regulation of intracellular signal transduction</TD><TD>biological process</TD><TD>GO:1902531</TD><TD>1566</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,IL6,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>4.748e-06</TD><TD>-12.26</TD><TD>eosinophil migration</TD><TD>biological process</TD><TD>GO:0072677</TD><TD>23</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.815e-06</TD><TD>-12.24</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>182</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,CXCL3,G0S2,MT1F</TD></TR>
<TR><TD>4.874e-06</TD><TD>-12.23</TD><TD>positive regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001934</TD><TD>970</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>5.215e-06</TD><TD>-12.16</TD><TD>KRAS.DF.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.DF.V1_UP</TD><TD>185</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,CCL20,CXCL3,DKK1</TD></TR>
<TR><TD>5.219e-06</TD><TD>-12.16</TD><TD>human chr17q11.2-q12</TD><TD>chromosome location</TD><TD>human chr17q11.2-q12</TD><TD>4</TD><TD>2</TD><TD>26250</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>5.354e-06</TD><TD>-12.14</TD><TD>GSE2706_UNSTIM_VS_8H_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_R848_DC_DN</TD><TD>186</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2,IL6,C15orf48,G0S2</TD></TR>
<TR><TD>5.496e-06</TD><TD>-12.11</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP</TD><TD>187</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5,CCL8,IL6,CD83</TD></TR>
<TR><TD>5.723e-06</TD><TD>-12.07</TD><TD>GPCR ligand binding</TD><TD>REACTOME pathways</TD><TD>R-HSA-500792</TD><TD>444</TD><TD>7</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>5.727e-06</TD><TD>-12.07</TD><TD>KEGG_HEMATOPOIETIC_CELL_LINEAGE</TD><TD>MSigDB lists</TD><TD>KEGG_HEMATOPOIETIC_CELL_LINEAGE</TD><TD>85</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>5.788e-06</TD><TD>-12.06</TD><TD>GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN</TD><TD>189</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,PTGS2,CCL5,CD83</TD></TR>
<TR><TD>6.250e-06</TD><TD>-11.98</TD><TD>GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN</TD><TD>192</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,NFKBIZ,PTGS2,CXCL2,CXCL3</TD></TR>
<TR><TD>6.284e-06</TD><TD>-11.98</TD><TD>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</TD><TD>87</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>6.410e-06</TD><TD>-11.96</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>193</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL8,G0S2,MT1F,CD83</TD></TR>
<TR><TD>6.569e-06</TD><TD>-11.93</TD><TD>positive regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042327</TD><TD>1006</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>6.740e-06</TD><TD>-11.91</TD><TD>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</TD><TD>MSigDB lists</TD><TD>HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION</TD><TD>195</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MMP3,IL6,CXCL6,DKK1</TD></TR>
<TR><TD>6.910e-06</TD><TD>-11.88</TD><TD>GSE22886_CTRL_VS_LPS_24H_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_CTRL_VS_LPS_24H_DC_DN</TD><TD>196</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5,CCL20,G0S2,CD83</TD></TR>
<TR><TD>6.951e-06</TD><TD>-11.88</TD><TD>positive regulation of lymphocyte migration</TD><TD>biological process</TD><TD>GO:2000403</TD><TD>26</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20</TD></TR>
<TR><TD>6.951e-06</TD><TD>-11.88</TD><TD>positive regulation of acute inflammatory response</TD><TD>biological process</TD><TD>GO:0002675</TD><TD>26</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>7.050e-06</TD><TD>-11.86</TD><TD>MODULE_385</TD><TD>MSigDB lists</TD><TD>MODULE_385</TD><TD>27</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL8,CXCL6</TD></TR>
<TR><TD>7.084e-06</TD><TD>-11.86</TD><TD>GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN</TD><TD>MSigDB lists</TD><TD>GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN</TD><TD>197</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,NFKBIZ,PTGS2,CSF3,CXCL3</TD></TR>
<TR><TD>7.487e-06</TD><TD>-11.80</TD><TD>VCAN (versican)</TD><TD>protein interactions</TD><TD>1462</TD><TD>26</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5,CCL20,CCL8</TD></TR>
<TR><TD>7.695e-06</TD><TD>-11.77</TD><TD>regulation of leukocyte proliferation</TD><TD>biological process</TD><TD>GO:0070663</TD><TD>194</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>8.142e-06</TD><TD>-11.72</TD><TD>regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001932</TD><TD>1334</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>8.415e-06</TD><TD>-11.69</TD><TD>MMP3 (matrix metallopeptidase 3)</TD><TD>protein interactions</TD><TD>4314</TD><TD>27</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,MMP3,CCL8</TD></TR>
<TR><TD>8.791e-06</TD><TD>-11.64</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G2</TD><TD>MSigDB lists</TD><TD>DAZARD_UV_RESPONSE_CLUSTER_G2</TD><TD>29</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CCL20,CXCL3</TD></TR>
<TR><TD>9.069e-06</TD><TD>-11.61</TD><TD>regulation of MAPK cascade</TD><TD>biological process</TD><TD>GO:0043408</TD><TD>778</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>9.274e-06</TD><TD>-11.59</TD><TD>IL6GCSFMGF</TD><TD>prints domains</TD><TD>PR00433</TD><TD>2</TD><TD>2</TD><TD>4759</TD><TD>15</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>9.759e-06</TD><TD>-11.54</TD><TD>RODRIGUES_NTN1_AND_DCC_TARGETS</TD><TD>MSigDB lists</TD><TD>RODRIGUES_NTN1_AND_DCC_TARGETS</TD><TD>30</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,MT1F,ELF3</TD></TR>
<TR><TD>1.009e-05</TD><TD>-11.50</TD><TD>chr17q11</TD><TD>MSigDB lists</TD><TD>chr17q11</TD><TD>98</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,CCL5,CCL8</TD></TR>
<TR><TD>1.054e-05</TD><TD>-11.46</TD><TD>regulation of peptidyl-tyrosine phosphorylation</TD><TD>biological process</TD><TD>GO:0050730</TD><TD>207</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,CCL5,CSF2,IL6</TD></TR>
<TR><TD>1.079e-05</TD><TD>-11.44</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GROSS_ELK3_TARGETS_DN</TD><TD>31</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,IL6</TD></TR>
<TR><TD>1.113e-05</TD><TD>-11.41</TD><TD>positive regulation of cell proliferation</TD><TD>biological process</TD><TD>GO:0008284</TD><TD>800</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,PTGS2,CSF3,IL11,CCL5,CSF2,IL6,TNFSF13B</TD></TR>
<TR><TD>1.220e-05</TD><TD>-11.31</TD><TD>locomotion</TD><TD>biological process</TD><TD>GO:0040011</TD><TD>1396</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>1.229e-05</TD><TD>-11.31</TD><TD>LABBE_TGFB1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>LABBE_TGFB1_TARGETS_DN</TD><TD>103</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,CXCL6,ELF3</TD></TR>
<TR><TD>1.229e-05</TD><TD>-11.31</TD><TD>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</TD><TD>MSigDB lists</TD><TD>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</TD><TD>103</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,C15orf48,ELF3,DKK1</TD></TR>
<TR><TD>1.265e-05</TD><TD>-11.28</TD><TD>IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>IMMUNE_RESPONSE</TD><TD>222</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL5,CCL20,IL6,CD83</TD></TR>
<TR><TD>1.288e-05</TD><TD>-11.26</TD><TD>CCR1 (chemokine (C-C motif) receptor 1)</TD><TD>protein interactions</TD><TD>1230</TD><TD>31</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>1.308e-05</TD><TD>-11.24</TD><TD>SCHOEN_NFKB_SIGNALING</TD><TD>MSigDB lists</TD><TD>SCHOEN_NFKB_SIGNALING</TD><TD>33</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CSF2</TD></TR>
<TR><TD>1.308e-05</TD><TD>-11.24</TD><TD>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</TD><TD>33</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,IL6,CXCL6</TD></TR>
<TR><TD>1.308e-05</TD><TD>-11.24</TD><TD>DORN_ADENOVIRUS_INFECTION_12HR_DN</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_12HR_DN</TD><TD>33</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83,ELF3</TD></TR>
<TR><TD>1.331e-05</TD><TD>-11.23</TD><TD>regulation of signal transduction</TD><TD>biological process</TD><TD>GO:0009966</TD><TD>2548</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>1.464e-05</TD><TD>-11.13</TD><TD>regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042325</TD><TD>1425</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>1.506e-05</TD><TD>-11.10</TD><TD>FOSTER_TOLERANT_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>FOSTER_TOLERANT_MACROPHAGE_DN</TD><TD>398</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,PTGS2,CXCL3,IL6,CD83</TD></TR>
<TR><TD>1.528e-05</TD><TD>-11.09</TD><TD>CELL_CELL_SIGNALING</TD><TD>MSigDB lists</TD><TD>CELL_CELL_SIGNALING</TD><TD>399</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CCL5,CCL20,CCL8,CXCL6</TD></TR>
<TR><TD>1.585e-05</TD><TD>-11.05</TD><TD>Legionellosis</TD><TD>KEGG pathways</TD><TD>ko05134</TD><TD>55</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CXCL3,IL6</TD></TR>
<TR><TD>1.585e-05</TD><TD>-11.05</TD><TD>Legionellosis</TD><TD>KEGG pathways</TD><TD>hsa05134</TD><TD>55</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CXCL3,IL6</TD></TR>
<TR><TD>1.610e-05</TD><TD>-11.04</TD><TD>SMID_BREAST_CANCER_BASAL_UP</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_BASAL_UP</TD><TD>615</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,PTGS2,CCL5,CCL20,CCL8,DKK1</TD></TR>
<TR><TD>1.677e-05</TD><TD>-11.00</TD><TD>REACTOME_SIGNALING_BY_GPCR</TD><TD>MSigDB lists</TD><TD>REACTOME_SIGNALING_BY_GPCR</TD><TD>872</TD><TD>8</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,MMP3,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>1.707e-05</TD><TD>-10.98</TD><TD>GNF2_PTX3</TD><TD>MSigDB lists</TD><TD>GNF2_PTX3</TD><TD>36</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6,CXCL6</TD></TR>
<TR><TD>1.758e-05</TD><TD>-10.95</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</TD><TD>409</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL8,CXCL3,CD83,DKK1</TD></TR>
<TR><TD>1.785e-05</TD><TD>-10.93</TD><TD>positive regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0010562</TD><TD>1138</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>1.785e-05</TD><TD>-10.93</TD><TD>positive regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0045937</TD><TD>1138</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>1.791e-05</TD><TD>-10.93</TD><TD>regulation of response to external stimulus</TD><TD>biological process</TD><TD>GO:0032101</TD><TD>854</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,PTGS2,CXCL2,CCL5,CXCL3,IL6,CXCL6</TD></TR>
<TR><TD>1.829e-05</TD><TD>-10.91</TD><TD>NOD-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04621</TD><TD>57</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CCL5,IL6</TD></TR>
<TR><TD>1.829e-05</TD><TD>-10.91</TD><TD>NOD-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04621</TD><TD>57</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CXCL2,CCL5,IL6</TD></TR>
<TR><TD>1.856e-05</TD><TD>-10.89</TD><TD>AMIT_EGF_RESPONSE_60_MCF10A</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_60_MCF10A</TD><TD>37</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,IL6</TD></TR>
<TR><TD>1.875e-05</TD><TD>-10.88</TD><TD>G-protein coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007186</TD><TD>1145</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,GPR183,CCL20,CCL8,CXCL3,CXCL6,CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>1.894e-05</TD><TD>-10.87</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.20.1250.10</TD><TD>50</TD><TD>3</TD><TD>9988</TD><TD>11</TD>
<TD>CSF3,CSF2,IL6</TD></TR>
<TR><TD>1.901e-05</TD><TD>-10.87</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</TD><TD>MSigDB lists</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP</TD><TD>115</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,MMP3,G0S2</TD></TR>
<TR><TD>1.917e-05</TD><TD>-10.86</TD><TD>V$NFKAPPAB_01</TD><TD>MSigDB lists</TD><TD>V$NFKAPPAB_01</TD><TD>242</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL2,CCL5,CD83,CXCL6</TD></TR>
<TR><TD>2.056e-05</TD><TD>-10.79</TD><TD>lymphocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0048247</TD><TD>37</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL20,CCL8</TD></TR>
<TR><TD>2.104e-05</TD><TD>-10.77</TD><TD>response to stress</TD><TD>biological process</TD><TD>GO:0006950</TD><TD>3601</TD><TD>15</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,NFKBIZ,CXCL2,CCL5,CSF2,CD83,ELF3</TD></TR>
<TR><TD>2.126e-05</TD><TD>-10.76</TD><TD>SENESE_HDAC1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SENESE_HDAC1_TARGETS_UP</TD><TD>423</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CSF2,MMP3,CCL20,CXCL3,G0S2</TD></TR>
<TR><TD>2.230e-05</TD><TD>-10.71</TD><TD>regulation of lymphocyte migration</TD><TD>biological process</TD><TD>GO:2000401</TD><TD>38</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20</TD></TR>
<TR><TD>2.230e-05</TD><TD>-10.71</TD><TD>positive regulation of protein modification process</TD><TD>biological process</TD><TD>GO:0031401</TD><TD>1170</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>2.242e-05</TD><TD>-10.71</TD><TD>positive regulation of lymphocyte proliferation</TD><TD>biological process</TD><TD>GO:0050671</TD><TD>116</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>2.248e-05</TD><TD>-10.70</TD><TD>ZHU_CMV_ALL_UP</TD><TD>MSigDB lists</TD><TD>ZHU_CMV_ALL_UP</TD><TD>120</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.319e-05</TD><TD>-10.67</TD><TD>positive regulation of mononuclear cell proliferation</TD><TD>biological process</TD><TD>GO:0032946</TD><TD>117</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>2.460e-05</TD><TD>-10.61</TD><TD>multi-organism process</TD><TD>biological process</TD><TD>GO:0051704</TD><TD>2266</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL20,CCL8,CXCL3,IL6,CXCL6,CXCL1,CXCL2,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>2.479e-05</TD><TD>-10.61</TD><TD>regulation of peptidyl-serine phosphorylation</TD><TD>biological process</TD><TD>GO:0033135</TD><TD>119</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,IL6,DKK1</TD></TR>
<TR><TD>2.522e-05</TD><TD>-10.59</TD><TD>positive regulation of lymphocyte activation</TD><TD>biological process</TD><TD>GO:0051251</TD><TD>248</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>2.647e-05</TD><TD>-10.54</TD><TD>positive regulation of leukocyte proliferation</TD><TD>biological process</TD><TD>GO:0070665</TD><TD>121</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>2.652e-05</TD><TD>-10.54</TD><TD>growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0070851</TD><TD>127</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>2.729e-05</TD><TD>-10.51</TD><TD>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</TD><TD>MSigDB lists</TD><TD>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</TD><TD>42</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CCL20,IL6</TD></TR>
<TR><TD>2.782e-05</TD><TD>-10.49</TD><TD>CCR1 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031726</TD><TD>6</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>2.931e-05</TD><TD>-10.44</TD><TD>MANTOVANI_NFKB_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>MANTOVANI_NFKB_TARGETS_UP</TD><TD>43</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,NFKBIZ</TD></TR>
<TR><TD>3.052e-05</TD><TD>-10.40</TD><TD>positive regulation of natural killer cell chemotaxis</TD><TD>biological process</TD><TD>GO:2000503</TD><TD>6</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>3.079e-05</TD><TD>-10.39</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN</TD><TD>130</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CXCL3</TD></TR>
<TR><TD>3.182e-05</TD><TD>-10.36</TD><TD>extracellular region part</TD><TD>cellular component</TD><TD>GO:0044421</TD><TD>3764</TD><TD>15</TD><TD>17570</TD><TD>25</TD>
<TD>CCL7,CSF3,IL11,MMP3,CCL20,CCL8,CXCL3,IL6,CXCL6,TNFSF13B,CXCL1,CXCL2,CCL5,CSF2,DKK1</TD></TR>
<TR><TD>3.201e-05</TD><TD>-10.35</TD><TD>cellular response to interferon-gamma</TD><TD>biological process</TD><TD>GO:0071346</TD><TD>127</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>3.267e-05</TD><TD>-10.33</TD><TD>cellular response to oxygen-containing compound</TD><TD>biological process</TD><TD>GO:1901701</TD><TD>928</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,CCL5,MMP3,CSF2,CCL20,IL6</TD></TR>
<TR><TD>3.267e-05</TD><TD>-10.33</TD><TD>SIGNAL_TRANSDUCTION</TD><TD>MSigDB lists</TD><TD>SIGNAL_TRANSDUCTION</TD><TD>1606</TD><TD>10</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,CCL20,CCL8,IL6,CXCL6,TNFSF13B,CXCL1,CCL5,CD83</TD></TR>
<TR><TD>3.359e-05</TD><TD>-10.30</TD><TD>WALLACE_PROSTATE_CANCER_RACE_UP</TD><TD>MSigDB lists</TD><TD>WALLACE_PROSTATE_CANCER_RACE_UP</TD><TD>272</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PIM2,CCL5,CCL8,CD83</TD></TR>
<TR><TD>3.506e-05</TD><TD>-10.26</TD><TD>WONG_ADULT_TISSUE_STEM_MODULE</TD><TD>MSigDB lists</TD><TD>WONG_ADULT_TISSUE_STEM_MODULE</TD><TD>694</TD><TD>7</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,NFKBIZ,PTGS2,CXCL2,CSF2,CCL5,IL6</TD></TR>
<TR><TD>3.570e-05</TD><TD>-10.24</TD><TD>MEL18_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>MEL18_DN.V1_UP</TD><TD>135</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF2,MT1F,CD83</TD></TR>
<TR><TD>4.011e-05</TD><TD>-10.12</TD><TD>CCR5 (chemokine (C-C motif) receptor 5 (gene/pseudogene))</TD><TD>protein interactions</TD><TD>1234</TD><TD>45</TD><TD>3</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.064e-05</TD><TD>-10.11</TD><TD>positive regulation of leukocyte activation</TD><TD>biological process</TD><TD>GO:0002696</TD><TD>274</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>4.144e-05</TD><TD>-10.09</TD><TD>cellular response to stimulus</TD><TD>biological process</TD><TD>GO:0051716</TD><TD>6201</TD><TD>19</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,MT1F</TD></TR>
<TR><TD>4.236e-05</TD><TD>-10.07</TD><TD>4_helix_cytokine_core</TD><TD>interpro domains</TD><TD>IPR012351</TD><TD>50</TD><TD>3</TD><TD>18293</TD><TD>25</TD>
<TD>CSF3,CSF2,IL6</TD></TR>
<TR><TD>4.351e-05</TD><TD>-10.04</TD><TD>MODULE_223</TD><TD>MSigDB lists</TD><TD>MODULE_223</TD><TD>142</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,IL6,CD83</TD></TR>
<TR><TD>4.351e-05</TD><TD>-10.04</TD><TD>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN</TD><TD>MSigDB lists</TD><TD>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN</TD><TD>49</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL6</TD></TR>
<TR><TD>4.624e-05</TD><TD>-9.98</TD><TD>BURTON_ADIPOGENESIS_PEAK_AT_2HR</TD><TD>MSigDB lists</TD><TD>BURTON_ADIPOGENESIS_PEAK_AT_2HR</TD><TD>50</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,IL6</TD></TR>
<TR><TD>4.740e-05</TD><TD>-9.96</TD><TD>positive regulation of cell activation</TD><TD>biological process</TD><TD>GO:0050867</TD><TD>283</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>4.818e-05</TD><TD>-9.94</TD><TD>lymphocyte migration</TD><TD>biological process</TD><TD>GO:0072676</TD><TD>49</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL20,CCL8</TD></TR>
<TR><TD>4.975e-05</TD><TD>-9.91</TD><TD>extracellular region</TD><TD>cellular component</TD><TD>GO:0005576</TD><TD>4445</TD><TD>16</TD><TD>17570</TD><TD>25</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,IL4I1,CXCL2,CCL5,CSF2,DKK1,CSF3,MMP3,IL6,CCL8,CXCL1</TD></TR>
<TR><TD>5.114e-05</TD><TD>-9.88</TD><TD>POSITIVE_REGULATION_OF_CELL_PROLIFERATION</TD><TD>MSigDB lists</TD><TD>POSITIVE_REGULATION_OF_CELL_PROLIFERATION</TD><TD>148</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,IL6,TNFSF13B</TD></TR>
<TR><TD>5.205e-05</TD><TD>-9.86</TD><TD>ZHENG_IL22_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>ZHENG_IL22_SIGNALING_UP</TD><TD>52</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CXCL3,CXCL6</TD></TR>
<TR><TD>5.205e-05</TD><TD>-9.86</TD><TD>ZHOU_TNF_SIGNALING_30MIN</TD><TD>MSigDB lists</TD><TD>ZHOU_TNF_SIGNALING_30MIN</TD><TD>52</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,IL6</TD></TR>
<TR><TD>5.278e-05</TD><TD>-9.85</TD><TD>regulation of signaling</TD><TD>biological process</TD><TD>GO:0023051</TD><TD>2886</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>5.368e-05</TD><TD>-9.83</TD><TD>ENK_UV_RESPONSE_EPIDERMIS_DN</TD><TD>MSigDB lists</TD><TD>ENK_UV_RESPONSE_EPIDERMIS_DN</TD><TD>499</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CXCL2,MMP3,CCL20,CD83</TD></TR>
<TR><TD>5.368e-05</TD><TD>-9.83</TD><TD>RESPONSE_TO_STRESS</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_STRESS</TD><TD>499</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL6,ELF3</TD></TR>
<TR><TD>5.388e-05</TD><TD>-9.83</TD><TD>KEGG_JAK_STAT_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_JAK_STAT_SIGNALING_PATHWAY</TD><TD>150</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,CSF2,IL6</TD></TR>
<TR><TD>5.428e-05</TD><TD>-9.82</TD><TD>CELL_PROLIFERATION_GO_0008283</TD><TD>MSigDB lists</TD><TD>CELL_PROLIFERATION_GO_0008283</TD><TD>500</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CSF3,PIM2,IL6,TNFSF13B</TD></TR>
<TR><TD>5.436e-05</TD><TD>-9.82</TD><TD>positive regulation of smooth muscle cell proliferation</TD><TD>biological process</TD><TD>GO:0048661</TD><TD>51</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>5.529e-05</TD><TD>-9.80</TD><TD>REGULATION_OF_CELL_PROLIFERATION</TD><TD>MSigDB lists</TD><TD>REGULATION_OF_CELL_PROLIFERATION</TD><TD>302</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,IL11,IL6,TNFSF13B</TD></TR>
<TR><TD>5.640e-05</TD><TD>-9.78</TD><TD>heparin binding</TD><TD>molecular function</TD><TD>GO:0008201</TD><TD>154</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CCL5,CCL8,CXCL6</TD></TR>
<TR><TD>5.671e-05</TD><TD>-9.78</TD><TD>response to interferon-gamma</TD><TD>biological process</TD><TD>GO:0034341</TD><TD>147</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>5.674e-05</TD><TD>-9.78</TD><TD>MYC_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>MYC_UP.V1_DN</TD><TD>152</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CCL20,CXCL3,IL6</TD></TR>
<TR><TD>5.683e-05</TD><TD>-9.78</TD><TD>response to acid chemical</TD><TD>biological process</TD><TD>GO:0001101</TD><TD>294</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,IL6,DKK1</TD></TR>
<TR><TD>5.688e-05</TD><TD>-9.77</TD><TD>positive regulation of fever generation</TD><TD>biological process</TD><TD>GO:0031622</TD><TD>8</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>5.688e-05</TD><TD>-9.77</TD><TD>regulation of fever generation</TD><TD>biological process</TD><TD>GO:0031620</TD><TD>8</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>5.714e-05</TD><TD>-9.77</TD><TD>human chr19q13.3-q13.4</TD><TD>chromosome location</TD><TD>human chr19q13.3-q13.4</TD><TD>12</TD><TD>2</TD><TD>26250</TD><TD>25</TD>
<TD>IL4I1,IL11</TD></TR>
<TR><TD>5.824e-05</TD><TD>-9.75</TD><TD>regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0019220</TD><TD>1669</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>6.059e-05</TD><TD>-9.71</TD><TD>leukocyte differentiation</TD><TD>biological process</TD><TD>GO:0002521</TD><TD>298</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>6.161e-05</TD><TD>-9.69</TD><TD>GROWTH_FACTOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GROWTH_FACTOR_ACTIVITY</TD><TD>55</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2,DKK1</TD></TR>
<TR><TD>6.161e-05</TD><TD>-9.69</TD><TD>WIERENGA_STAT5A_TARGETS_GROUP2</TD><TD>MSigDB lists</TD><TD>WIERENGA_STAT5A_TARGETS_GROUP2</TD><TD>55</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CCL5,CD83</TD></TR>
<TR><TD>6.227e-05</TD><TD>-9.68</TD><TD>regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0051174</TD><TD>1682</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>6.247e-05</TD><TD>-9.68</TD><TD>regulation of cell communication</TD><TD>biological process</TD><TD>GO:0010646</TD><TD>2931</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,G0S2,IL6,PIM2,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>6.278e-05</TD><TD>-9.68</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</TD><TD>156</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6,MT1F,DKK1</TD></TR>
<TR><TD>6.456e-05</TD><TD>-9.65</TD><TD>positive regulation of tyrosine phosphorylation of STAT protein</TD><TD>biological process</TD><TD>GO:0042531</TD><TD>54</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>6.504e-05</TD><TD>-9.64</TD><TD>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</TD><TD>MSigDB lists</TD><TD>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</TD><TD>56</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL5,CXCL6</TD></TR>
<TR><TD>6.752e-05</TD><TD>-9.60</TD><TD>IMMUNE_SYSTEM_PROCESS</TD><TD>MSigDB lists</TD><TD>IMMUNE_SYSTEM_PROCESS</TD><TD>315</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL5,CCL20,IL6,CD83</TD></TR>
<TR><TD>6.809e-05</TD><TD>-9.59</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</TD><TD>MSigDB lists</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN</TD><TD>9</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,IL6</TD></TR>
<TR><TD>6.858e-05</TD><TD>-9.59</TD><TD>regulation of protein modification process</TD><TD>biological process</TD><TD>GO:0031399</TD><TD>1701</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>6.859e-05</TD><TD>-9.59</TD><TD>DASU_IL6_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>DASU_IL6_SIGNALING_UP</TD><TD>57</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CXCL3,IL6</TD></TR>
<TR><TD>7.270e-05</TD><TD>-9.53</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</TD><TD>MSigDB lists</TD><TD>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</TD><TD>162</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL20,C15orf48,TNFSF13B</TD></TR>
<TR><TD>7.306e-05</TD><TD>-9.52</TD><TD>regulation of natural killer cell chemotaxis</TD><TD>biological process</TD><TD>GO:2000501</TD><TD>9</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>7.446e-05</TD><TD>-9.51</TD><TD>WNT_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>WNT_UP.V1_DN</TD><TD>163</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,PIM2,MMP3,G0S2</TD></TR>
<TR><TD>7.606e-05</TD><TD>-9.48</TD><TD>BROWNE_HCMV_INFECTION_1HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_1HR_UP</TD><TD>59</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,IL6</TD></TR>
<TR><TD>7.625e-05</TD><TD>-9.48</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN</TD><TD>164</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2,CCL5,CCL8</TD></TR>
<TR><TD>7.828e-05</TD><TD>-9.46</TD><TD>MODULE_220</TD><TD>MSigDB lists</TD><TD>MODULE_220</TD><TD>325</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,IL11,IL6,ELF3</TD></TR>
<TR><TD>7.919e-05</TD><TD>-9.44</TD><TD>Signaling by GPCR</TD><TD>REACTOME pathways</TD><TD>R-HSA-372790</TD><TD>1230</TD><TD>9</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,MMP3,CCL20,CXCL3,CXCL6,CXCL1,CXCL2,CSF2,CCL5</TD></TR>
<TR><TD>8.180e-05</TD><TD>-9.41</TD><TD>GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>167</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,G0S2,CD83</TD></TR>
<TR><TD>8.317e-05</TD><TD>-9.39</TD><TD>receptor antagonist activity</TD><TD>molecular function</TD><TD>GO:0048019</TD><TD>10</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>8.475e-05</TD><TD>-9.38</TD><TD>positive regulation of hemopoiesis</TD><TD>biological process</TD><TD>GO:1903708</TD><TD>163</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,IL6,CD83</TD></TR>
<TR><TD>8.504e-05</TD><TD>-9.37</TD><TD>JU_AGING_TERC_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>JU_AGING_TERC_TARGETS_UP</TD><TD>10</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CXCL6</TD></TR>
<TR><TD>8.504e-05</TD><TD>-9.37</TD><TD>AUJLA_IL22_AND_IL17A_SIGNALING</TD><TD>MSigDB lists</TD><TD>AUJLA_IL22_AND_IL17A_SIGNALING</TD><TD>10</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3</TD></TR>
<TR><TD>8.567e-05</TD><TD>-9.37</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN</TD><TD>169</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,PIM2,CCL20,TNFSF13B</TD></TR>
<TR><TD>8.765e-05</TD><TD>-9.34</TD><TD>GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN</TD><TD>170</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2,CSF2,G0S2</TD></TR>
<TR><TD>9.065e-05</TD><TD>-9.31</TD><TD>single organism signaling</TD><TD>biological process</TD><TD>GO:0044700</TD><TD>5196</TD><TD>17</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,CD83,DKK1,GPR183,CSF3,IL6,CCL8,G0S2,CXCL1</TD></TR>
<TR><TD>9.125e-05</TD><TD>-9.30</TD><TD>cellular response to ethanol</TD><TD>biological process</TD><TD>GO:0071361</TD><TD>10</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>9.139e-05</TD><TD>-9.30</TD><TD>signaling</TD><TD>biological process</TD><TD>GO:0023052</TD><TD>5199</TD><TD>17</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,GPR183,CSF3,CCL8,IL6,G0S2,CXCL1</TD></TR>
<TR><TD>9.305e-05</TD><TD>-9.28</TD><TD>regulation of tyrosine phosphorylation of STAT protein</TD><TD>biological process</TD><TD>GO:0042509</TD><TD>61</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>9.703e-05</TD><TD>-9.24</TD><TD>DIRMEIER_LMP1_RESPONSE_EARLY</TD><TD>MSigDB lists</TD><TD>DIRMEIER_LMP1_RESPONSE_EARLY</TD><TD>64</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,NFKBIZ,CD83</TD></TR>
<TR><TD>9.749e-05</TD><TD>-9.24</TD><TD>Hematopoietic cell lineage</TD><TD>KEGG pathways</TD><TD>hsa04640</TD><TD>87</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>9.749e-05</TD><TD>-9.24</TD><TD>Hematopoietic cell lineage</TD><TD>KEGG pathways</TD><TD>ko04640</TD><TD>87</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>1.016e-04</TD><TD>-9.19</TD><TD>phospholipase activator activity</TD><TD>molecular function</TD><TD>GO:0016004</TD><TD>11</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.016e-04</TD><TD>-9.19</TD><TD>receptor inhibitor activity</TD><TD>molecular function</TD><TD>GO:0030547</TD><TD>11</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>1.019e-04</TD><TD>-9.19</TD><TD>positive regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045597</TD><TD>796</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,CSF2,IL6,DKK1,CD83</TD></TR>
<TR><TD>1.047e-04</TD><TD>-9.16</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN</TD><TD>178</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,PTGS2,IL6</TD></TR>
<TR><TD>1.088e-04</TD><TD>-9.13</TD><TD>positive regulation of cellular protein metabolic process</TD><TD>biological process</TD><TD>GO:0032270</TD><TD>1430</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>1.114e-04</TD><TD>-9.10</TD><TD>positive regulation of heat generation</TD><TD>biological process</TD><TD>GO:0031652</TD><TD>11</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>1.117e-04</TD><TD>-9.10</TD><TD>GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN</TD><TD>MSigDB lists</TD><TD>GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN</TD><TD>181</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,G0S2</TD></TR>
<TR><TD>1.141e-04</TD><TD>-9.08</TD><TD>GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP</TD><TD>182</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,IL6,CD83</TD></TR>
<TR><TD>1.141e-04</TD><TD>-9.08</TD><TD>GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP</TD><TD>182</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,CXCL2,IL6</TD></TR>
<TR><TD>1.152e-04</TD><TD>-9.07</TD><TD>positive regulation of developmental process</TD><TD>biological process</TD><TD>GO:0051094</TD><TD>1108</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6,TNFSF13B,CSF2,CCL5,CD83,DKK1</TD></TR>
<TR><TD>1.155e-04</TD><TD>-9.07</TD><TD>WANG_SMARCE1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>WANG_SMARCE1_TARGETS_DN</TD><TD>353</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,C15orf48,CXCL6</TD></TR>
<TR><TD>1.160e-04</TD><TD>-9.06</TD><TD>cell communication</TD><TD>biological process</TD><TD>GO:0007154</TD><TD>5288</TD><TD>17</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,CD83,DKK1,GPR183,CSF3,IL6,CCL8,G0S2,CXCL1</TD></TR>
<TR><TD>1.171e-04</TD><TD>-9.05</TD><TD>CCR2 (chemokine (C-C motif) receptor 2)</TD><TD>protein interactions</TD><TD>729230</TD><TD>11</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,CCL8</TD></TR>
<TR><TD>1.177e-04</TD><TD>-9.05</TD><TD>positive regulation of B cell activation</TD><TD>biological process</TD><TD>GO:0050871</TD><TD>66</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6,TNFSF13B</TD></TR>
<TR><TD>1.190e-04</TD><TD>-9.04</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>184</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>1.215e-04</TD><TD>-9.02</TD><TD>GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP</TD><TD>185</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL1,NFKBIZ,CSF3</TD></TR>
<TR><TD>1.231e-04</TD><TD>-9.00</TD><TD>regulation of acute inflammatory response</TD><TD>biological process</TD><TD>GO:0002673</TD><TD>67</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.231e-04</TD><TD>-9.00</TD><TD>positive regulation of JAK-STAT cascade</TD><TD>biological process</TD><TD>GO:0046427</TD><TD>67</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>1.267e-04</TD><TD>-8.97</TD><TD>GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN</TD><TD>187</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF2,CCL20,CXCL3</TD></TR>
<TR><TD>1.268e-04</TD><TD>-8.97</TD><TD>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</TD><TD>MSigDB lists</TD><TD>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</TD><TD>70</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CXCL6</TD></TR>
<TR><TD>1.320e-04</TD><TD>-8.93</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDM_UP</TD><TD>189</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL2,IL6,CD83</TD></TR>
<TR><TD>1.320e-04</TD><TD>-8.93</TD><TD>human chr1q32.2</TD><TD>chromosome location</TD><TD>human chr1q32.2</TD><TD>18</TD><TD>2</TD><TD>26250</TD><TD>25</TD>
<TD>G0S2,ELF3</TD></TR>
<TR><TD>1.322e-04</TD><TD>-8.93</TD><TD>MODULE_154</TD><TD>MSigDB lists</TD><TD>MODULE_154</TD><TD>71</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF2</TD></TR>
<TR><TD>1.336e-04</TD><TD>-8.92</TD><TD>regulation of heat generation</TD><TD>biological process</TD><TD>GO:0031650</TD><TD>12</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>1.347e-04</TD><TD>-8.91</TD><TD>GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP</TD><TD>190</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL1,NFKBIZ,TNFSF13B</TD></TR>
<TR><TD>1.374e-04</TD><TD>-8.89</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>191</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8,G0S2,CD83</TD></TR>
<TR><TD>1.402e-04</TD><TD>-8.87</TD><TD>GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_2H_BMDM_UP</TD><TD>192</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,CSF2,IL6</TD></TR>
<TR><TD>1.412e-04</TD><TD>-8.87</TD><TD>regulation of lymphocyte proliferation</TD><TD>biological process</TD><TD>GO:0050670</TD><TD>186</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>1.431e-04</TD><TD>-8.85</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDM_UP</TD><TD>193</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,NFKBIZ,CXCL2,IL6</TD></TR>
<TR><TD>1.431e-04</TD><TD>-8.85</TD><TD>GSE360_CTRL_VS_T_GONDII_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_T_GONDII_MAC_DN</TD><TD>193</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,G0S2,CXCL3,CD83</TD></TR>
<TR><TD>1.438e-04</TD><TD>-8.85</TD><TD>lipase activator activity</TD><TD>molecular function</TD><TD>GO:0060229</TD><TD>13</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.441e-04</TD><TD>-8.84</TD><TD>regulation of mononuclear cell proliferation</TD><TD>biological process</TD><TD>GO:0032944</TD><TD>187</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>1.489e-04</TD><TD>-8.81</TD><TD>GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>195</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF2,G0S2,CD83</TD></TR>
<TR><TD>1.489e-04</TD><TD>-8.81</TD><TD>HALLMARK_KRAS_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>HALLMARK_KRAS_SIGNALING_UP</TD><TD>195</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF2,CCL20,G0S2</TD></TR>
<TR><TD>1.518e-04</TD><TD>-8.79</TD><TD>GSE7460_TCONV_VS_TREG_LN_DN</TD><TD>MSigDB lists</TD><TD>GSE7460_TCONV_VS_TREG_LN_DN</TD><TD>196</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,CXCL3,CD83</TD></TR>
<TR><TD>1.518e-04</TD><TD>-8.79</TD><TD>PLASARI_TGFB1_TARGETS_10HR_UP</TD><TD>MSigDB lists</TD><TD>PLASARI_TGFB1_TARGETS_10HR_UP</TD><TD>196</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CCL20,IL6</TD></TR>
<TR><TD>1.548e-04</TD><TD>-8.77</TD><TD>GSE20715_0H_VS_48H_OZONE_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE20715_0H_VS_48H_OZONE_LUNG_DN</TD><TD>197</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,MMP3,IL6,ELF3</TD></TR>
<TR><TD>1.558e-04</TD><TD>-8.77</TD><TD>regulation of cell death</TD><TD>biological process</TD><TD>GO:0010941</TD><TD>1498</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,MMP3,G0S2,IL6,PIM2,CSF2,CCL5</TD></TR>
<TR><TD>1.582e-04</TD><TD>-8.75</TD><TD>glycosaminoglycan binding</TD><TD>molecular function</TD><TD>GO:0005539</TD><TD>201</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CCL5,CCL8,CXCL6</TD></TR>
<TR><TD>1.595e-04</TD><TD>-8.74</TD><TD>positive regulation of T cell activation</TD><TD>biological process</TD><TD>GO:0050870</TD><TD>192</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.595e-04</TD><TD>-8.74</TD><TD>cellular response to lipid</TD><TD>biological process</TD><TD>GO:0071396</TD><TD>366</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,CSF2,CCL20,IL6</TD></TR>
<TR><TD>1.609e-04</TD><TD>-8.73</TD><TD>HALLMARK_INTERFERON_GAMMA_RESPONSE</TD><TD>MSigDB lists</TD><TD>HALLMARK_INTERFERON_GAMMA_RESPONSE</TD><TD>199</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.611e-04</TD><TD>-8.73</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HAN_SATB1_TARGETS_UP</TD><TD>379</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,MMP3,IL6,G0S2</TD></TR>
<TR><TD>1.619e-04</TD><TD>-8.73</TD><TD>MODULE_357</TD><TD>MSigDB lists</TD><TD>MODULE_357</TD><TD>76</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF2</TD></TR>
<TR><TD>1.619e-04</TD><TD>-8.73</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>MSigDB lists</TD><TD>LINDVALL_IMMORTALIZED_BY_TERT_DN</TD><TD>76</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MMP3,IL6</TD></TR>
<TR><TD>1.619e-04</TD><TD>-8.73</TD><TD>MODULE_297</TD><TD>MSigDB lists</TD><TD>MODULE_297</TD><TD>76</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CSF2</TD></TR>
<TR><TD>1.641e-04</TD><TD>-8.72</TD><TD>WIERENGA_STAT5A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>WIERENGA_STAT5A_TARGETS_UP</TD><TD>200</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CSF2,CCL5,CD83</TD></TR>
<TR><TD>1.641e-04</TD><TD>-8.72</TD><TD>HALLMARK_ALLOGRAFT_REJECTION</TD><TD>MSigDB lists</TD><TD>HALLMARK_ALLOGRAFT_REJECTION</TD><TD>200</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CCL5,IL6</TD></TR>
<TR><TD>1.644e-04</TD><TD>-8.71</TD><TD>signal transduction</TD><TD>biological process</TD><TD>GO:0007165</TD><TD>4816</TD><TD>16</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,CD83,DKK1,GPR183,CSF3,IL6,CCL8,G0S2,CXCL1</TD></TR>
<TR><TD>1.657e-04</TD><TD>-8.71</TD><TD>regulation of lymphocyte activation</TD><TD>biological process</TD><TD>GO:0051249</TD><TD>369</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.714e-04</TD><TD>-8.67</TD><TD>WU_HBX_TARGETS_1_UP</TD><TD>MSigDB lists</TD><TD>WU_HBX_TARGETS_1_UP</TD><TD>14</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>1.714e-04</TD><TD>-8.67</TD><TD>BIOCARTA_IL17_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_IL17_PATHWAY</TD><TD>14</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.727e-04</TD><TD>-8.66</TD><TD>positive regulation of homotypic cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0034112</TD><TD>196</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.749e-04</TD><TD>-8.65</TD><TD>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</TD><TD>MSigDB lists</TD><TD>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</TD><TD>78</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6,CXCL6</TD></TR>
<TR><TD>1.749e-04</TD><TD>-8.65</TD><TD>ONDER_CDH1_SIGNALING_VIA_CTNNB1</TD><TD>MSigDB lists</TD><TD>ONDER_CDH1_SIGNALING_VIA_CTNNB1</TD><TD>78</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CD83</TD></TR>
<TR><TD>1.761e-04</TD><TD>-8.64</TD><TD>positive regulation of leukocyte cell-cell adhesion</TD><TD>biological process</TD><TD>GO:1903039</TD><TD>197</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.770e-04</TD><TD>-8.64</TD><TD>positive regulation of protein metabolic process</TD><TD>biological process</TD><TD>GO:0051247</TD><TD>1523</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5</TD></TR>
<TR><TD>1.787e-04</TD><TD>-8.63</TD><TD>positive regulation of cytokine production</TD><TD>biological process</TD><TD>GO:0001819</TD><TD>375</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF2,CCL20,IL6,CD83</TD></TR>
<TR><TD>1.907e-04</TD><TD>-8.56</TD><TD>MARKEY_RB1_ACUTE_LOF_UP</TD><TD>MSigDB lists</TD><TD>MARKEY_RB1_ACUTE_LOF_UP</TD><TD>208</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL2,MMP3,CCL5</TD></TR>
<TR><TD>1.956e-04</TD><TD>-8.54</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</TD><TD>81</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL20,CCL8</TD></TR>
<TR><TD>2.047e-04</TD><TD>-8.49</TD><TD>MODULE_6</TD><TD>MSigDB lists</TD><TD>MODULE_6</TD><TD>399</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CCL5,G0S2,ELF3</TD></TR>
<TR><TD>2.178e-04</TD><TD>-8.43</TD><TD>MODULE_375</TD><TD>MSigDB lists</TD><TD>MODULE_375</TD><TD>84</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,CXCL2</TD></TR>
<TR><TD>2.178e-04</TD><TD>-8.43</TD><TD>MANTOVANI_VIRAL_GPCR_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>MANTOVANI_VIRAL_GPCR_SIGNALING_UP</TD><TD>84</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,NFKBIZ</TD></TR>
<TR><TD>2.256e-04</TD><TD>-8.40</TD><TD>LEE_LIVER_CANCER_HEPATOBLAST</TD><TD>MSigDB lists</TD><TD>LEE_LIVER_CANCER_HEPATOBLAST</TD><TD>16</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>2.256e-04</TD><TD>-8.40</TD><TD>BAKER_HEMATOPOIESIS_STAT3_TARGETS</TD><TD>MSigDB lists</TD><TD>BAKER_HEMATOPOIESIS_STAT3_TARGETS</TD><TD>16</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,IL6</TD></TR>
<TR><TD>2.409e-04</TD><TD>-8.33</TD><TD>cell-cell signaling</TD><TD>biological process</TD><TD>GO:0007267</TD><TD>914</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL5,CCL20,CCL8,IL6,CXCL6</TD></TR>
<TR><TD>2.496e-04</TD><TD>-8.30</TD><TD>regulation of smooth muscle cell proliferation</TD><TD>biological process</TD><TD>GO:0048660</TD><TD>85</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.496e-04</TD><TD>-8.30</TD><TD>positive regulation of T cell proliferation</TD><TD>biological process</TD><TD>GO:0042102</TD><TD>85</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>2.575e-04</TD><TD>-8.26</TD><TD>MODULE_176</TD><TD>MSigDB lists</TD><TD>MODULE_176</TD><TD>225</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,MMP3,CCL20,CXCL3</TD></TR>
<TR><TD>2.584e-04</TD><TD>-8.26</TD><TD>BURTON_ADIPOGENESIS_9</TD><TD>MSigDB lists</TD><TD>BURTON_ADIPOGENESIS_9</TD><TD>89</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,PTGS2</TD></TR>
<TR><TD>2.586e-04</TD><TD>-8.26</TD><TD>positive regulation of cellular metabolic process</TD><TD>biological process</TD><TD>GO:0031325</TD><TD>2864</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,IL6,PIM2,CSF2,CCL5,ELF3</TD></TR>
<TR><TD>2.606e-04</TD><TD>-8.25</TD><TD>sulfur compound binding</TD><TD>molecular function</TD><TD>GO:1901681</TD><TD>229</TD><TD>4</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,CCL5,CCL8,CXCL6</TD></TR>
<TR><TD>2.743e-04</TD><TD>-8.20</TD><TD>MODULE_5</TD><TD>MSigDB lists</TD><TD>MODULE_5</TD><TD>425</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,G0S2,IL6</TD></TR>
<TR><TD>2.765e-04</TD><TD>-8.19</TD><TD>regulation of JAK-STAT cascade</TD><TD>biological process</TD><TD>GO:0046425</TD><TD>88</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>2.847e-04</TD><TD>-8.16</TD><TD>WINTER_HYPOXIA_METAGENE</TD><TD>MSigDB lists</TD><TD>WINTER_HYPOXIA_METAGENE</TD><TD>231</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,PIM2,IL6,ELF3</TD></TR>
<TR><TD>2.850e-04</TD><TD>-8.16</TD><TD>LU_IL4_SIGNALING</TD><TD>MSigDB lists</TD><TD>LU_IL4_SIGNALING</TD><TD>92</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL5,IL6</TD></TR>
<TR><TD>2.871e-04</TD><TD>-8.16</TD><TD>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP</TD><TD>MSigDB lists</TD><TD>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP</TD><TD>18</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1</TD></TR>
<TR><TD>2.871e-04</TD><TD>-8.16</TD><TD>KOBAYASHI_EGFR_SIGNALING_6HR_DN</TD><TD>MSigDB lists</TD><TD>KOBAYASHI_EGFR_SIGNALING_6HR_DN</TD><TD>18</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,G0S2</TD></TR>
<TR><TD>2.895e-04</TD><TD>-8.15</TD><TD>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</TD><TD>MSigDB lists</TD><TD>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</TD><TD>430</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CXCL2,CXCL3,MT1F</TD></TR>
<TR><TD>2.990e-04</TD><TD>-8.12</TD><TD>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</TD><TD>MSigDB lists</TD><TD>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</TD><TD>234</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,MMP3,CXCL3,IL6</TD></TR>
<TR><TD>3.089e-04</TD><TD>-8.08</TD><TD>V$IRF1_01</TD><TD>MSigDB lists</TD><TD>V$IRF1_01</TD><TD>236</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>3.089e-04</TD><TD>-8.08</TD><TD>GAL_LEUKEMIC_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>GAL_LEUKEMIC_STEM_CELL_DN</TD><TD>236</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5,CSF2,G0S2</TD></TR>
<TR><TD>3.152e-04</TD><TD>-8.06</TD><TD>cellular response to alcohol</TD><TD>biological process</TD><TD>GO:0097306</TD><TD>92</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,IL6</TD></TR>
<TR><TD>3.152e-04</TD><TD>-8.06</TD><TD>positive regulation of peptidyl-serine phosphorylation</TD><TD>biological process</TD><TD>GO:0033138</TD><TD>92</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,IL6</TD></TR>
<TR><TD>3.206e-04</TD><TD>-8.05</TD><TD>RASHI_NFKB1_TARGETS</TD><TD>MSigDB lists</TD><TD>RASHI_NFKB1_TARGETS</TD><TD>19</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2</TD></TR>
<TR><TD>3.206e-04</TD><TD>-8.05</TD><TD>AMUNDSON_GAMMA_RADIATION_RESISTANCE</TD><TD>MSigDB lists</TD><TD>AMUNDSON_GAMMA_RADIATION_RESISTANCE</TD><TD>19</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,TNFSF13B</TD></TR>
<TR><TD>3.230e-04</TD><TD>-8.04</TD><TD>BROWNE_HCMV_INFECTION_10HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_10HR_UP</TD><TD>96</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8,IL6</TD></TR>
<TR><TD>3.237e-04</TD><TD>-8.04</TD><TD>CCL7 (chemokine (C-C motif) ligand 7)</TD><TD>protein interactions</TD><TD>6354</TD><TD>18</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7,MMP3</TD></TR>
<TR><TD>3.262e-04</TD><TD>-8.03</TD><TD>leukocyte activation</TD><TD>biological process</TD><TD>GO:0045321</TD><TD>427</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11,CCL5,CSF2,IL6</TD></TR>
<TR><TD>3.288e-04</TD><TD>-8.02</TD><TD>positive regulation of cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0022409</TD><TD>232</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>3.292e-04</TD><TD>-8.02</TD><TD>MODULE_123</TD><TD>MSigDB lists</TD><TD>MODULE_123</TD><TD>240</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,CXCL2,ELF3</TD></TR>
<TR><TD>3.297e-04</TD><TD>-8.02</TD><TD>regulation of leukocyte activation</TD><TD>biological process</TD><TD>GO:0002694</TD><TD>428</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>3.322e-04</TD><TD>-8.01</TD><TD>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</TD><TD>MSigDB lists</TD><TD>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</TD><TD>443</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CXCL2,IL6,G0S2</TD></TR>
<TR><TD>3.358e-04</TD><TD>-8.00</TD><TD>positive regulation of protein import into nucleus</TD><TD>biological process</TD><TD>GO:0042307</TD><TD>94</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>3.391e-04</TD><TD>-7.99</TD><TD>RODWELL_AGING_KIDNEY_UP</TD><TD>MSigDB lists</TD><TD>RODWELL_AGING_KIDNEY_UP</TD><TD>445</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CXCL1,NFKBIZ,CCL5,C15orf48</TD></TR>
<TR><TD>3.432e-04</TD><TD>-7.98</TD><TD>MODULE_121</TD><TD>MSigDB lists</TD><TD>MODULE_121</TD><TD>98</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,IL6</TD></TR>
<TR><TD>3.572e-04</TD><TD>-7.94</TD><TD>positive regulation of protein import</TD><TD>biological process</TD><TD>GO:1904591</TD><TD>96</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>3.672e-04</TD><TD>-7.91</TD><TD>V$TATA_01</TD><TD>MSigDB lists</TD><TD>V$TATA_01</TD><TD>247</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,CCL5,DKK1</TD></TR>
<TR><TD>3.683e-04</TD><TD>-7.91</TD><TD>positive regulation of inflammatory response</TD><TD>biological process</TD><TD>GO:0050729</TD><TD>97</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>3.750e-04</TD><TD>-7.89</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</TD><TD>MSigDB lists</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP</TD><TD>101</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,NFKBIZ</TD></TR>
<TR><TD>3.799e-04</TD><TD>-7.88</TD><TD>response to virus</TD><TD>biological process</TD><TD>GO:0009615</TD><TD>241</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PIM2,CCL5,CCL8,IL6</TD></TR>
<TR><TD>3.860e-04</TD><TD>-7.86</TD><TD>WESTON_VEGFA_TARGETS</TD><TD>MSigDB lists</TD><TD>WESTON_VEGFA_TARGETS</TD><TD>102</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,MMP3</TD></TR>
<TR><TD>3.972e-04</TD><TD>-7.83</TD><TD>KEEN_RESPONSE_TO_ROSIGLITAZONE_DN</TD><TD>MSigDB lists</TD><TD>KEEN_RESPONSE_TO_ROSIGLITAZONE_DN</TD><TD>103</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,CXCL2</TD></TR>
<TR><TD>3.972e-04</TD><TD>-7.83</TD><TD>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</TD><TD>MSigDB lists</TD><TD>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</TD><TD>103</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CXCL2,CXCL3</TD></TR>
<TR><TD>4.012e-04</TD><TD>-7.82</TD><TD>DPP4 (dipeptidyl-peptidase 4)</TD><TD>protein interactions</TD><TD>1803</TD><TD>20</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>4.041e-04</TD><TD>-7.81</TD><TD>regulation of biological process</TD><TD>biological process</TD><TD>GO:0050789</TD><TD>10636</TD><TD>23</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>4.055e-04</TD><TD>-7.81</TD><TD>positive regulation of metabolic process</TD><TD>biological process</TD><TD>GO:0009893</TD><TD>3495</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,IL6,CXCL1,PIM2,CSF2,CCL5,ELF3</TD></TR>
<TR><TD>4.082e-04</TD><TD>-7.80</TD><TD>MODULE_112</TD><TD>MSigDB lists</TD><TD>MODULE_112</TD><TD>254</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,MMP3,CCL20,CXCL3</TD></TR>
<TR><TD>4.217e-04</TD><TD>-7.77</TD><TD>regulation of lymphocyte chemotaxis</TD><TD>biological process</TD><TD>GO:1901623</TD><TD>21</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>4.217e-04</TD><TD>-7.77</TD><TD>positive regulation of T cell migration</TD><TD>biological process</TD><TD>GO:2000406</TD><TD>21</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>4.392e-04</TD><TD>-7.73</TD><TD>regulation of B cell activation</TD><TD>biological process</TD><TD>GO:0050864</TD><TD>103</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6,TNFSF13B</TD></TR>
<TR><TD>4.392e-04</TD><TD>-7.73</TD><TD>response to amino acid</TD><TD>biological process</TD><TD>GO:0043200</TD><TD>103</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,MMP3,IL6</TD></TR>
<TR><TD>4.405e-04</TD><TD>-7.73</TD><TD>Signal Transduction</TD><TD>REACTOME pathways</TD><TD>R-HSA-162582</TD><TD>2357</TD><TD>11</TD><TD>8202</TD><TD>15</TD>
<TD>CCL7,MMP3,CCL20,CXCL3,IL6,CXCL6,CXCL1,CXCL2,CCL5,CSF2,DKK1</TD></TR>
<TR><TD>4.442e-04</TD><TD>-7.72</TD><TD>SENESE_HDAC2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SENESE_HDAC2_TARGETS_UP</TD><TD>107</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CSF2,G0S2</TD></TR>
<TR><TD>4.458e-04</TD><TD>-7.72</TD><TD>KRAS.600_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.600_UP.V1_UP</TD><TD>260</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,G0S2,CXCL3</TD></TR>
<TR><TD>4.564e-04</TD><TD>-7.69</TD><TD>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP</TD><TD>MSigDB lists</TD><TD>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP</TD><TD>108</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,IL11,PTGS2</TD></TR>
<TR><TD>4.591e-04</TD><TD>-7.69</TD><TD>regulation of cell activation</TD><TD>biological process</TD><TD>GO:0050865</TD><TD>460</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>4.689e-04</TD><TD>-7.67</TD><TD>BOSCO_TH1_CYTOTOXIC_MODULE</TD><TD>MSigDB lists</TD><TD>BOSCO_TH1_CYTOTOXIC_MODULE</TD><TD>109</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL7,CCL8</TD></TR>
<TR><TD>4.728e-04</TD><TD>-7.66</TD><TD>UROSEVIC_RESPONSE_TO_IMIQUIMOD</TD><TD>MSigDB lists</TD><TD>UROSEVIC_RESPONSE_TO_IMIQUIMOD</TD><TD>23</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,IL6</TD></TR>
<TR><TD>4.869e-04</TD><TD>-7.63</TD><TD>CCL2 (chemokine (C-C motif) ligand 2)</TD><TD>protein interactions</TD><TD>6347</TD><TD>22</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5,MMP3</TD></TR>
<TR><TD>4.998e-04</TD><TD>-7.60</TD><TD>STK33_UP</TD><TD>MSigDB lists</TD><TD>STK33_UP</TD><TD>268</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,C15orf48</TD></TR>
<TR><TD>5.153e-04</TD><TD>-7.57</TD><TD>YAN_ESCAPE_FROM_ANOIKIS</TD><TD>MSigDB lists</TD><TD>YAN_ESCAPE_FROM_ANOIKIS</TD><TD>24</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>5.184e-04</TD><TD>-7.56</TD><TD>positive regulation of protein localization to nucleus</TD><TD>biological process</TD><TD>GO:1900182</TD><TD>109</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>5.324e-04</TD><TD>-7.54</TD><TD>positive regulation of nucleocytoplasmic transport</TD><TD>biological process</TD><TD>GO:0046824</TD><TD>110</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>5.355e-04</TD><TD>-7.53</TD><TD>positive regulation of cellular biosynthetic process</TD><TD>biological process</TD><TD>GO:0031328</TD><TD>1763</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,PIM2,CCL5,CSF2,CCL20,IL6,ELF3</TD></TR>
<TR><TD>5.527e-04</TD><TD>-7.50</TD><TD>regulation of T cell migration</TD><TD>biological process</TD><TD>GO:2000404</TD><TD>24</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>5.527e-04</TD><TD>-7.50</TD><TD>positive regulation of CD4-positive, alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0043372</TD><TD>24</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>5.583e-04</TD><TD>-7.49</TD><TD>ENK_UV_RESPONSE_EPIDERMIS_UP</TD><TD>MSigDB lists</TD><TD>ENK_UV_RESPONSE_EPIDERMIS_UP</TD><TD>276</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,MMP3,G0S2,ELF3</TD></TR>
<TR><TD>5.596e-04</TD><TD>-7.49</TD><TD>EXOCYTOSIS</TD><TD>MSigDB lists</TD><TD>EXOCYTOSIS</TD><TD>25</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>5.625e-04</TD><TD>-7.48</TD><TD>MODULE_289</TD><TD>MSigDB lists</TD><TD>MODULE_289</TD><TD>116</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,CXCL2</TD></TR>
<TR><TD>5.764e-04</TD><TD>-7.46</TD><TD>REACTOME_GPCR_DOWNSTREAM_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_GPCR_DOWNSTREAM_SIGNALING</TD><TD>772</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>5.912e-04</TD><TD>-7.43</TD><TD>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</TD><TD>MSigDB lists</TD><TD>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</TD><TD>118</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,MT1F,DKK1</TD></TR>
<TR><TD>6.005e-04</TD><TD>-7.42</TD><TD>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</TD><TD>MSigDB lists</TD><TD>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</TD><TD>778</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL11,CXCL2,CSF2,CXCL3,IL6</TD></TR>
<TR><TD>6.057e-04</TD><TD>-7.41</TD><TD>GENTILE_UV_HIGH_DOSE_UP</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_HIGH_DOSE_UP</TD><TD>26</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,MMP3</TD></TR>
<TR><TD>6.134e-04</TD><TD>-7.40</TD><TD>BROWNE_HCMV_INFECTION_14HR_DN</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_14HR_DN</TD><TD>283</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,G0S2,MT1F,DKK1</TD></TR>
<TR><TD>6.146e-04</TD><TD>-7.39</TD><TD>positive regulation of biosynthetic process</TD><TD>biological process</TD><TD>GO:0009891</TD><TD>1796</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,PIM2,CCL5,CSF2,CCL20,IL6,ELF3</TD></TR>
<TR><TD>6.216e-04</TD><TD>-7.38</TD><TD>HORIUCHI_WTAP_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HORIUCHI_WTAP_TARGETS_UP</TD><TD>284</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,CXCL6</TD></TR>
<TR><TD>6.497e-04</TD><TD>-7.34</TD><TD>neutrophil mediated immunity</TD><TD>biological process</TD><TD>GO:0002446</TD><TD>26</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>6.510e-04</TD><TD>-7.34</TD><TD>regulation of T cell activation</TD><TD>biological process</TD><TD>GO:0050863</TD><TD>278</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>6.536e-04</TD><TD>-7.33</TD><TD>OLSSON_E2F3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>OLSSON_E2F3_TARGETS_UP</TD><TD>27</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,ELF3</TD></TR>
<TR><TD>6.536e-04</TD><TD>-7.33</TD><TD>chr13q32</TD><TD>MSigDB lists</TD><TD>chr13q32</TD><TD>27</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,TNFSF13B</TD></TR>
<TR><TD>6.574e-04</TD><TD>-7.33</TD><TD>GPCR downstream signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-388396</TD><TD>928</TD><TD>7</TD><TD>8202</TD><TD>15</TD>
<TD>CXCL1,CXCL2,CCL5,CSF2,CCL20,CXCL3,CXCL6</TD></TR>
<TR><TD>6.672e-04</TD><TD>-7.31</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</TD><TD>MSigDB lists</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</TD><TD>123</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,CCL5</TD></TR>
<TR><TD>6.784e-04</TD><TD>-7.30</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</TD><TD>MSigDB lists</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</TD><TD>518</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,NFKBIZ,PTGS2,MMP3,IL6</TD></TR>
<TR><TD>6.964e-04</TD><TD>-7.27</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_UP</TD><TD>MSigDB lists</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_UP</TD><TD>521</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,NFKBIZ,PTGS2,CXCL6</TD></TR>
<TR><TD>6.964e-04</TD><TD>-7.27</TD><TD>ENK_UV_RESPONSE_KERATINOCYTE_UP</TD><TD>MSigDB lists</TD><TD>ENK_UV_RESPONSE_KERATINOCYTE_UP</TD><TD>521</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,CXCL3,DKK1</TD></TR>
<TR><TD>6.993e-04</TD><TD>-7.27</TD><TD>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</TD><TD>MSigDB lists</TD><TD>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</TD><TD>125</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,CXCL2</TD></TR>
<TR><TD>6.997e-04</TD><TD>-7.26</TD><TD>Spinal Cord Injury</TD><TD>WikiPathways</TD><TD>WP2431</TD><TD>112</TD><TD>4</TD><TD>4455</TD><TD>17</TD>
<TD>CXCL1,CXCL2,IL6,TNFSF13B</TD></TR>
<TR><TD>7.010e-04</TD><TD>-7.26</TD><TD>positive regulation of CD4-positive, alpha-beta T cell activation</TD><TD>biological process</TD><TD>GO:2000516</TD><TD>27</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>7.033e-04</TD><TD>-7.26</TD><TD>PID_TCR_CALCIUM_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_TCR_CALCIUM_PATHWAY</TD><TD>28</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>7.033e-04</TD><TD>-7.26</TD><TD>HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_BINDING</TD><TD>MSigDB lists</TD><TD>HEMATOPOIETIN_INTERFERON_CLASSD200_DOMAIN_CYTOKINE_RECEPTOR_BINDING</TD><TD>28</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2</TD></TR>
<TR><TD>7.033e-04</TD><TD>-7.26</TD><TD>MODULE_488</TD><TD>MSigDB lists</TD><TD>MODULE_488</TD><TD>28</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>7.326e-04</TD><TD>-7.22</TD><TD>nef (p27)</TD><TD>protein interactions</TD><TD>156110</TD><TD>763</TD><TD>6</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5,CSF2,CCL20,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>7.334e-04</TD><TD>-7.22</TD><TD>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</TD><TD>MSigDB lists</TD><TD>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</TD><TD>527</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL2,MMP3,CCL5</TD></TR>
<TR><TD>7.334e-04</TD><TD>-7.22</TD><TD>MODULE_84</TD><TD>MSigDB lists</TD><TD>MODULE_84</TD><TD>527</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,PIM2,CCL5,IL6</TD></TR>
<TR><TD>7.335e-04</TD><TD>-7.22</TD><TD>regulation of leukocyte cell-cell adhesion</TD><TD>biological process</TD><TD>GO:1903037</TD><TD>287</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>7.492e-04</TD><TD>-7.20</TD><TD>PTEN_DN.V2_UP</TD><TD>MSigDB lists</TD><TD>PTEN_DN.V2_UP</TD><TD>128</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,G0S2</TD></TR>
<TR><TD>7.492e-04</TD><TD>-7.20</TD><TD>KRAS.BREAST_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.BREAST_UP.V1_UP</TD><TD>128</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CSF2,CXCL3</TD></TR>
<TR><TD>7.547e-04</TD><TD>-7.19</TD><TD>LY_AGING_PREMATURE_DN</TD><TD>MSigDB lists</TD><TD>LY_AGING_PREMATURE_DN</TD><TD>29</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,MMP3</TD></TR>
<TR><TD>7.984e-04</TD><TD>-7.13</TD><TD>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</TD><TD>MSigDB lists</TD><TD>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</TD><TD>537</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL3,IL6,MT1F</TD></TR>
<TR><TD>8.014e-04</TD><TD>-7.13</TD><TD>hemopoiesis</TD><TD>biological process</TD><TD>GO:0030097</TD><TD>520</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>8.079e-04</TD><TD>-7.12</TD><TD>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</TD><TD>MSigDB lists</TD><TD>SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN</TD><TD>30</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3</TD></TR>
<TR><TD>8.079e-04</TD><TD>-7.12</TD><TD>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</TD><TD>MSigDB lists</TD><TD>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</TD><TD>30</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,IL6</TD></TR>
<TR><TD>8.079e-04</TD><TD>-7.12</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>MSigDB lists</TD><TD>KIM_LRRC3B_TARGETS</TD><TD>30</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5</TD></TR>
<TR><TD>8.192e-04</TD><TD>-7.11</TD><TD>KRAS.LUNG_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.LUNG_UP.V1_UP</TD><TD>132</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CCL20,G0S2</TD></TR>
<TR><TD>8.232e-04</TD><TD>-7.10</TD><TD>regulation of homotypic cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0034110</TD><TD>296</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>8.503e-04</TD><TD>-7.07</TD><TD>NUCB1 (nucleobindin 1)</TD><TD>protein interactions</TD><TD>4924</TD><TD>29</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2,MMP3</TD></TR>
<TR><TD>8.557e-04</TD><TD>-7.06</TD><TD>KRAS.300_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>KRAS.300_UP.V1_UP</TD><TD>134</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CXCL3,G0S2</TD></TR>
<TR><TD>8.629e-04</TD><TD>-7.06</TD><TD>AMIT_SERUM_RESPONSE_40_MCF10A</TD><TD>MSigDB lists</TD><TD>AMIT_SERUM_RESPONSE_40_MCF10A</TD><TD>31</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>8.629e-04</TD><TD>-7.06</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</TD><TD>MSigDB lists</TD><TD>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</TD><TD>31</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2</TD></TR>
<TR><TD>8.629e-04</TD><TD>-7.06</TD><TD>HUMORAL_IMMUNE_RESPONSE</TD><TD>MSigDB lists</TD><TD>HUMORAL_IMMUNE_RESPONSE</TD><TD>31</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>8.743e-04</TD><TD>-7.04</TD><TD>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</TD><TD>MSigDB lists</TD><TD>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</TD><TD>135</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF3,CXCL2</TD></TR>
<TR><TD>9.050e-04</TD><TD>-7.01</TD><TD>positive regulation of leukocyte differentiation</TD><TD>biological process</TD><TD>GO:1902107</TD><TD>132</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83</TD></TR>
<TR><TD>9.254e-04</TD><TD>-6.99</TD><TD>regulation of vascular endothelial growth factor production</TD><TD>biological process</TD><TD>GO:0010574</TD><TD>31</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>9.514e-04</TD><TD>-6.96</TD><TD>BMI1_DN_MEL18_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>BMI1_DN_MEL18_DN.V1_UP</TD><TD>139</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CSF2,MT1F</TD></TR>
<TR><TD>9.524e-04</TD><TD>-6.96</TD><TD>human chr13q32-q34</TD><TD>chromosome location</TD><TD>human chr13q32-q34</TD><TD>1</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>9.524e-04</TD><TD>-6.96</TD><TD>human chr3p12-q12</TD><TD>chromosome location</TD><TD>human chr3p12-q12</TD><TD>1</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>9.524e-04</TD><TD>-6.96</TD><TD>human chr1q25.2-q25.3</TD><TD>chromosome location</TD><TD>human chr1q25.2-q25.3</TD><TD>1</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>9.589e-04</TD><TD>-6.95</TD><TD>Jak-STAT signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04630</TD><TD>158</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>9.589e-04</TD><TD>-6.95</TD><TD>Jak-STAT signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04630</TD><TD>158</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>9.621e-04</TD><TD>-6.95</TD><TD>positive regulation of macromolecule metabolic process</TD><TD>biological process</TD><TD>GO:0010604</TD><TD>2797</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,PIM2,CSF2,CCL5,ELF3</TD></TR>
<TR><TD>9.862e-04</TD><TD>-6.92</TD><TD>regulation of CD4-positive, alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0043370</TD><TD>32</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>9.916e-04</TD><TD>-6.92</TD><TD>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</TD><TD>MSigDB lists</TD><TD>PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN</TD><TD>141</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,DKK1</TD></TR>
<TR><TD>1.023e-03</TD><TD>-6.89</TD><TD>regulation of cytokine production</TD><TD>biological process</TD><TD>GO:0001817</TD><TD>549</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF2,CCL20,IL6,CD83</TD></TR>
<TR><TD>1.036e-03</TD><TD>-6.87</TD><TD>MMP9 (matrix metallopeptidase 9)</TD><TD>protein interactions</TD><TD>4318</TD><TD>32</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>1.038e-03</TD><TD>-6.87</TD><TD>KEGG_PRION_DISEASES</TD><TD>MSigDB lists</TD><TD>KEGG_PRION_DISEASES</TD><TD>34</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.038e-03</TD><TD>-6.87</TD><TD>PLASARI_TGFB1_TARGETS_1HR_UP</TD><TD>MSigDB lists</TD><TD>PLASARI_TGFB1_TARGETS_1HR_UP</TD><TD>34</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.047e-03</TD><TD>-6.86</TD><TD>regulation of cellular process</TD><TD>biological process</TD><TD>GO:0050794</TD><TD>10106</TD><TD>22</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2</TD></TR>
<TR><TD>1.050e-03</TD><TD>-6.86</TD><TD>regulation of hemopoiesis</TD><TD>biological process</TD><TD>GO:1903706</TD><TD>316</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,IL6,CD83</TD></TR>
<TR><TD>1.050e-03</TD><TD>-6.86</TD><TD>response to alcohol</TD><TD>biological process</TD><TD>GO:0097305</TD><TD>316</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.073e-03</TD><TD>-6.84</TD><TD>regulation of T cell proliferation</TD><TD>biological process</TD><TD>GO:0042129</TD><TD>140</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,TNFSF13B</TD></TR>
<TR><TD>1.119e-03</TD><TD>-6.79</TD><TD>WTGAAAT_UNKNOWN</TD><TD>MSigDB lists</TD><TD>WTGAAAT_UNKNOWN</TD><TD>579</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2,CCL8,G0S2,DKK1</TD></TR>
<TR><TD>1.126e-03</TD><TD>-6.79</TD><TD>regulation of protein complex assembly</TD><TD>biological process</TD><TD>GO:0043254</TD><TD>322</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,MMP3,CSF2,DKK1</TD></TR>
<TR><TD>1.142e-03</TD><TD>-6.78</TD><TD>biological regulation</TD><TD>biological process</TD><TD>GO:0065007</TD><TD>11168</TD><TD>23</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>1.143e-03</TD><TD>-6.77</TD><TD>regulation of cellular protein metabolic process</TD><TD>biological process</TD><TD>GO:0032268</TD><TD>2389</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>1.164e-03</TD><TD>-6.76</TD><TD>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN</TD><TD>MSigDB lists</TD><TD>CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN</TD><TD>36</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>1.164e-03</TD><TD>-6.76</TD><TD>MODULE_521</TD><TD>MSigDB lists</TD><TD>MODULE_521</TD><TD>36</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.164e-03</TD><TD>-6.76</TD><TD>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</TD><TD>MSigDB lists</TD><TD>UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN</TD><TD>36</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2</TD></TR>
<TR><TD>1.187e-03</TD><TD>-6.74</TD><TD>positive regulation of response to wounding</TD><TD>biological process</TD><TD>GO:1903036</TD><TD>145</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.200e-03</TD><TD>-6.73</TD><TD>hematopoietic or lymphoid organ development</TD><TD>biological process</TD><TD>GO:0048534</TD><TD>569</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>1.220e-03</TD><TD>-6.71</TD><TD>negative regulation of biological process</TD><TD>biological process</TD><TD>GO:0048519</TD><TD>4447</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,MMP3,CCL8,IL6,CXCL1,PIM2,CSF2,CCL5,MT1F,DKK1,CD83,ELF3</TD></TR>
<TR><TD>1.230e-03</TD><TD>-6.70</TD><TD>PID_IL23_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_IL23_PATHWAY</TD><TD>37</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>1.235e-03</TD><TD>-6.70</TD><TD>regulation of reactive oxygen species metabolic process</TD><TD>biological process</TD><TD>GO:2000377</TD><TD>147</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,MMP3,IL6</TD></TR>
<TR><TD>1.235e-03</TD><TD>-6.70</TD><TD>response to glucocorticoid</TD><TD>biological process</TD><TD>GO:0051384</TD><TD>147</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.248e-03</TD><TD>-6.69</TD><TD>negative regulation of muscle organ development</TD><TD>biological process</TD><TD>GO:0048635</TD><TD>36</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,DKK1</TD></TR>
<TR><TD>1.248e-03</TD><TD>-6.69</TD><TD>regulation of CD4-positive, alpha-beta T cell activation</TD><TD>biological process</TD><TD>GO:2000514</TD><TD>36</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.279e-03</TD><TD>-6.66</TD><TD>SNF5_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>SNF5_DN.V1_DN</TD><TD>154</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,NFKBIZ,MMP3</TD></TR>
<TR><TD>1.311e-03</TD><TD>-6.64</TD><TD>SDC2 (syndecan 2)</TD><TD>protein interactions</TD><TD>6383</TD><TD>36</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183,CSF2</TD></TR>
<TR><TD>1.318e-03</TD><TD>-6.63</TD><TD>positive regulation of nitric oxide metabolic process</TD><TD>biological process</TD><TD>GO:1904407</TD><TD>37</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.318e-03</TD><TD>-6.63</TD><TD>positive regulation of B cell proliferation</TD><TD>biological process</TD><TD>GO:0030890</TD><TD>37</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,TNFSF13B</TD></TR>
<TR><TD>1.318e-03</TD><TD>-6.63</TD><TD>positive regulation of nitric oxide biosynthetic process</TD><TD>biological process</TD><TD>GO:0045429</TD><TD>37</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.361e-03</TD><TD>-6.60</TD><TD>response to oxidative stress</TD><TD>biological process</TD><TD>GO:0006979</TD><TD>339</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,IL6</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>COX-2</TD><TD>interpro domains</TD><TD>IPR029576</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>GM_colony-stim-fac</TD><TD>interpro domains</TD><TD>IPR000773</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>IL-11_mml</TD><TD>interpro domains</TD><TD>IPR020412</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>IL-6</TD><TD>interpro domains</TD><TD>IPR003574</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>CCL5</TD><TD>interpro domains</TD><TD>IPR030595</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>G0S2</TD><TD>interpro domains</TD><TD>IPR016821</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>IL-11</TD><TD>interpro domains</TD><TD>IPR020438</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>1.367e-03</TD><TD>-6.60</TD><TD>Stromelysin_1</TD><TD>interpro domains</TD><TD>IPR028700</TD><TD>1</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.377e-03</TD><TD>-6.59</TD><TD>CSR_LATE_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>CSR_LATE_UP.V1_UP</TD><TD>158</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,MT1F,CXCL6</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>receptor signaling protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030298</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>granulocyte macrophage colony-stimulating factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005129</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>interleukin-11 receptor binding</TD><TD>molecular function</TD><TD>GO:0005142</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>IL11</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>chemokine receptor antagonist activity</TD><TD>molecular function</TD><TD>GO:0046817</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>L-amino-acid oxidase activity</TD><TD>molecular function</TD><TD>GO:0001716</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>CCR4 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031729</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.58</TD><TD>granulocyte colony-stimulating factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005130</TD><TD>1</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CSF3</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.57</TD><TD>MODULE_12</TD><TD>MSigDB lists</TD><TD>MODULE_12</TD><TD>353</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,G0S2,IL6</TD></TR>
<TR><TD>1.436e-03</TD><TD>-6.55</TD><TD>TRAYNOR_RETT_SYNDROM_UP</TD><TD>MSigDB lists</TD><TD>TRAYNOR_RETT_SYNDROM_UP</TD><TD>40</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,IL6</TD></TR>
<TR><TD>1.436e-03</TD><TD>-6.55</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_DN</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_DN</TD><TD>40</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>positive regulation of interleukin-1 alpha biosynthetic process</TD><TD>biological process</TD><TD>GO:0050726</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>negative regulation of Frizzled-LRP5/6 complex assembly</TD><TD>biological process</TD><TD>GO:1904723</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment</TD><TD>biological process</TD><TD>GO:1901296</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>regulation of interleukin-1 alpha biosynthetic process</TD><TD>biological process</TD><TD>GO:0050721</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>response to alkyl hydroperoxide</TD><TD>biological process</TD><TD>GO:0033195</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>regulation of Frizzled-LRP5/6 complex assembly</TD><TD>biological process</TD><TD>GO:1904711</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>glucagon secretion</TD><TD>biological process</TD><TD>GO:0070091</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>cellular response to alkyl hydroperoxide</TD><TD>biological process</TD><TD>GO:0071448</TD><TD>1</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.464e-03</TD><TD>-6.53</TD><TD>positive regulation of alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0046638</TD><TD>39</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.465e-03</TD><TD>-6.53</TD><TD>response to corticosteroid</TD><TD>biological process</TD><TD>GO:0031960</TD><TD>156</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.465e-03</TD><TD>-6.53</TD><TD>humoral immune response</TD><TD>biological process</TD><TD>GO:0006959</TD><TD>156</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6,CD83</TD></TR>
<TR><TD>1.469e-03</TD><TD>-6.52</TD><TD>negative regulation of cell death</TD><TD>biological process</TD><TD>GO:0060548</TD><TD>894</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,PIM2,CCL5,CSF2,IL6</TD></TR>
<TR><TD>1.475e-03</TD><TD>-6.52</TD><TD>positive regulation of cell death</TD><TD>biological process</TD><TD>GO:0010942</TD><TD>596</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,G0S2,IL6</TD></TR>
<TR><TD>1.479e-03</TD><TD>-6.52</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN</TD><TD>162</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CXCL3,TNFSF13B</TD></TR>
<TR><TD>1.497e-03</TD><TD>-6.50</TD><TD>IL11RA (interleukin 11 receptor, alpha)</TD><TD>protein interactions</TD><TD>3590</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>IL11</TD></TR>
<TR><TD>1.497e-03</TD><TD>-6.50</TD><TD>Nos2 (nitric oxide synthase 2, inducible)</TD><TD>protein interactions</TD><TD>18126</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.497e-03</TD><TD>-6.50</TD><TD>KREMEN1 (kringle containing transmembrane protein 1)</TD><TD>protein interactions</TD><TD>83999</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.497e-03</TD><TD>-6.50</TD><TD>Jun (jun proto-oncogene)</TD><TD>protein interactions</TD><TD>24516</TD><TD>1</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>GCSF</TD><TD>pfam domains</TD><TD>PF16647</TD><TD>1</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>CSF3</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>GM_CSF</TD><TD>pfam domains</TD><TD>PF01109</TD><TD>1</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>G0-G1_switch_2</TD><TD>pfam domains</TD><TD>PF15103</TD><TD>1</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>IL6</TD><TD>pfam domains</TD><TD>PF00489</TD><TD>1</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.503e-03</TD><TD>-6.50</TD><TD>IL11</TD><TD>pfam domains</TD><TD>PF07400</TD><TD>1</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>1.526e-03</TD><TD>-6.49</TD><TD>Transcriptional misregulation in cancer</TD><TD>KEGG pathways</TD><TD>hsa05202</TD><TD>179</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>NFKBIZ,CSF2,MMP3,IL6</TD></TR>
<TR><TD>1.526e-03</TD><TD>-6.49</TD><TD>Transcriptional misregulation in cancer</TD><TD>KEGG pathways</TD><TD>ko05202</TD><TD>179</TD><TD>4</TD><TD>6908</TD><TD>20</TD>
<TD>NFKBIZ,CSF2,MMP3,IL6</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>immune system development</TD><TD>biological process</TD><TD>GO:0002520</TD><TD>601</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CSF3,IL11,CSF2,IL6</TD></TR>
<TR><TD>1.583e-03</TD><TD>-6.45</TD><TD>AMIT_EGF_RESPONSE_40_HELA</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_40_HELA</TD><TD>42</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.586e-03</TD><TD>-6.45</TD><TD>GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN</TD><TD>166</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,C15orf48</TD></TR>
<TR><TD>1.603e-03</TD><TD>-6.44</TD><TD>positive regulation of macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0010557</TD><TD>1634</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,PIM2,CCL5,CSF2,CCL20,IL6,ELF3</TD></TR>
<TR><TD>1.614e-03</TD><TD>-6.43</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP</TD><TD>167</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,G0S2</TD></TR>
<TR><TD>1.614e-03</TD><TD>-6.43</TD><TD>GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP</TD><TD>167</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PIM2,CCL20</TD></TR>
<TR><TD>1.623e-03</TD><TD>-6.42</TD><TD>receptor regulator activity</TD><TD>molecular function</TD><TD>GO:0030545</TD><TD>43</TD><TD>2</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>1.633e-03</TD><TD>-6.42</TD><TD>negative regulation of neuron death</TD><TD>biological process</TD><TD>GO:1901215</TD><TD>162</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,IL6</TD></TR>
<TR><TD>1.637e-03</TD><TD>-6.41</TD><TD>regulation of anatomical structure morphogenesis</TD><TD>biological process</TD><TD>GO:0022603</TD><TD>913</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CCL5,IL6,DKK1,TNFSF13B</TD></TR>
<TR><TD>1.641e-03</TD><TD>-6.41</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN</TD><TD>168</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2,CCL5</TD></TR>
<TR><TD>1.641e-03</TD><TD>-6.41</TD><TD>GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>MSigDB lists</TD><TD>GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>168</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL20,G0S2</TD></TR>
<TR><TD>1.658e-03</TD><TD>-6.40</TD><TD>DORN_ADENOVIRUS_INFECTION_24HR_DN</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_24HR_DN</TD><TD>43</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.658e-03</TD><TD>-6.40</TD><TD>STREICHER_LSM1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>STREICHER_LSM1_TARGETS_UP</TD><TD>43</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,ELF3</TD></TR>
<TR><TD>1.670e-03</TD><TD>-6.40</TD><TD>GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>169</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2,G0S2</TD></TR>
<TR><TD>1.674e-03</TD><TD>-6.39</TD><TD>Response to antidepressants(PMID:20360315)</TD><TD>GWAS genes</TD><TD>Response to antidepressants(PMID:20360315)</TD><TD>4</TD><TD>1</TD><TD>2389</TD><TD>1</TD>
<TD>IL11</TD></TR>
<TR><TD>1.680e-03</TD><TD>-6.39</TD><TD>gag (Pr55(Gag))</TD><TD>protein interactions</TD><TD>155030</TD><TD>895</TD><TD>6</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5,CSF2,CCL20,CCL8,IL6,CD83</TD></TR>
<TR><TD>1.685e-03</TD><TD>-6.39</TD><TD>GM_CSF</TD><TD>prosite domains</TD><TD>PS00702</TD><TD>1</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.698e-03</TD><TD>-6.38</TD><TD>GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>170</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,G0S2,MT1F</TD></TR>
<TR><TD>1.698e-03</TD><TD>-6.38</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN</TD><TD>170</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,G0S2,TNFSF13B</TD></TR>
<TR><TD>1.733e-03</TD><TD>-6.36</TD><TD>positive regulation of cell adhesion</TD><TD>biological process</TD><TD>GO:0045785</TD><TD>362</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.736e-03</TD><TD>-6.36</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN</TD><TD>44</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>1.756e-03</TD><TD>-6.34</TD><TD>GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN</TD><TD>172</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,MT1F,CD83</TD></TR>
<TR><TD>1.778e-03</TD><TD>-6.33</TD><TD>positive regulation of reactive oxygen species biosynthetic process</TD><TD>biological process</TD><TD>GO:1903428</TD><TD>43</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.781e-03</TD><TD>-6.33</TD><TD>regulation of protein import into nucleus</TD><TD>biological process</TD><TD>GO:0042306</TD><TD>167</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>1.815e-03</TD><TD>-6.31</TD><TD>KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION</TD><TD>MSigDB lists</TD><TD>KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION</TD><TD>45</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>1.845e-03</TD><TD>-6.30</TD><TD>GSE2706_2H_VS_8H_LPS_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_LPS_STIM_DC_DN</TD><TD>175</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,C15orf48,CXCL6</TD></TR>
<TR><TD>1.874e-03</TD><TD>-6.28</TD><TD>regulation of protein import</TD><TD>biological process</TD><TD>GO:1904589</TD><TD>170</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>1.875e-03</TD><TD>-6.28</TD><TD>GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP</TD><TD>176</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,IL6</TD></TR>
<TR><TD>1.896e-03</TD><TD>-6.27</TD><TD>regulation of cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0022407</TD><TD>371</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.896e-03</TD><TD>-6.27</TD><TD>RESPONSE_TO_VIRUS</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_VIRUS</TD><TD>46</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.896e-03</TD><TD>-6.27</TD><TD>PID_NFAT_TFPATHWAY</TD><TD>MSigDB lists</TD><TD>PID_NFAT_TFPATHWAY</TD><TD>46</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>1.905e-03</TD><TD>-6.26</TD><TD>positive regulation of protein complex assembly</TD><TD>biological process</TD><TD>GO:0031334</TD><TD>171</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,MMP3,CSF2</TD></TR>
<TR><TD>1.905e-03</TD><TD>-6.26</TD><TD>GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>177</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,NFKBIZ,G0S2</TD></TR>
<TR><TD>1.925e-03</TD><TD>-6.25</TD><TD>negative regulation of cell proliferation</TD><TD>biological process</TD><TD>GO:0008285</TD><TD>633</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,PTGS2,PIM2,CCL8,IL6</TD></TR>
<TR><TD>1.936e-03</TD><TD>-6.25</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN</TD><TD>178</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20,IL6</TD></TR>
<TR><TD>1.936e-03</TD><TD>-6.25</TD><TD>SECRETION</TD><TD>MSigDB lists</TD><TD>SECRETION</TD><TD>178</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5,CCL8</TD></TR>
<TR><TD>1.936e-03</TD><TD>-6.25</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP</TD><TD>178</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,G0S2,CD83</TD></TR>
<TR><TD>1.936e-03</TD><TD>-6.25</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN</TD><TD>178</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,TNFSF13B</TD></TR>
<TR><TD>1.950e-03</TD><TD>-6.24</TD><TD>regulation of protein metabolic process</TD><TD>biological process</TD><TD>GO:0051246</TD><TD>2557</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,CSF2,CCL5,DKK1</TD></TR>
<TR><TD>1.967e-03</TD><TD>-6.23</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN</TD><TD>179</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL5,CCL8</TD></TR>
<TR><TD>1.967e-03</TD><TD>-6.23</TD><TD>GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN</TD><TD>179</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CCL20,C15orf48</TD></TR>
<TR><TD>1.967e-03</TD><TD>-6.23</TD><TD>WU_CELL_MIGRATION</TD><TD>MSigDB lists</TD><TD>WU_CELL_MIGRATION</TD><TD>179</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,MT1F</TD></TR>
<TR><TD>1.970e-03</TD><TD>-6.23</TD><TD>cellular response to oxidative stress</TD><TD>biological process</TD><TD>GO:0034599</TD><TD>173</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,MMP3,IL6</TD></TR>
<TR><TD>1.971e-03</TD><TD>-6.23</TD><TD>CSF2</TD><TD>smart domains</TD><TD>SM00040</TD><TD>1</TD><TD>1</TD><TD>9131</TD><TD>18</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.979e-03</TD><TD>-6.23</TD><TD>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</TD><TD>MSigDB lists</TD><TD>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</TD><TD>47</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3,DKK1</TD></TR>
<TR><TD>1.979e-03</TD><TD>-6.23</TD><TD>OLSSON_E2F3_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>OLSSON_E2F3_TARGETS_DN</TD><TD>47</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MT1F</TD></TR>
<TR><TD>1.999e-03</TD><TD>-6.22</TD><TD>GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN</TD><TD>180</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CCL8</TD></TR>
<TR><TD>2.001e-03</TD><TD>-6.21</TD><TD>regulation of developmental process</TD><TD>biological process</TD><TD>GO:0050793</TD><TD>2113</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,PTGS2,CSF3,IL6,TNFSF13B,CSF2,CCL5,DKK1,CD83</TD></TR>
<TR><TD>2.011e-03</TD><TD>-6.21</TD><TD>MODULE_53</TD><TD>MSigDB lists</TD><TD>MODULE_53</TD><TD>390</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,PIM2,CXCL2,CCL5</TD></TR>
<TR><TD>2.031e-03</TD><TD>-6.20</TD><TD>GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>181</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL20,CCL8</TD></TR>
<TR><TD>2.031e-03</TD><TD>-6.20</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN</TD><TD>181</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CXCL3,C15orf48</TD></TR>
<TR><TD>2.032e-03</TD><TD>-6.20</TD><TD>myeloid leukocyte mediated immunity</TD><TD>biological process</TD><TD>GO:0002444</TD><TD>46</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>2.048e-03</TD><TD>-6.19</TD><TD>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</TD><TD>MSigDB lists</TD><TD>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</TD><TD>392</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL8,CXCL3,MT1F</TD></TR>
<TR><TD>2.063e-03</TD><TD>-6.18</TD><TD>E2F1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>E2F1_UP.V1_DN</TD><TD>182</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ,PTGS2</TD></TR>
<TR><TD>2.063e-03</TD><TD>-6.18</TD><TD>GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN</TD><TD>182</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CCL8</TD></TR>
<TR><TD>2.095e-03</TD><TD>-6.17</TD><TD>LEF1_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>LEF1_UP.V1_UP</TD><TD>183</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,G0S2,DKK1</TD></TR>
<TR><TD>2.095e-03</TD><TD>-6.17</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN</TD><TD>183</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CSF3,MT1F</TD></TR>
<TR><TD>2.095e-03</TD><TD>-6.17</TD><TD>LEF1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>LEF1_UP.V1_DN</TD><TD>183</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CCL20,ELF3</TD></TR>
<TR><TD>2.121e-03</TD><TD>-6.16</TD><TD>regulation of alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0046637</TD><TD>47</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>2.143e-03</TD><TD>-6.15</TD><TD>NF-kappa B signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04064</TD><TD>91</TD><TD>3</TD><TD>6908</TD><TD>20</TD>
<TD>PTGS2,CXCL2,TNFSF13B</TD></TR>
<TR><TD>2.149e-03</TD><TD>-6.14</TD><TD>SUNG_METASTASIS_STROMA_DN</TD><TD>MSigDB lists</TD><TD>SUNG_METASTASIS_STROMA_DN</TD><TD>49</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,MT1F</TD></TR>
<TR><TD>2.161e-03</TD><TD>-6.14</TD><TD>GSE22886_NEUTROPHIL_VS_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE22886_NEUTROPHIL_VS_DC_UP</TD><TD>185</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,PIM2</TD></TR>
<TR><TD>2.195e-03</TD><TD>-6.12</TD><TD>GSE360_L_MAJOR_VS_T_GONDII_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_T_GONDII_MAC_UP</TD><TD>186</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF2,CCL20</TD></TR>
<TR><TD>2.195e-03</TD><TD>-6.12</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP</TD><TD>186</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,CCL5</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin triggered resolvin D biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY66-395</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin triggered resolvin E biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY66-394</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin-triggered lipoxin biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY66-393</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin triggered resolvin E biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY66-394</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin-triggered lipoxin biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY66-393</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.205e-03</TD><TD>-6.12</TD><TD>aspirin triggered resolvin D biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY66-395</TD><TD>2</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.225e-03</TD><TD>-6.11</TD><TD>RUTELLA_RESPONSE_TO_HGF_UP</TD><TD>MSigDB lists</TD><TD>RUTELLA_RESPONSE_TO_HGF_UP</TD><TD>401</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL8,CXCL3,MT1F</TD></TR>
<TR><TD>2.228e-03</TD><TD>-6.11</TD><TD>GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>187</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5,MT1F</TD></TR>
<TR><TD>2.262e-03</TD><TD>-6.09</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP</TD><TD>188</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,G0S2,MT1F</TD></TR>
<TR><TD>2.262e-03</TD><TD>-6.09</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN</TD><TD>MSigDB lists</TD><TD>GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN</TD><TD>188</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CXCL3</TD></TR>
<TR><TD>2.262e-03</TD><TD>-6.09</TD><TD>GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_CPG_1H_BMDM_DN</TD><TD>188</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2,IL6</TD></TR>
<TR><TD>2.297e-03</TD><TD>-6.08</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN</TD><TD>189</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F,CXCL6,DKK1</TD></TR>
<TR><TD>2.297e-03</TD><TD>-6.08</TD><TD>GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP</TD><TD>189</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3,CXCL2</TD></TR>
<TR><TD>2.297e-03</TD><TD>-6.08</TD><TD>GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN</TD><TD>MSigDB lists</TD><TD>GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN</TD><TD>189</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2,CCL8</TD></TR>
<TR><TD>2.303e-03</TD><TD>-6.07</TD><TD>cellular response to amino acid stimulus</TD><TD>biological process</TD><TD>GO:0071230</TD><TD>49</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,MMP3</TD></TR>
<TR><TD>2.303e-03</TD><TD>-6.07</TD><TD>regulation of nitric oxide biosynthetic process</TD><TD>biological process</TD><TD>GO:0045428</TD><TD>49</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>2.331e-03</TD><TD>-6.06</TD><TD>GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN</TD><TD>190</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL1,NFKBIZ</TD></TR>
<TR><TD>2.366e-03</TD><TD>-6.05</TD><TD>GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN</TD><TD>191</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5,CD83</TD></TR>
<TR><TD>2.374e-03</TD><TD>-6.04</TD><TD>cell activation</TD><TD>biological process</TD><TD>GO:0001775</TD><TD>664</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11,CCL5,CSF2,IL6</TD></TR>
<TR><TD>2.397e-03</TD><TD>-6.03</TD><TD>positive regulation of transcription factor import into nucleus</TD><TD>biological process</TD><TD>GO:0042993</TD><TD>50</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3</TD></TR>
<TR><TD>2.402e-03</TD><TD>-6.03</TD><TD>GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_CPG_12H_BMDM_DN</TD><TD>192</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,NFKBIZ,PTGS2</TD></TR>
<TR><TD>2.402e-03</TD><TD>-6.03</TD><TD>GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN</TD><TD>192</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,NFKBIZ,CXCL3</TD></TR>
<TR><TD>2.402e-03</TD><TD>-6.03</TD><TD>GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP</TD><TD>192</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,G0S2</TD></TR>
<TR><TD>2.402e-03</TD><TD>-6.03</TD><TD>GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_POLYIC_12H_BMDM_DN</TD><TD>192</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CCL5,CD83</TD></TR>
<TR><TD>2.417e-03</TD><TD>-6.03</TD><TD>KRIEG_HYPOXIA_VIA_KDM3A</TD><TD>MSigDB lists</TD><TD>KRIEG_HYPOXIA_VIA_KDM3A</TD><TD>52</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,C15orf48</TD></TR>
<TR><TD>2.417e-03</TD><TD>-6.03</TD><TD>BROWNE_HCMV_INFECTION_4HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_4HR_UP</TD><TD>52</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2</TD></TR>
<TR><TD>2.417e-03</TD><TD>-6.03</TD><TD>VILIMAS_NOTCH1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>VILIMAS_NOTCH1_TARGETS_UP</TD><TD>52</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>2.437e-03</TD><TD>-6.02</TD><TD>GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN</TD><TD>193</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL8,TNFSF13B</TD></TR>
<TR><TD>2.437e-03</TD><TD>-6.02</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_UP</TD><TD>193</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,PTGS2,CCL5</TD></TR>
<TR><TD>2.437e-03</TD><TD>-6.02</TD><TD>GSE360_DC_VS_MAC_L_DONOVANI_UP</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_L_DONOVANI_UP</TD><TD>193</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL8,CD83</TD></TR>
<TR><TD>2.437e-03</TD><TD>-6.02</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP</TD><TD>193</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,CXCL3</TD></TR>
<TR><TD>2.437e-03</TD><TD>-6.02</TD><TD>GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_1H_BMDM_DN</TD><TD>193</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2,CXCL2</TD></TR>
<TR><TD>2.455e-03</TD><TD>-6.01</TD><TD>REGULATION_OF_BIOLOGICAL_QUALITY</TD><TD>MSigDB lists</TD><TD>REGULATION_OF_BIOLOGICAL_QUALITY</TD><TD>412</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.473e-03</TD><TD>-6.00</TD><TD>GSE360_CTRL_VS_L_DONOVANI_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_L_DONOVANI_DC_DN</TD><TD>194</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,G0S2,CD83</TD></TR>
<TR><TD>2.473e-03</TD><TD>-6.00</TD><TD>GSE17721_0.5H_VS_24H_CPG_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_24H_CPG_BMDM_DN</TD><TD>194</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5,CXCL6</TD></TR>
<TR><TD>2.473e-03</TD><TD>-6.00</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDM_DN</TD><TD>194</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL3,CXCL6</TD></TR>
<TR><TD>2.473e-03</TD><TD>-6.00</TD><TD>GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN</TD><TD>194</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CSF2,C15orf48</TD></TR>
<TR><TD>2.496e-03</TD><TD>-5.99</TD><TD>positive regulation of multicellular organismal process</TD><TD>biological process</TD><TD>GO:0051240</TD><TD>1353</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,CSF2,CCL20,IL6,CD83</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>GSE20715_0H_VS_6H_OZONE_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE20715_0H_VS_6H_OZONE_LUNG_DN</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL6,ELF3</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>HALLMARK_COMPLEMENT</TD><TD>MSigDB lists</TD><TD>HALLMARK_COMPLEMENT</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5,IL6</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6,CXCL6</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL6,ELF3</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,G0S2,CD83</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP</TD><TD>195</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CSF2,IL6</TD></TR>
<TR><TD>2.583e-03</TD><TD>-5.96</TD><TD>GSE17721_LPS_VS_CPG_1H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_CPG_1H_BMDM_DN</TD><TD>197</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2,CXCL3</TD></TR>
<TR><TD>2.590e-03</TD><TD>-5.96</TD><TD>positive regulation of alpha-beta T cell activation</TD><TD>biological process</TD><TD>GO:0046635</TD><TD>52</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>2.603e-03</TD><TD>-5.95</TD><TD>KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY</TD><TD>54</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>2.610e-03</TD><TD>-5.95</TD><TD>regulation of protein localization to nucleus</TD><TD>biological process</TD><TD>GO:1900180</TD><TD>191</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>2.621e-03</TD><TD>-5.94</TD><TD>HALLMARK_IL2_STAT5_SIGNALING</TD><TD>MSigDB lists</TD><TD>HALLMARK_IL2_STAT5_SIGNALING</TD><TD>198</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CSF2,CD83</TD></TR>
<TR><TD>2.631e-03</TD><TD>-5.94</TD><TD>HAN_SATB1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HAN_SATB1_TARGETS_DN</TD><TD>420</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,PTGS2,IL6</TD></TR>
<TR><TD>2.658e-03</TD><TD>-5.93</TD><TD>GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN</TD><TD>199</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,G0S2,CD83</TD></TR>
<TR><TD>2.689e-03</TD><TD>-5.92</TD><TD>regulation of epithelial cell apoptotic process</TD><TD>biological process</TD><TD>GO:1904035</TD><TD>53</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,IL6</TD></TR>
<TR><TD>2.788e-03</TD><TD>-5.88</TD><TD>prostaglandin-endoperoxide synthase activity</TD><TD>molecular function</TD><TD>GO:0004666</TD><TD>2</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.789e-03</TD><TD>-5.88</TD><TD>positive regulation of nitrogen compound metabolic process</TD><TD>biological process</TD><TD>GO:0051173</TD><TD>1781</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,PIM2,CCL5,CSF2,IL6,ELF3</TD></TR>
<TR><TD>2.797e-03</TD><TD>-5.88</TD><TD>YAMASHITA_METHYLATED_IN_PROSTATE_CANCER</TD><TD>MSigDB lists</TD><TD>YAMASHITA_METHYLATED_IN_PROSTATE_CANCER</TD><TD>56</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,G0S2</TD></TR>
<TR><TD>2.797e-03</TD><TD>-5.88</TD><TD>AMIT_SERUM_RESPONSE_60_MCF10A</TD><TD>MSigDB lists</TD><TD>AMIT_SERUM_RESPONSE_60_MCF10A</TD><TD>56</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20</TD></TR>
<TR><TD>2.799e-03</TD><TD>-5.88</TD><TD>positive regulation of molecular function</TD><TD>biological process</TD><TD>GO:0044093</TD><TD>1782</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CSF3,CCL20,CCL8,IL6,CXCL1,CSF2,CCL5</TD></TR>
<TR><TD>2.812e-03</TD><TD>-5.87</TD><TD>HOMEOSTATIC_PROCESS</TD><TD>MSigDB lists</TD><TD>HOMEOSTATIC_PROCESS</TD><TD>203</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5,IL6</TD></TR>
<TR><TD>2.849e-03</TD><TD>-5.86</TD><TD>regulation of angiogenesis</TD><TD>biological process</TD><TD>GO:0045765</TD><TD>197</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.855e-03</TD><TD>-5.86</TD><TD>human chr7p21</TD><TD>chromosome location</TD><TD>human chr7p21</TD><TD>3</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.890e-03</TD><TD>-5.85</TD><TD>myeloid cell differentiation</TD><TD>biological process</TD><TD>GO:0030099</TD><TD>198</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,CSF2</TD></TR>
<TR><TD>2.891e-03</TD><TD>-5.85</TD><TD>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</TD><TD>MSigDB lists</TD><TD>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</TD><TD>205</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL2,CXCL6</TD></TR>
<TR><TD>2.896e-03</TD><TD>-5.84</TD><TD>TATCTGG,MIR-488</TD><TD>MSigDB lists</TD><TD>TATCTGG,MIR-488</TD><TD>57</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CD83</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>cellular response to vitamin K</TD><TD>biological process</TD><TD>GO:0071307</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>positive regulation of interleukin-1 biosynthetic process</TD><TD>biological process</TD><TD>GO:0045362</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>regulation of interleukin-1 biosynthetic process</TD><TD>biological process</TD><TD>GO:0045360</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>positive regulation of platelet-derived growth factor production</TD><TD>biological process</TD><TD>GO:0090362</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>positive regulation of heart induction</TD><TD>biological process</TD><TD>GO:1901321</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment</TD><TD>biological process</TD><TD>GO:1901295</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>cellular response to high density lipoprotein particle stimulus</TD><TD>biological process</TD><TD>GO:0071403</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway</TD><TD>biological process</TD><TD>GO:0090082</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.917e-03</TD><TD>-5.84</TD><TD>hepatic immune response</TD><TD>biological process</TD><TD>GO:0002384</TD><TD>2</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.991e-03</TD><TD>-5.81</TD><TD>FAM160B1 (family with sequence similarity 160, member B1)</TD><TD>protein interactions</TD><TD>57700</TD><TD>2</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.991e-03</TD><TD>-5.81</TD><TD>SLC2A5 (solute carrier family 2 (facilitated glucose/fructose transporter), member 5)</TD><TD>protein interactions</TD><TD>6518</TD><TD>2</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.991e-03</TD><TD>-5.81</TD><TD>PDSS1 (prenyl (decaprenyl) diphosphate synthase, subunit 1)</TD><TD>protein interactions</TD><TD>23590</TD><TD>2</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.991e-03</TD><TD>-5.81</TD><TD>ORMDL2 (ORMDL sphingolipid biosynthesis regulator 2)</TD><TD>protein interactions</TD><TD>29095</TD><TD>2</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.991e-03</TD><TD>-5.81</TD><TD>TK2 (thymidine kinase 2, mitochondrial)</TD><TD>protein interactions</TD><TD>7084</TD><TD>2</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.997e-03</TD><TD>-5.81</TD><TD>NAKAMURA_ADIPOGENESIS_EARLY_UP</TD><TD>MSigDB lists</TD><TD>NAKAMURA_ADIPOGENESIS_EARLY_UP</TD><TD>58</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F,DKK1</TD></TR>
<TR><TD>2.997e-03</TD><TD>-5.81</TD><TD>ISSAEVA_MLL2_TARGETS</TD><TD>MSigDB lists</TD><TD>ISSAEVA_MLL2_TARGETS</TD><TD>58</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3,DKK1</TD></TR>
<TR><TD>2.997e-03</TD><TD>-5.81</TD><TD>regulation of B cell proliferation</TD><TD>biological process</TD><TD>GO:0030888</TD><TD>56</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,TNFSF13B</TD></TR>
<TR><TD>3.022e-03</TD><TD>-5.80</TD><TD>protein binding</TD><TD>molecular function</TD><TD>GO:0005515</TD><TD>10510</TD><TD>21</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,CXCL2,CCL5,CSF2,DKK1,ELF3,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>3.027e-03</TD><TD>-5.80</TD><TD>EBV LMP1 signaling</TD><TD>WikiPathways</TD><TD>WP262</TD><TD>22</TD><TD>2</TD><TD>4455</TD><TD>17</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>3.080e-03</TD><TD>-5.78</TD><TD>Calcium signaling in the CD4+ TCR pathway</TD><TD>Pathway Interaction DB</TD><TD>tcrcalciumpathway</TD><TD>28</TD><TD>2</TD><TD>2227</TD><TD>7</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>3.083e-03</TD><TD>-5.78</TD><TD>regulation of apoptotic process</TD><TD>biological process</TD><TD>GO:0042981</TD><TD>1404</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11,PIM2,CCL5,CSF2,G0S2,IL6</TD></TR>
<TR><TD>3.099e-03</TD><TD>-5.78</TD><TD>AMIT_EGF_RESPONSE_240_HELA</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_240_HELA</TD><TD>59</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,DKK1</TD></TR>
<TR><TD>3.104e-03</TD><TD>-5.78</TD><TD>positive regulation of phosphatidylinositol 3-kinase signaling</TD><TD>biological process</TD><TD>GO:0014068</TD><TD>57</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5</TD></TR>
<TR><TD>3.144e-03</TD><TD>-5.76</TD><TD>regulation of nucleocytoplasmic transport</TD><TD>biological process</TD><TD>GO:0046822</TD><TD>204</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>3.152e-03</TD><TD>-5.76</TD><TD>INTRLEUKIN11</TD><TD>prints domains</TD><TD>PR01927</TD><TD>1</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>IL11</TD></TR>
<TR><TD>3.152e-03</TD><TD>-5.76</TD><TD>GMCSFACTOR</TD><TD>prints domains</TD><TD>PR00693</TD><TD>1</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>CSF2</TD></TR>
<TR><TD>3.152e-03</TD><TD>-5.76</TD><TD>INTLKN11MAML</TD><TD>prints domains</TD><TD>PR01943</TD><TD>1</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>IL11</TD></TR>
<TR><TD>3.162e-03</TD><TD>-5.76</TD><TD>TGANTCA_V$AP1_C</TD><TD>MSigDB lists</TD><TD>TGANTCA_V$AP1_C</TD><TD>1074</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CSF3,IL11,MMP3,G0S2,IL6</TD></TR>
<TR><TD>3.204e-03</TD><TD>-5.74</TD><TD>CUI_GLUCOSE_DEPRIVATION</TD><TD>MSigDB lists</TD><TD>CUI_GLUCOSE_DEPRIVATION</TD><TD>60</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,ELF3</TD></TR>
<TR><TD>3.204e-03</TD><TD>-5.74</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</TD><TD>60</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,G0S2</TD></TR>
<TR><TD>3.209e-03</TD><TD>-5.74</TD><TD>regulation of programmed cell death</TD><TD>biological process</TD><TD>GO:0043067</TD><TD>1414</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11,PIM2,CCL5,CSF2,G0S2,IL6</TD></TR>
<TR><TD>3.241e-03</TD><TD>-5.73</TD><TD>SMID_BREAST_CANCER_NORMAL_LIKE_UP</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_NORMAL_LIKE_UP</TD><TD>445</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL2,CCL5,IL6</TD></TR>
<TR><TD>3.264e-03</TD><TD>-5.72</TD><TD>response to inorganic substance</TD><TD>biological process</TD><TD>GO:0010035</TD><TD>431</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,MMP3,IL6,MT1F</TD></TR>
<TR><TD>3.400e-03</TD><TD>-5.68</TD><TD>Amoebiasis</TD><TD>KEGG pathways</TD><TD>ko05146</TD><TD>107</TD><TD>3</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CSF2,IL6</TD></TR>
<TR><TD>3.400e-03</TD><TD>-5.68</TD><TD>Amoebiasis</TD><TD>KEGG pathways</TD><TD>hsa05146</TD><TD>107</TD><TD>3</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CSF2,IL6</TD></TR>
<TR><TD>3.526e-03</TD><TD>-5.65</TD><TD>GERHOLD_ADIPOGENESIS_DN</TD><TD>MSigDB lists</TD><TD>GERHOLD_ADIPOGENESIS_DN</TD><TD>63</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,G0S2</TD></TR>
<TR><TD>3.526e-03</TD><TD>-5.65</TD><TD>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</TD><TD>MSigDB lists</TD><TD>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</TD><TD>63</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,IL6</TD></TR>
<TR><TD>3.526e-03</TD><TD>-5.65</TD><TD>PID_MYC_REPRESS_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_MYC_REPRESS_PATHWAY</TD><TD>63</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>3.546e-03</TD><TD>-5.64</TD><TD>cellular response to ketone</TD><TD>biological process</TD><TD>GO:1901655</TD><TD>61</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>3.550e-03</TD><TD>-5.64</TD><TD>lymphocyte differentiation</TD><TD>biological process</TD><TD>GO:0030098</TD><TD>213</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11,IL6</TD></TR>
<TR><TD>3.573e-03</TD><TD>-5.63</TD><TD>V$CEBP_Q2</TD><TD>MSigDB lists</TD><TD>V$CEBP_Q2</TD><TD>221</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,NFKBIZ,G0S2</TD></TR>
<TR><TD>3.661e-03</TD><TD>-5.61</TD><TD>regulation of reactive oxygen species biosynthetic process</TD><TD>biological process</TD><TD>GO:1903426</TD><TD>62</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>3.692e-03</TD><TD>-5.60</TD><TD>regulation of vasculature development</TD><TD>biological process</TD><TD>GO:1901342</TD><TD>216</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>3.711e-03</TD><TD>-5.60</TD><TD>V$NFKB_Q6_01</TD><TD>MSigDB lists</TD><TD>V$NFKB_Q6_01</TD><TD>224</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CSF3,CCL5</TD></TR>
<TR><TD>3.740e-03</TD><TD>-5.59</TD><TD>defense response to bacterium</TD><TD>biological process</TD><TD>GO:0042742</TD><TD>217</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20,IL6,CXCL6</TD></TR>
<TR><TD>3.756e-03</TD><TD>-5.58</TD><TD>regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045595</TD><TD>1454</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,CSF2,IL6,DKK1,CD83</TD></TR>
<TR><TD>3.805e-03</TD><TD>-5.57</TD><TD>V$AP2ALPHA_01</TD><TD>MSigDB lists</TD><TD>V$AP2ALPHA_01</TD><TD>226</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,IL11,CD83</TD></TR>
<TR><TD>3.862e-03</TD><TD>-5.56</TD><TD>AMIT_EGF_RESPONSE_120_HELA</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_120_HELA</TD><TD>66</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2</TD></TR>
<TR><TD>3.896e-03</TD><TD>-5.55</TD><TD>leukocyte homeostasis</TD><TD>biological process</TD><TD>GO:0001776</TD><TD>64</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>3.978e-03</TD><TD>-5.53</TD><TD>KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION</TD><TD>MSigDB lists</TD><TD>KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION</TD><TD>67</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL5</TD></TR>
<TR><TD>4.095e-03</TD><TD>-5.50</TD><TD>Flavin_amine_oxidase</TD><TD>interpro domains</TD><TD>IPR001613</TD><TD>3</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.095e-03</TD><TD>-5.50</TD><TD>B12D</TD><TD>interpro domains</TD><TD>IPR010530</TD><TD>3</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>C15orf48</TD></TR>
<TR><TD>4.095e-03</TD><TD>-5.50</TD><TD>PIM1/2/3</TD><TD>interpro domains</TD><TD>IPR017348</TD><TD>3</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.095e-03</TD><TD>-5.50</TD><TD>FURUKAWA_DUSP6_TARGETS_PCI35_UP</TD><TD>MSigDB lists</TD><TD>FURUKAWA_DUSP6_TARGETS_PCI35_UP</TD><TD>68</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>C15orf48,TNFSF13B</TD></TR>
<TR><TD>4.095e-03</TD><TD>-5.50</TD><TD>WESTON_VEGFA_TARGETS_3HR</TD><TD>MSigDB lists</TD><TD>WESTON_VEGFA_TARGETS_3HR</TD><TD>68</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MMP3</TD></TR>
<TR><TD>4.179e-03</TD><TD>-5.48</TD><TD>CCR2 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031727</TD><TD>3</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL7</TD></TR>
<TR><TD>4.179e-03</TD><TD>-5.48</TD><TD>arachidonate 15-lipoxygenase activity</TD><TD>molecular function</TD><TD>GO:0050473</TD><TD>3</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.194e-03</TD><TD>-5.47</TD><TD>V$OCT1_05</TD><TD>MSigDB lists</TD><TD>V$OCT1_05</TD><TD>234</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,IL6,DKK1</TD></TR>
<TR><TD>4.213e-03</TD><TD>-5.47</TD><TD>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</TD><TD>MSigDB lists</TD><TD>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</TD><TD>69</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2</TD></TR>
<TR><TD>4.213e-03</TD><TD>-5.47</TD><TD>PID_AP1_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_AP1_PATHWAY</TD><TD>69</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>4.244e-03</TD><TD>-5.46</TD><TD>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</TD><TD>MSigDB lists</TD><TD>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</TD><TD>235</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PIM2,CCL5</TD></TR>
<TR><TD>4.263e-03</TD><TD>-5.46</TD><TD>interleukin-6 receptor complex</TD><TD>cellular component</TD><TD>GO:0005896</TD><TD>3</TD><TD>1</TD><TD>17570</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.295e-03</TD><TD>-5.45</TD><TD>V$AP2GAMMA_01</TD><TD>MSigDB lists</TD><TD>V$AP2GAMMA_01</TD><TD>236</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,IL11,CD83</TD></TR>
<TR><TD>4.343e-03</TD><TD>-5.44</TD><TD>PLG (plasminogen)</TD><TD>protein interactions</TD><TD>5340</TD><TD>66</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL2,MMP3</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>neutrophil apoptotic process</TD><TD>biological process</TD><TD>GO:0001781</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>maintenance of blood-brain barrier</TD><TD>biological process</TD><TD>GO:0035633</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>B cell costimulation</TD><TD>biological process</TD><TD>GO:0031296</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>regulation of STAT protein import into nucleus</TD><TD>biological process</TD><TD>GO:2000364</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>negative regulation of synaptic transmission, dopaminergic</TD><TD>biological process</TD><TD>GO:0032227</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>positive regulation of STAT protein import into nucleus</TD><TD>biological process</TD><TD>GO:2000366</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>positive regulation of fibroblast growth factor production</TD><TD>biological process</TD><TD>GO:0090271</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>negative regulation of chemokine biosynthetic process</TD><TD>biological process</TD><TD>GO:0045079</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>regulation of heart induction by regulation of canonical Wnt signaling pathway</TD><TD>biological process</TD><TD>GO:0090081</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.373e-03</TD><TD>-5.43</TD><TD>regulation of platelet-derived growth factor production</TD><TD>biological process</TD><TD>GO:0090361</TD><TD>3</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.449e-03</TD><TD>-5.42</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</TD><TD>MSigDB lists</TD><TD>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</TD><TD>239</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL5,C15orf48</TD></TR>
<TR><TD>4.455e-03</TD><TD>-5.41</TD><TD>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</TD><TD>MSigDB lists</TD><TD>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9</TD><TD>71</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CD83,ELF3</TD></TR>
<TR><TD>4.475e-03</TD><TD>-5.41</TD><TD>Prion diseases</TD><TD>KEGG pathways</TD><TD>ko05020</TD><TD>35</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>4.475e-03</TD><TD>-5.41</TD><TD>Prion diseases</TD><TD>KEGG pathways</TD><TD>hsa05020</TD><TD>35</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>4.483e-03</TD><TD>-5.41</TD><TD>TMED8 (transmembrane p24 trafficking protein family member 8)</TD><TD>protein interactions</TD><TD>283578</TD><TD>3</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.483e-03</TD><TD>-5.41</TD><TD>SPOCK3 (sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3)</TD><TD>protein interactions</TD><TD>50859</TD><TD>3</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.504e-03</TD><TD>-5.40</TD><TD>B12D</TD><TD>pfam domains</TD><TD>PF06522</TD><TD>3</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>C15orf48</TD></TR>
<TR><TD>4.579e-03</TD><TD>-5.39</TD><TD>BRUECKNER_TARGETS_OF_MIRLET7A3_DN</TD><TD>MSigDB lists</TD><TD>BRUECKNER_TARGETS_OF_MIRLET7A3_DN</TD><TD>72</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL3</TD></TR>
<TR><TD>4.607e-03</TD><TD>-5.38</TD><TD>KOBAYASHI_EGFR_SIGNALING_24HR_DN</TD><TD>MSigDB lists</TD><TD>KOBAYASHI_EGFR_SIGNALING_24HR_DN</TD><TD>242</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,G0S2,DKK1</TD></TR>
<TR><TD>4.619e-03</TD><TD>-5.38</TD><TD>regulation of leukocyte differentiation</TD><TD>biological process</TD><TD>GO:1902105</TD><TD>234</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83</TD></TR>
<TR><TD>4.642e-03</TD><TD>-5.37</TD><TD>regulation of alpha-beta T cell activation</TD><TD>biological process</TD><TD>GO:0046634</TD><TD>70</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>4.660e-03</TD><TD>-5.37</TD><TD>V$STAT_Q6</TD><TD>MSigDB lists</TD><TD>V$STAT_Q6</TD><TD>243</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,MMP3,CCL20</TD></TR>
<TR><TD>4.771e-03</TD><TD>-5.35</TD><TD>CHEN_METABOLIC_SYNDROM_NETWORK</TD><TD>MSigDB lists</TD><TD>CHEN_METABOLIC_SYNDROM_NETWORK</TD><TD>1167</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL2,MMP3,CD83,ELF3,TNFSF13B</TD></TR>
<TR><TD>4.773e-03</TD><TD>-5.34</TD><TD>positive regulation of T cell differentiation</TD><TD>biological process</TD><TD>GO:0045582</TD><TD>71</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>4.773e-03</TD><TD>-5.34</TD><TD>negative regulation of hormone secretion</TD><TD>biological process</TD><TD>GO:0046888</TD><TD>71</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,IL6</TD></TR>
<TR><TD>4.826e-03</TD><TD>-5.33</TD><TD>negative regulation of signaling</TD><TD>biological process</TD><TD>GO:0023057</TD><TD>1132</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11,CCL5,CSF2,IL6,DKK1</TD></TR>
<TR><TD>4.830e-03</TD><TD>-5.33</TD><TD>RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP</TD><TD>MSigDB lists</TD><TD>RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP</TD><TD>74</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,G0S2</TD></TR>
<TR><TD>4.900e-03</TD><TD>-5.32</TD><TD>regulation of neuron death</TD><TD>biological process</TD><TD>GO:1901214</TD><TD>239</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5,IL6</TD></TR>
<TR><TD>4.958e-03</TD><TD>-5.31</TD><TD>JACKSON_DNMT1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>JACKSON_DNMT1_TARGETS_UP</TD><TD>75</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2</TD></TR>
<TR><TD>5.082e-03</TD><TD>-5.28</TD><TD>negative regulation of cell communication</TD><TD>biological process</TD><TD>GO:0010648</TD><TD>1144</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11,CCL5,CSF2,IL6,DKK1</TD></TR>
<TR><TD>5.088e-03</TD><TD>-5.28</TD><TD>GAVIN_FOXP3_TARGETS_CLUSTER_P2</TD><TD>MSigDB lists</TD><TD>GAVIN_FOXP3_TARGETS_CLUSTER_P2</TD><TD>76</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>5.088e-03</TD><TD>-5.28</TD><TD>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</TD><TD>MSigDB lists</TD><TD>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP</TD><TD>76</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>5.099e-03</TD><TD>-5.28</TD><TD>V$BACH1_01</TD><TD>MSigDB lists</TD><TD>V$BACH1_01</TD><TD>251</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,MMP3</TD></TR>
<TR><TD>5.099e-03</TD><TD>-5.28</TD><TD>V$AP1_01</TD><TD>MSigDB lists</TD><TD>V$AP1_01</TD><TD>251</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,IL6</TD></TR>
<TR><TD>5.174e-03</TD><TD>-5.26</TD><TD>regulation of phosphatidylinositol 3-kinase signaling</TD><TD>biological process</TD><TD>GO:0014066</TD><TD>74</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5</TD></TR>
<TR><TD>5.174e-03</TD><TD>-5.26</TD><TD>positive regulation of DNA replication</TD><TD>biological process</TD><TD>GO:0045740</TD><TD>74</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>5.213e-03</TD><TD>-5.26</TD><TD>V$CP2_01</TD><TD>MSigDB lists</TD><TD>V$CP2_01</TD><TD>253</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,NFKBIZ,CSF2</TD></TR>
<TR><TD>5.219e-03</TD><TD>-5.26</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>MSigDB lists</TD><TD>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</TD><TD>77</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,G0S2</TD></TR>
<TR><TD>5.219e-03</TD><TD>-5.26</TD><TD>RESPONSE_TO_OTHER_ORGANISM</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_OTHER_ORGANISM</TD><TD>77</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>5.309e-03</TD><TD>-5.24</TD><TD>positive regulation of intracellular protein transport</TD><TD>biological process</TD><TD>GO:0090316</TD><TD>246</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>5.328e-03</TD><TD>-5.23</TD><TD>V$NFKB_C</TD><TD>MSigDB lists</TD><TD>V$NFKB_C</TD><TD>255</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,PTGS2,CCL5</TD></TR>
<TR><TD>5.353e-03</TD><TD>-5.23</TD><TD>IL23-mediated signaling events</TD><TD>Pathway Interaction DB</TD><TD>il23pathway</TD><TD>37</TD><TD>2</TD><TD>2227</TD><TD>7</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>5.456e-03</TD><TD>-5.21</TD><TD>Dickkopf_N</TD><TD>interpro domains</TD><TD>IPR006796</TD><TD>4</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>5.486e-03</TD><TD>-5.21</TD><TD>HARRIS_HYPOXIA</TD><TD>MSigDB lists</TD><TD>HARRIS_HYPOXIA</TD><TD>79</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>5.486e-03</TD><TD>-5.21</TD><TD>MUNSHI_MULTIPLE_MYELOMA_UP</TD><TD>MSigDB lists</TD><TD>MUNSHI_MULTIPLE_MYELOMA_UP</TD><TD>79</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CSF2</TD></TR>
<TR><TD>5.498e-03</TD><TD>-5.20</TD><TD>positive regulation of GTPase activity</TD><TD>biological process</TD><TD>GO:0043547</TD><TD>499</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>5.498e-03</TD><TD>-5.20</TD><TD>secretion by cell</TD><TD>biological process</TD><TD>GO:0032940</TD><TD>499</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>5.564e-03</TD><TD>-5.19</TD><TD>V$CEBP_Q2_01</TD><TD>MSigDB lists</TD><TD>V$CEBP_Q2_01</TD><TD>259</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL8,TNFSF13B</TD></TR>
<TR><TD>5.622e-03</TD><TD>-5.18</TD><TD>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>MORI_SMALL_PRE_BII_LYMPHOCYTE_UP</TD><TD>80</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CSF2</TD></TR>
<TR><TD>5.622e-03</TD><TD>-5.18</TD><TD>PID_REG_GR_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_REG_GR_PATHWAY</TD><TD>80</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>5.623e-03</TD><TD>-5.18</TD><TD>ROZANOV_MMP14_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>ROZANOV_MMP14_TARGETS_UP</TD><TD>260</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL20,CD83</TD></TR>
<TR><TD>5.651e-03</TD><TD>-5.18</TD><TD>regulation of cellular metabolic process</TD><TD>biological process</TD><TD>GO:0031323</TD><TD>5773</TD><TD>15</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,MMP3,CCL20,CCL8,IL6,NFKBIZ,PIM2,CCL5,CSF2,DKK1,ELF3</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>positive regulation of cell-cell adhesion mediated by integrin</TD><TD>biological process</TD><TD>GO:0033634</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>nicotinamide metabolic process</TD><TD>biological process</TD><TD>GO:0006769</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>negative regulation of macrophage apoptotic process</TD><TD>biological process</TD><TD>GO:2000110</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>negative regulation of mesodermal cell fate specification</TD><TD>biological process</TD><TD>GO:0042662</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>regulation of heart induction</TD><TD>biological process</TD><TD>GO:0090381</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>response to vitamin K</TD><TD>biological process</TD><TD>GO:0032571</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>negative regulation of cytolysis</TD><TD>biological process</TD><TD>GO:0045918</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>positive regulation of germinal center formation</TD><TD>biological process</TD><TD>GO:0002636</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>regulation of endodermal cell fate specification</TD><TD>biological process</TD><TD>GO:0042663</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>cellular response to morphine</TD><TD>biological process</TD><TD>GO:0071315</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>negative regulation of Wnt signaling pathway involved in heart development</TD><TD>biological process</TD><TD>GO:0003308</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>response to high density lipoprotein particle</TD><TD>biological process</TD><TD>GO:0055099</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>5.827e-03</TD><TD>-5.15</TD><TD>positive regulation of type B pancreatic cell apoptotic process</TD><TD>biological process</TD><TD>GO:2000676</TD><TD>4</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>5.866e-03</TD><TD>-5.14</TD><TD>positive regulation of cytoplasmic transport</TD><TD>biological process</TD><TD>GO:1903651</TD><TD>255</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>5.875e-03</TD><TD>-5.14</TD><TD>response to vitamin</TD><TD>biological process</TD><TD>GO:0033273</TD><TD>79</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>5.973e-03</TD><TD>-5.12</TD><TD>TATAAA_V$TATA_01</TD><TD>MSigDB lists</TD><TD>TATAAA_V$TATA_01</TD><TD>1222</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3,MMP3,CCL5,G0S2,DKK1</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>PTGIS (prostaglandin I2 (prostacyclin) synthase)</TD><TD>protein interactions</TD><TD>5740</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>SPOCK1 (sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1)</TD><TD>protein interactions</TD><TD>6695</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>ZNF821 (zinc finger protein 821)</TD><TD>protein interactions</TD><TD>55565</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PIM2</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>MMP10 (matrix metallopeptidase 10)</TD><TD>protein interactions</TD><TD>4319</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>SMDT1 (single-pass membrane protein with aspartate-rich tail 1)</TD><TD>protein interactions</TD><TD>91689</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>Vcp (valosin containing protein)</TD><TD>protein interactions</TD><TD>269523</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>5.974e-03</TD><TD>-5.12</TD><TD>MAP3K15 (mitogen-activated protein kinase kinase kinase 15)</TD><TD>protein interactions</TD><TD>389840</TD><TD>4</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>6.001e-03</TD><TD>-5.12</TD><TD>Dickkopf_N</TD><TD>pfam domains</TD><TD>PF04706</TD><TD>4</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>6.052e-03</TD><TD>-5.11</TD><TD>negative regulation of apoptotic process</TD><TD>biological process</TD><TD>GO:0043066</TD><TD>826</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,PIM2,CCL5,CSF2,IL6</TD></TR>
<TR><TD>6.115e-03</TD><TD>-5.10</TD><TD>POOLA_INVASIVE_BREAST_CANCER_UP</TD><TD>MSigDB lists</TD><TD>POOLA_INVASIVE_BREAST_CANCER_UP</TD><TD>268</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,MMP3,CCL8</TD></TR>
<TR><TD>6.168e-03</TD><TD>-5.09</TD><TD>positive regulation of myeloid cell differentiation</TD><TD>biological process</TD><TD>GO:0045639</TD><TD>81</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5</TD></TR>
<TR><TD>6.168e-03</TD><TD>-5.09</TD><TD>positive regulation of reactive oxygen species metabolic process</TD><TD>biological process</TD><TD>GO:2000379</TD><TD>81</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>6.168e-03</TD><TD>-5.09</TD><TD>positive regulation of translation</TD><TD>biological process</TD><TD>GO:0045727</TD><TD>81</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>6.181e-03</TD><TD>-5.09</TD><TD>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</TD><TD>MSigDB lists</TD><TD>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</TD><TD>84</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5</TD></TR>
<TR><TD>6.181e-03</TD><TD>-5.09</TD><TD>SECRETORY_PATHWAY</TD><TD>MSigDB lists</TD><TD>SECRETORY_PATHWAY</TD><TD>84</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>6.181e-03</TD><TD>-5.09</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</TD><TD>MSigDB lists</TD><TD>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</TD><TD>84</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,DKK1</TD></TR>
<TR><TD>6.181e-03</TD><TD>-5.09</TD><TD>KIM_GLIS2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KIM_GLIS2_TARGETS_UP</TD><TD>84</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,TNFSF13B</TD></TR>
<TR><TD>6.316e-03</TD><TD>-5.06</TD><TD>positive regulation of protein kinase B signaling</TD><TD>biological process</TD><TD>GO:0051897</TD><TD>82</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>6.334e-03</TD><TD>-5.06</TD><TD>negative regulation of programmed cell death</TD><TD>biological process</TD><TD>GO:0043069</TD><TD>835</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,PIM2,CCL5,CSF2,IL6</TD></TR>
<TR><TD>6.371e-03</TD><TD>-5.06</TD><TD>TBK1.DF_UP</TD><TD>MSigDB lists</TD><TD>TBK1.DF_UP</TD><TD>272</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,G0S2,CD83</TD></TR>
<TR><TD>6.466e-03</TD><TD>-5.04</TD><TD>positive regulation of lymphocyte differentiation</TD><TD>biological process</TD><TD>GO:0045621</TD><TD>83</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>6.524e-03</TD><TD>-5.03</TD><TD>regulation of hormone secretion</TD><TD>biological process</TD><TD>GO:0046883</TD><TD>265</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,CCL5,IL6</TD></TR>
<TR><TD>6.555e-03</TD><TD>-5.03</TD><TD>negative regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048523</TD><TD>4068</TD><TD>12</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,MMP3,CCL8,IL6,CXCL1,PIM2,CSF2,CCL5,DKK1,ELF3</TD></TR>
<TR><TD>6.566e-03</TD><TD>-5.03</TD><TD>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</TD><TD>MSigDB lists</TD><TD>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</TD><TD>275</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL6</TD></TR>
<TR><TD>6.900e-03</TD><TD>-4.98</TD><TD>WANG_MLL_TARGETS</TD><TD>MSigDB lists</TD><TD>WANG_MLL_TARGETS</TD><TD>280</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,IL6,G0S2</TD></TR>
<TR><TD>6.913e-03</TD><TD>-4.97</TD><TD>HECKER_IFNB1_TARGETS</TD><TD>MSigDB lists</TD><TD>HECKER_IFNB1_TARGETS</TD><TD>89</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,G0S2</TD></TR>
<TR><TD>6.955e-03</TD><TD>-4.97</TD><TD>oxysterol binding</TD><TD>molecular function</TD><TD>GO:0008142</TD><TD>5</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>GPR183</TD></TR>
<TR><TD>7.009e-03</TD><TD>-4.96</TD><TD>regulation of inflammatory response</TD><TD>biological process</TD><TD>GO:0050727</TD><TD>272</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>7.020e-03</TD><TD>-4.96</TD><TD>FUJIWARA_PARK2_IN_LIVER_CANCER_DN</TD><TD>MSigDB lists</TD><TD>FUJIWARA_PARK2_IN_LIVER_CANCER_DN</TD><TD>5</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>7.020e-03</TD><TD>-4.96</TD><TD>WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN</TD><TD>MSigDB lists</TD><TD>WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN</TD><TD>5</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>7.020e-03</TD><TD>-4.96</TD><TD>JU_AGING_TERC_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>JU_AGING_TERC_TARGETS_DN</TD><TD>5</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>7.064e-03</TD><TD>-4.95</TD><TD>HILLION_HMGA1B_TARGETS</TD><TD>MSigDB lists</TD><TD>HILLION_HMGA1B_TARGETS</TD><TD>90</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CSF2</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>immunoglobulin secretion</TD><TD>biological process</TD><TD>GO:0048305</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>cellular response to isoquinoline alkaloid</TD><TD>biological process</TD><TD>GO:0071317</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>positive regulation of unsaturated fatty acid biosynthetic process</TD><TD>biological process</TD><TD>GO:2001280</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>positive regulation of prostaglandin biosynthetic process</TD><TD>biological process</TD><TD>GO:0031394</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>negative regulation of chemokine-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0070100</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>positive regulation of interleukin-23 production</TD><TD>biological process</TD><TD>GO:0032747</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>regulation of complement-dependent cytotoxicity</TD><TD>biological process</TD><TD>GO:1903659</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL11</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>T-helper 17 cell lineage commitment</TD><TD>biological process</TD><TD>GO:0072540</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>positive regulation of synaptic plasticity</TD><TD>biological process</TD><TD>GO:0031915</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.278e-03</TD><TD>-4.92</TD><TD>regulation of fibroblast growth factor production</TD><TD>biological process</TD><TD>GO:0090270</TD><TD>5</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.462e-03</TD><TD>-4.90</TD><TD>CCR6 (chemokine (C-C motif) receptor 6)</TD><TD>protein interactions</TD><TD>1235</TD><TD>5</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>7.563e-03</TD><TD>-4.88</TD><TD>hair cycle</TD><TD>biological process</TD><TD>GO:0042633</TD><TD>90</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,DKK1</TD></TR>
<TR><TD>7.563e-03</TD><TD>-4.88</TD><TD>molting cycle</TD><TD>biological process</TD><TD>GO:0042303</TD><TD>90</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,DKK1</TD></TR>
<TR><TD>7.688e-03</TD><TD>-4.87</TD><TD>regulation of metabolic process</TD><TD>biological process</TD><TD>GO:0019222</TD><TD>6593</TD><TD>16</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CCL5,CSF2,DKK1,ELF3,GPR183,CSF3,PTGS2,MMP3,IL6,CCL8,CXCL1,NFKBIZ,PIM2</TD></TR>
<TR><TD>7.718e-03</TD><TD>-4.86</TD><TD>C20 prostanoid biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY66-374</TD><TD>7</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.718e-03</TD><TD>-4.86</TD><TD>C20 prostanoid biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY66-374</TD><TD>7</TD><TD>1</TD><TD>907</TD><TD>1</TD>
<TD>PTGS2</TD></TR>
<TR><TD>7.726e-03</TD><TD>-4.86</TD><TD>tissue remodeling</TD><TD>biological process</TD><TD>GO:0048771</TD><TD>91</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,ELF3</TD></TR>
<TR><TD>7.771e-03</TD><TD>-4.86</TD><TD>large_intestine-rectum-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-rectum-adenoma</TD><TD>103</TD><TD>2</TD><TD>17775</TD><TD>23</TD>
<TD>MMP3,TNFSF13B</TD></TR>
<TR><TD>7.876e-03</TD><TD>-4.84</TD><TD>regulation of GTPase activity</TD><TD>biological process</TD><TD>GO:0043087</TD><TD>553</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>7.891e-03</TD><TD>-4.84</TD><TD>B cell differentiation</TD><TD>biological process</TD><TD>GO:0030183</TD><TD>92</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11</TD></TR>
<TR><TD>7.963e-03</TD><TD>-4.83</TD><TD>Intestinal immune network for IgA production</TD><TD>KEGG pathways</TD><TD>hsa04672</TD><TD>47</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>7.963e-03</TD><TD>-4.83</TD><TD>Intestinal immune network for IgA production</TD><TD>KEGG pathways</TD><TD>ko04672</TD><TD>47</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>7.963e-03</TD><TD>-4.83</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</TD><TD>295</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,DKK1</TD></TR>
<TR><TD>8.002e-03</TD><TD>-4.83</TD><TD>WIELAND_UP_BY_HBV_INFECTION</TD><TD>MSigDB lists</TD><TD>WIELAND_UP_BY_HBV_INFECTION</TD><TD>96</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>8.157e-03</TD><TD>-4.81</TD><TD>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</TD><TD>MSigDB lists</TD><TD>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</TD><TD>578</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20,IL6,ELF3</TD></TR>
<TR><TD>8.163e-03</TD><TD>-4.81</TD><TD>RICKMAN_HEAD_AND_NECK_CANCER_C</TD><TD>MSigDB lists</TD><TD>RICKMAN_HEAD_AND_NECK_CANCER_C</TD><TD>97</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,DKK1</TD></TR>
<TR><TD>8.225e-03</TD><TD>-4.80</TD><TD>regulation of transcription factor import into nucleus</TD><TD>biological process</TD><TD>GO:0042990</TD><TD>94</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3</TD></TR>
<TR><TD>8.278e-03</TD><TD>-4.79</TD><TD>positive regulation of apoptotic process</TD><TD>biological process</TD><TD>GO:0043065</TD><TD>561</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,G0S2,IL6</TD></TR>
<TR><TD>8.326e-03</TD><TD>-4.79</TD><TD>BASSO_CD40_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>BASSO_CD40_SIGNALING_UP</TD><TD>98</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CD83</TD></TR>
<TR><TD>8.326e-03</TD><TD>-4.79</TD><TD>TAVAZOIE_METASTASIS</TD><TD>MSigDB lists</TD><TD>TAVAZOIE_METASTASIS</TD><TD>98</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3</TD></TR>
<TR><TD>8.340e-03</TD><TD>-4.79</TD><TD>CCR5 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031730</TD><TD>6</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.340e-03</TD><TD>-4.79</TD><TD>co-receptor binding</TD><TD>molecular function</TD><TD>GO:0039706</TD><TD>6</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>DKK1</TD></TR>
<TR><TD>8.394e-03</TD><TD>-4.78</TD><TD>cellular response to reactive oxygen species</TD><TD>biological process</TD><TD>GO:0034614</TD><TD>95</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3,IL6</TD></TR>
<TR><TD>8.394e-03</TD><TD>-4.78</TD><TD>regulation of cytokine biosynthetic process</TD><TD>biological process</TD><TD>GO:0042035</TD><TD>95</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20,IL6</TD></TR>
<TR><TD>8.418e-03</TD><TD>-4.78</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>MSigDB lists</TD><TD>PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN</TD><TD>6</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>8.418e-03</TD><TD>-4.78</TD><TD>GERHOLD_RESPONSE_TO_TZD_UP</TD><TD>MSigDB lists</TD><TD>GERHOLD_RESPONSE_TO_TZD_UP</TD><TD>6</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>8.491e-03</TD><TD>-4.77</TD><TD>LABBE_TGFB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LABBE_TGFB1_TARGETS_UP</TD><TD>99</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2</TD></TR>
<TR><TD>8.515e-03</TD><TD>-4.77</TD><TD>regulation of protein targeting</TD><TD>biological process</TD><TD>GO:1903533</TD><TD>292</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>8.536e-03</TD><TD>-4.76</TD><TD>positive regulation of programmed cell death</TD><TD>biological process</TD><TD>GO:0043068</TD><TD>566</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,G0S2,IL6</TD></TR>
<TR><TD>8.565e-03</TD><TD>-4.76</TD><TD>myeloid leukocyte activation</TD><TD>biological process</TD><TD>GO:0002274</TD><TD>96</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2</TD></TR>
<TR><TD>8.601e-03</TD><TD>-4.76</TD><TD>positive regulation of gene expression</TD><TD>biological process</TD><TD>GO:0010628</TD><TD>1690</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,PIM2,CCL5,CSF2,IL6,ELF3</TD></TR>
<TR><TD>8.633e-03</TD><TD>-4.75</TD><TD>Malaria</TD><TD>KEGG pathways</TD><TD>ko05144</TD><TD>49</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>8.633e-03</TD><TD>-4.75</TD><TD>Malaria</TD><TD>KEGG pathways</TD><TD>hsa05144</TD><TD>49</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>8.645e-03</TD><TD>-4.75</TD><TD>GENTILE_UV_HIGH_DOSE_DN</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_HIGH_DOSE_DN</TD><TD>304</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,MMP3,DKK1</TD></TR>
<TR><TD>8.657e-03</TD><TD>-4.75</TD><TD>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</TD><TD>MSigDB lists</TD><TD>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</TD><TD>100</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,IL6</TD></TR>
<TR><TD>8.657e-03</TD><TD>-4.75</TD><TD>WOO_LIVER_CANCER_RECURRENCE_UP</TD><TD>MSigDB lists</TD><TD>WOO_LIVER_CANCER_RECURRENCE_UP</TD><TD>100</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>8.723e-03</TD><TD>-4.74</TD><TD>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</TD><TD>MSigDB lists</TD><TD>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</TD><TD>305</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL3,MT1F</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>positive regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090336</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>regulation of endodermal cell differentiation</TD><TD>biological process</TD><TD>GO:1903224</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>dibenzo-p-dioxin metabolic process</TD><TD>biological process</TD><TD>GO:0018894</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>activation of phospholipase D activity</TD><TD>biological process</TD><TD>GO:0031584</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>epithelial cell proliferation involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060664</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>negative regulation of interleukin-4 production</TD><TD>biological process</TD><TD>GO:0032713</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CD83</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>positive regulation of mast cell chemotaxis</TD><TD>biological process</TD><TD>GO:0060754</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>epithelial fluid transport</TD><TD>biological process</TD><TD>GO:0042045</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>regulation of Wnt signaling pathway involved in heart development</TD><TD>biological process</TD><TD>GO:0003307</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>myeloid cell apoptotic process</TD><TD>biological process</TD><TD>GO:0033028</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>negative regulation of hydrogen peroxide metabolic process</TD><TD>biological process</TD><TD>GO:0010727</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>positive regulation of interleukin-1 alpha production</TD><TD>biological process</TD><TD>GO:0032730</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>positive regulation of transmission of nerve impulse</TD><TD>biological process</TD><TD>GO:0051971</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>positive regulation of activation of JAK2 kinase activity</TD><TD>biological process</TD><TD>GO:0010535</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.728e-03</TD><TD>-4.74</TD><TD>regulation of interleukin-1 alpha production</TD><TD>biological process</TD><TD>GO:0032650</TD><TD>6</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>8.738e-03</TD><TD>-4.74</TD><TD>positive regulation of cellular amide metabolic process</TD><TD>biological process</TD><TD>GO:0034250</TD><TD>97</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>8.756e-03</TD><TD>-4.74</TD><TD>cellular calcium ion homeostasis</TD><TD>biological process</TD><TD>GO:0006874</TD><TD>295</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>8.824e-03</TD><TD>-4.73</TD><TD>KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</TD><TD>101</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>8.879e-03</TD><TD>-4.72</TD><TD>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</TD><TD>MSigDB lists</TD><TD>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP</TD><TD>307</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CCL5</TD></TR>
<TR><TD>8.912e-03</TD><TD>-4.72</TD><TD>myeloid leukocyte differentiation</TD><TD>biological process</TD><TD>GO:0002573</TD><TD>98</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CSF2</TD></TR>
<TR><TD>8.918e-03</TD><TD>-4.72</TD><TD>Calcineurin-regulated NFAT-dependent transcription in lymphocytes</TD><TD>Pathway Interaction DB</TD><TD>nfat_tfpathway</TD><TD>48</TD><TD>2</TD><TD>2227</TD><TD>7</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>8.933e-03</TD><TD>-4.72</TD><TD>response to organonitrogen compound</TD><TD>biological process</TD><TD>GO:0010243</TD><TD>907</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,CSF2,IL6</TD></TR>
<TR><TD>8.948e-03</TD><TD>-4.72</TD><TD>ITPRIPL1 (inositol 1,4,5-trisphosphate receptor interacting protein-like 1)</TD><TD>protein interactions</TD><TD>150771</TD><TD>6</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>8.948e-03</TD><TD>-4.72</TD><TD>TNFRSF13C (tumor necrosis factor receptor superfamily, member 13C)</TD><TD>protein interactions</TD><TD>115650</TD><TD>6</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>8.948e-03</TD><TD>-4.72</TD><TD>Igfbp7 (insulin-like growth factor binding protein 7)</TD><TD>protein interactions</TD><TD>29817</TD><TD>6</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>8.948e-03</TD><TD>-4.72</TD><TD>PIGQ (phosphatidylinositol glycan anchor biosynthesis class Q)</TD><TD>protein interactions</TD><TD>9091</TD><TD>6</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>9.078e-03</TD><TD>-4.70</TD><TD>vpr (p15)</TD><TD>protein interactions</TD><TD>155807</TD><TD>562</TD><TD>4</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6,CD83</TD></TR>
<TR><TD>9.083e-03</TD><TD>-4.70</TD><TD>response to metal ion</TD><TD>biological process</TD><TD>GO:0010038</TD><TD>299</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6,MT1F</TD></TR>
<TR><TD>9.088e-03</TD><TD>-4.70</TD><TD>lymphocyte activation involved in immune response</TD><TD>biological process</TD><TD>GO:0002285</TD><TD>99</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6</TD></TR>
<TR><TD>9.113e-03</TD><TD>-4.70</TD><TD>Nicotinamide salvaging</TD><TD>REACTOME pathways</TD><TD>R-HSA-197264</TD><TD>5</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>PTGS2</TD></TR>
<TR><TD>9.163e-03</TD><TD>-4.69</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>MSigDB lists</TD><TD>SUNG_METASTASIS_STROMA_UP</TD><TD>103</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,DKK1</TD></TR>
<TR><TD>9.428e-03</TD><TD>-4.66</TD><TD>AMINEOXDASEF</TD><TD>prints domains</TD><TD>PR00757</TD><TD>3</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>IL4I1</TD></TR>
<TR><TD>9.444e-03</TD><TD>-4.66</TD><TD>regulation of muscle organ development</TD><TD>biological process</TD><TD>GO:0048634</TD><TD>101</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,DKK1</TD></TR>
<TR><TD>9.508e-03</TD><TD>-4.66</TD><TD>JAZAG_TGFB1_SIGNALING_UP</TD><TD>MSigDB lists</TD><TD>JAZAG_TGFB1_SIGNALING_UP</TD><TD>105</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5</TD></TR>
<TR><TD>9.508e-03</TD><TD>-4.66</TD><TD>REACTOME_SIGNALING_BY_ILS</TD><TD>MSigDB lists</TD><TD>REACTOME_SIGNALING_BY_ILS</TD><TD>105</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>9.508e-03</TD><TD>-4.66</TD><TD>BRUECKNER_TARGETS_OF_MIRLET7A3_UP</TD><TD>MSigDB lists</TD><TD>BRUECKNER_TARGETS_OF_MIRLET7A3_UP</TD><TD>105</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3,DKK1</TD></TR>
<TR><TD>9.508e-03</TD><TD>-4.66</TD><TD>CELLULAR_CATION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>CELLULAR_CATION_HOMEOSTASIS</TD><TD>105</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>9.508e-03</TD><TD>-4.66</TD><TD>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</TD><TD>MSigDB lists</TD><TD>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</TD><TD>105</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CXCL6</TD></TR>
<TR><TD>9.624e-03</TD><TD>-4.64</TD><TD>regulation of fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045598</TD><TD>102</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>9.624e-03</TD><TD>-4.64</TD><TD>fat cell differentiation</TD><TD>biological process</TD><TD>GO:0045444</TD><TD>102</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11</TD></TR>
<TR><TD>9.724e-03</TD><TD>-4.63</TD><TD>interleukin-6 receptor binding</TD><TD>molecular function</TD><TD>GO:0005138</TD><TD>7</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>IL6</TD></TR>
<TR><TD>9.815e-03</TD><TD>-4.62</TD><TD>KUWANO_RNA_STABILIZED_BY_NO</TD><TD>MSigDB lists</TD><TD>KUWANO_RNA_STABILIZED_BY_NO</TD><TD>7</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>9.815e-03</TD><TD>-4.62</TD><TD>WANG_ESOPHAGUS_CANCER_PROGRESSION_UP</TD><TD>MSigDB lists</TD><TD>WANG_ESOPHAGUS_CANCER_PROGRESSION_UP</TD><TD>7</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3</TD></TR>
<TR><TD>9.847e-03</TD><TD>-4.62</TD><TD>calcium ion homeostasis</TD><TD>biological process</TD><TD>GO:0055074</TD><TD>308</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>1.002e-02</TD><TD>-4.60</TD><TD>cellular divalent inorganic cation homeostasis</TD><TD>biological process</TD><TD>GO:0072503</TD><TD>310</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>1.004e-02</TD><TD>-4.60</TD><TD>CCANNAGRKGGC_UNKNOWN</TD><TD>MSigDB lists</TD><TD>CCANNAGRKGGC_UNKNOWN</TD><TD>108</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.004e-02</TD><TD>-4.60</TD><TD>MODULE_456</TD><TD>MSigDB lists</TD><TD>MODULE_456</TD><TD>108</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.004e-02</TD><TD>-4.60</TD><TD>CATION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>CATION_HOMEOSTASIS</TD><TD>108</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>positive regulation of activation of Janus kinase activity</TD><TD>biological process</TD><TD>GO:0010536</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>negative regulation of cardiac muscle cell differentiation</TD><TD>biological process</TD><TD>GO:2000726</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>negative regulation of collagen biosynthetic process</TD><TD>biological process</TD><TD>GO:0032966</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>negative regulation of gastrulation</TD><TD>biological process</TD><TD>GO:2000542</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>negative regulation of cell fate specification</TD><TD>biological process</TD><TD>GO:0009996</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>inflammatory cell apoptotic process</TD><TD>biological process</TD><TD>GO:0006925</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>T-helper 17 type immune response</TD><TD>biological process</TD><TD>GO:0072538</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0090335</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>Wnt signaling pathway involved in somitogenesis</TD><TD>biological process</TD><TD>GO:0090244</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of unsaturated fatty acid biosynthetic process</TD><TD>biological process</TD><TD>GO:2001279</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of circadian sleep/wake cycle, non-REM sleep</TD><TD>biological process</TD><TD>GO:0045188</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>negative regulation of mesoderm development</TD><TD>biological process</TD><TD>GO:2000381</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of prostaglandin biosynthetic process</TD><TD>biological process</TD><TD>GO:0031392</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of mesodermal cell fate specification</TD><TD>biological process</TD><TD>GO:0042661</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>positive regulation of cell migration involved in sprouting angiogenesis</TD><TD>biological process</TD><TD>GO:0090050</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>T-helper 17 cell differentiation</TD><TD>biological process</TD><TD>GO:0072539</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>positive regulation of T-helper 2 cell differentiation</TD><TD>biological process</TD><TD>GO:0045630</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>mammary gland involution</TD><TD>biological process</TD><TD>GO:0060056</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.018e-02</TD><TD>-4.59</TD><TD>regulation of mast cell chemotaxis</TD><TD>biological process</TD><TD>GO:0060753</TD><TD>7</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>CELF2 (CUGBP, Elav-like family member 2)</TD><TD>protein interactions</TD><TD>10659</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>TMEM39A (transmembrane protein 39A)</TD><TD>protein interactions</TD><TD>55254</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>TNFRSF17 (tumor necrosis factor receptor superfamily, member 17)</TD><TD>protein interactions</TD><TD>608</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>CCR4 (chemokine (C-C motif) receptor 4)</TD><TD>protein interactions</TD><TD>1233</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>CXCL1 (chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha))</TD><TD>protein interactions</TD><TD>2919</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL1</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>EHF (ets homologous factor)</TD><TD>protein interactions</TD><TD>26298</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>AMZ2 (archaelysin family metallopeptidase 2)</TD><TD>protein interactions</TD><TD>51321</TD><TD>7</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.055e-02</TD><TD>-4.55</TD><TD>secretion</TD><TD>biological process</TD><TD>GO:0046903</TD><TD>602</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>1.060e-02</TD><TD>-4.55</TD><TD>TGACCTY_V$ERR1_Q2</TD><TD>MSigDB lists</TD><TD>TGACCTY_V$ERR1_Q2</TD><TD>978</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF2,CCL20,G0S2,ELF3</TD></TR>
<TR><TD>1.072e-02</TD><TD>-4.54</TD><TD>PHONG_TNF_RESPONSE_NOT_VIA_P38</TD><TD>MSigDB lists</TD><TD>PHONG_TNF_RESPONSE_NOT_VIA_P38</TD><TD>329</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,G0S2,CD83</TD></TR>
<TR><TD>1.074e-02</TD><TD>-4.53</TD><TD>gland morphogenesis</TD><TD>biological process</TD><TD>GO:0022612</TD><TD>108</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,ELF3</TD></TR>
<TR><TD>1.076e-02</TD><TD>-4.53</TD><TD>MODULE_208</TD><TD>MSigDB lists</TD><TD>MODULE_208</TD><TD>112</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>1.093e-02</TD><TD>-4.52</TD><TD>Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5339717</TD><TD>6</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.093e-02</TD><TD>-4.52</TD><TD>Synthesis of 15-eicosatetraenoic acid derivatives</TD><TD>REACTOME pathways</TD><TD>R-HSA-2142770</TD><TD>6</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.093e-02</TD><TD>-4.52</TD><TD>regulation of T cell differentiation</TD><TD>biological process</TD><TD>GO:0045580</TD><TD>109</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.096e-02</TD><TD>-4.51</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.640.10</TD><TD>10</TD><TD>1</TD><TD>9988</TD><TD>11</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>positive regulation of cellular protein localization</TD><TD>biological process</TD><TD>GO:1903829</TD><TD>322</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>1.113e-02</TD><TD>-4.50</TD><TD>RESPONSE_TO_BIOTIC_STIMULUS</TD><TD>MSigDB lists</TD><TD>RESPONSE_TO_BIOTIC_STIMULUS</TD><TD>114</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.115e-02</TD><TD>-4.50</TD><TD>single-organism cellular process</TD><TD>biological process</TD><TD>GO:0044763</TD><TD>11471</TD><TD>22</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,IL4I1,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,PIM2</TD></TR>
<TR><TD>1.116e-02</TD><TD>-4.50</TD><TD>cellular response to organonitrogen compound</TD><TD>biological process</TD><TD>GO:0071417</TD><TD>612</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,CSF2</TD></TR>
<TR><TD>1.121e-02</TD><TD>-4.49</TD><TD>GALIE_TUMOR_ANGIOGENESIS</TD><TD>MSigDB lists</TD><TD>GALIE_TUMOR_ANGIOGENESIS</TD><TD>8</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.121e-02</TD><TD>-4.49</TD><TD>ZERBINI_RESPONSE_TO_SULINDAC_UP</TD><TD>MSigDB lists</TD><TD>ZERBINI_RESPONSE_TO_SULINDAC_UP</TD><TD>8</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.121e-02</TD><TD>-4.49</TD><TD>KONDO_HYPOXIA</TD><TD>MSigDB lists</TD><TD>KONDO_HYPOXIA</TD><TD>8</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.121e-02</TD><TD>-4.49</TD><TD>ISHIKAWA_STING_SIGNALING</TD><TD>MSigDB lists</TD><TD>ISHIKAWA_STING_SIGNALING</TD><TD>8</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.123e-02</TD><TD>-4.49</TD><TD>regulation of cell adhesion</TD><TD>biological process</TD><TD>GO:0030155</TD><TD>613</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6,CD83,TNFSF13B</TD></TR>
<TR><TD>1.129e-02</TD><TD>-4.48</TD><TD>TWEAK Signaling Pathway</TD><TD>WikiPathways</TD><TD>WP2036</TD><TD>43</TD><TD>2</TD><TD>4455</TD><TD>17</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>positive regulation of angiogenesis</TD><TD>biological process</TD><TD>GO:0045766</TD><TD>111</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>MODULE_345</TD><TD>MSigDB lists</TD><TD>MODULE_345</TD><TD>115</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>1.137e-02</TD><TD>-4.48</TD><TD>human chr6p23</TD><TD>chromosome location</TD><TD>human chr6p23</TD><TD>12</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>CD83</TD></TR>
<TR><TD>1.151e-02</TD><TD>-4.46</TD><TD>SECRETION_BY_CELL</TD><TD>MSigDB lists</TD><TD>SECRETION_BY_CELL</TD><TD>116</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of activation of JAK2 kinase activity</TD><TD>biological process</TD><TD>GO:0010534</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of chemokine-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0070099</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>T-helper cell lineage commitment</TD><TD>biological process</TD><TD>GO:0002295</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>interleukin-6-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0070102</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of macrophage apoptotic process</TD><TD>biological process</TD><TD>GO:2000109</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>cellular response to hydroperoxide</TD><TD>biological process</TD><TD>GO:0071447</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of interleukin-23 production</TD><TD>biological process</TD><TD>GO:0032667</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of cytolysis</TD><TD>biological process</TD><TD>GO:0042268</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>neutrophil homeostasis</TD><TD>biological process</TD><TD>GO:0001780</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>negative regulation of collagen metabolic process</TD><TD>biological process</TD><TD>GO:0010713</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.45</TD><TD>regulation of cell-cell adhesion mediated by integrin</TD><TD>biological process</TD><TD>GO:0033632</TD><TD>8</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.170e-02</TD><TD>-4.45</TD><TD>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</TD><TD>MSigDB lists</TD><TD>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</TD><TD>117</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>NRXN3 (neurexin 3)</TD><TD>protein interactions</TD><TD>9369</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>TMEM131 (transmembrane protein 131)</TD><TD>protein interactions</TD><TD>23505</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>HAPLN1 (hyaluronan and proteoglycan link protein 1)</TD><TD>protein interactions</TD><TD>1404</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>MAP3K6 (mitogen-activated protein kinase kinase kinase 6)</TD><TD>protein interactions</TD><TD>9064</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>PTGS1 (prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase))</TD><TD>protein interactions</TD><TD>5742</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>GPC1 (glypican 1)</TD><TD>protein interactions</TD><TD>2817</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>CXCL2 (chemokine (C-X-C motif) ligand 2)</TD><TD>protein interactions</TD><TD>2920</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CXCL2</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>GPC6 (glypican 6)</TD><TD>protein interactions</TD><TD>10082</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.191e-02</TD><TD>-4.43</TD><TD>PTHLH (parathyroid hormone-like hormone)</TD><TD>protein interactions</TD><TD>5744</TD><TD>8</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.195e-02</TD><TD>-4.43</TD><TD>FEVR_CTNNB1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>FEVR_CTNNB1_TARGETS_UP</TD><TD>646</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,G0S2,TNFSF13B,CXCL6</TD></TR>
<TR><TD>1.196e-02</TD><TD>-4.43</TD><TD>divalent inorganic cation homeostasis</TD><TD>biological process</TD><TD>GO:0072507</TD><TD>331</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>1.208e-02</TD><TD>-4.42</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>MSigDB lists</TD><TD>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP</TD><TD>119</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>C15orf48,MT1F</TD></TR>
<TR><TD>1.231e-02</TD><TD>-4.40</TD><TD>human chr10q11.2</TD><TD>chromosome location</TD><TD>human chr10q11.2</TD><TD>13</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.247e-02</TD><TD>-4.38</TD><TD>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</TD><TD>MSigDB lists</TD><TD>COLINA_TARGETS_OF_4EBP1_AND_4EBP2</TD><TD>348</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CCL5,CXCL6</TD></TR>
<TR><TD>1.247e-02</TD><TD>-4.38</TD><TD>DAIRKEE_TERT_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>DAIRKEE_TERT_TARGETS_UP</TD><TD>348</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,CXCL6</TD></TR>
<TR><TD>1.247e-02</TD><TD>-4.38</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>MISSIAGLIA_REGULATED_BY_METHYLATION_UP</TD><TD>121</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL20</TD></TR>
<TR><TD>1.247e-02</TD><TD>-4.38</TD><TD>V$IRF2_01</TD><TD>MSigDB lists</TD><TD>V$IRF2_01</TD><TD>121</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,TNFSF13B</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5</TD><TD>MSigDB lists</TD><TD>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>EPITHELIAL_CELL_DIFFERENTIATION</TD><TD>MSigDB lists</TD><TD>EPITHELIAL_CELL_DIFFERENTIATION</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>HOFFMAN_CLOCK_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HOFFMAN_CLOCK_TARGETS_DN</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN</TD><TD>MSigDB lists</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP</TD><TD>MSigDB lists</TD><TD>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>KONG_E2F1_TARGETS</TD><TD>MSigDB lists</TD><TD>KONG_E2F1_TARGETS</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>AGARWAL_AKT_PATHWAY_TARGETS</TD><TD>MSigDB lists</TD><TD>AGARWAL_AKT_PATHWAY_TARGETS</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>MATZUK_MATERNAL_EFFECT</TD><TD>MSigDB lists</TD><TD>MATZUK_MATERNAL_EFFECT</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.260e-02</TD><TD>-4.37</TD><TD>OXFORD_RALA_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>OXFORD_RALA_TARGETS_UP</TD><TD>9</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>1.261e-02</TD><TD>-4.37</TD><TD>response to nitrogen compound</TD><TD>biological process</TD><TD>GO:1901698</TD><TD>987</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,CSF2,IL6</TD></TR>
<TR><TD>1.266e-02</TD><TD>-4.37</TD><TD>MODULE_99</TD><TD>MSigDB lists</TD><TD>MODULE_99</TD><TD>350</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,MMP3,CCL8</TD></TR>
<TR><TD>1.286e-02</TD><TD>-4.35</TD><TD>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</TD><TD>MSigDB lists</TD><TD>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</TD><TD>1436</TD><TD>6</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,C15orf48,IL6,CD83,TNFSF13B,DKK1</TD></TR>
<TR><TD>1.286e-02</TD><TD>-4.35</TD><TD>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</TD><TD>123</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,DKK1</TD></TR>
<TR><TD>1.292e-02</TD><TD>-4.35</TD><TD>response to ethanol</TD><TD>biological process</TD><TD>GO:0045471</TD><TD>119</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>1.296e-02</TD><TD>-4.35</TD><TD>positive regulation of intracellular transport</TD><TD>biological process</TD><TD>GO:0032388</TD><TD>341</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>1.298e-02</TD><TD>-4.34</TD><TD>POSITIVE_REGULATION_OF_CELLULAR_PROCESS</TD><TD>MSigDB lists</TD><TD>POSITIVE_REGULATION_OF_CELLULAR_PROCESS</TD><TD>662</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,IL6,TNFSF13B</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>regulation of activation of Janus kinase activity</TD><TD>biological process</TD><TD>GO:0010533</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>regulation of type B pancreatic cell apoptotic process</TD><TD>biological process</TD><TD>GO:2000674</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>positive regulation of protein import into nucleus, translocation</TD><TD>biological process</TD><TD>GO:0033160</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>cellular response to lipoteichoic acid</TD><TD>biological process</TD><TD>GO:0071223</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>response to lipoteichoic acid</TD><TD>biological process</TD><TD>GO:0070391</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>positive regulation of podosome assembly</TD><TD>biological process</TD><TD>GO:0071803</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>negative regulation of multicellular organismal metabolic process</TD><TD>biological process</TD><TD>GO:0044252</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>response to fructose</TD><TD>biological process</TD><TD>GO:0009750</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.306e-02</TD><TD>-4.34</TD><TD>CD4-positive, alpha-beta T cell lineage commitment</TD><TD>biological process</TD><TD>GO:0043373</TD><TD>9</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.313e-02</TD><TD>-4.33</TD><TD>RYTTCCTG_V$ETS2_B</TD><TD>MSigDB lists</TD><TD>RYTTCCTG_V$ETS2_B</TD><TD>1031</TD><TD>5</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CSF2,MMP3,CCL20,TNFSF13B</TD></TR>
<TR><TD>1.314e-02</TD><TD>-4.33</TD><TD>-</TD><TD>gene3d domains</TD><TD>4.10.10.10</TD><TD>12</TD><TD>1</TD><TD>9988</TD><TD>11</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.315e-02</TD><TD>-4.33</TD><TD>LU_EZH2_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>LU_EZH2_TARGETS_DN</TD><TD>355</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,MMP3,DKK1</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>human chr2q36.3</TD><TD>chromosome location</TD><TD>human chr2q36.3</TD><TD>14</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.327e-02</TD><TD>-4.32</TD><TD>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</TD><TD>MSigDB lists</TD><TD>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</TD><TD>125</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,MT1F</TD></TR>
<TR><TD>1.327e-02</TD><TD>-4.32</TD><TD>LENAOUR_DENDRITIC_CELL_MATURATION_DN</TD><TD>MSigDB lists</TD><TD>LENAOUR_DENDRITIC_CELL_MATURATION_DN</TD><TD>125</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>1.327e-02</TD><TD>-4.32</TD><TD>MODULE_292</TD><TD>MSigDB lists</TD><TD>MODULE_292</TD><TD>125</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>1.327e-02</TD><TD>-4.32</TD><TD>GERY_CEBP_TARGETS</TD><TD>MSigDB lists</TD><TD>GERY_CEBP_TARGETS</TD><TD>125</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>1.334e-02</TD><TD>-4.32</TD><TD>positive regulation of vasculature development</TD><TD>biological process</TD><TD>GO:1904018</TD><TD>121</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>CCL13 (chemokine (C-C motif) ligand 13)</TD><TD>protein interactions</TD><TD>6357</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>MMP13 (matrix metallopeptidase 13)</TD><TD>protein interactions</TD><TD>4322</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>LRIG3 (leucine-rich repeats and immunoglobulin-like domains 3)</TD><TD>protein interactions</TD><TD>121227</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>CCL8 (chemokine (C-C motif) ligand 8)</TD><TD>protein interactions</TD><TD>6355</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>KIAA0319L (KIAA0319-like)</TD><TD>protein interactions</TD><TD>79932</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>GPC3 (glypican 3)</TD><TD>protein interactions</TD><TD>2719</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.339e-02</TD><TD>-4.31</TD><TD>TNFSF12 (tumor necrosis factor (ligand) superfamily, member 12)</TD><TD>protein interactions</TD><TD>8742</TD><TD>9</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.347e-02</TD><TD>-4.31</TD><TD>MODULE_171</TD><TD>MSigDB lists</TD><TD>MODULE_171</TD><TD>126</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>1.347e-02</TD><TD>-4.31</TD><TD>E2F3_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>E2F3_UP.V1_DN</TD><TD>126</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,IL6</TD></TR>
<TR><TD>1.347e-02</TD><TD>-4.31</TD><TD>MODULE_436</TD><TD>MSigDB lists</TD><TD>MODULE_436</TD><TD>126</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CSF3</TD></TR>
<TR><TD>1.355e-02</TD><TD>-4.30</TD><TD>regulation of protein kinase B signaling</TD><TD>biological process</TD><TD>GO:0051896</TD><TD>122</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL6</TD></TR>
<TR><TD>1.359e-02</TD><TD>-4.30</TD><TD>Amino_oxidase</TD><TD>interpro domains</TD><TD>IPR002937</TD><TD>10</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.359e-02</TD><TD>-4.30</TD><TD>Haem_peroxidase</TD><TD>interpro domains</TD><TD>IPR010255</TD><TD>10</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.359e-02</TD><TD>-4.30</TD><TD>Metalthion_vert_metal_BS</TD><TD>interpro domains</TD><TD>IPR018064</TD><TD>10</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.359e-02</TD><TD>-4.30</TD><TD>Haem_peroxidase_animal</TD><TD>interpro domains</TD><TD>IPR019791</TD><TD>10</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.388e-02</TD><TD>-4.28</TD><TD>ION_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>ION_HOMEOSTASIS</TD><TD>128</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>1.388e-02</TD><TD>-4.28</TD><TD>chr1q32</TD><TD>MSigDB lists</TD><TD>chr1q32</TD><TD>128</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,ELF3</TD></TR>
<TR><TD>1.397e-02</TD><TD>-4.27</TD><TD>response to transition metal nanoparticle</TD><TD>biological process</TD><TD>GO:1990267</TD><TD>124</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,MT1F</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>MODULE_557</TD><TD>MSigDB lists</TD><TD>MODULE_557</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>SCHLESINGER_METHYLATED_IN_COLON_CANCER</TD><TD>MSigDB lists</TD><TD>SCHLESINGER_METHYLATED_IN_COLON_CANCER</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>HEDVAT_ELF4_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HEDVAT_ELF4_TARGETS_UP</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>MURAKAMI_UV_RESPONSE_1HR_DN</TD><TD>MSigDB lists</TD><TD>MURAKAMI_UV_RESPONSE_1HR_DN</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>REACTOME_IL_6_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_IL_6_SIGNALING</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>BIOCARTA_IL5_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_IL5_PATHWAY</TD><TD>10</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>Cytosolic DNA-sensing pathway</TD><TD>KEGG pathways</TD><TD>hsa04623</TD><TD>63</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.399e-02</TD><TD>-4.27</TD><TD>Cytosolic DNA-sensing pathway</TD><TD>KEGG pathways</TD><TD>ko04623</TD><TD>63</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.406e-02</TD><TD>-4.26</TD><TD>innate immune response</TD><TD>biological process</TD><TD>GO:0045087</TD><TD>1014</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CSF2,CCL20,CCL8</TD></TR>
<TR><TD>1.407e-02</TD><TD>-4.26</TD><TD>MIKKELSEN_ES_ICP_WITH_H3K4ME3</TD><TD>MSigDB lists</TD><TD>MIKKELSEN_ES_ICP_WITH_H3K4ME3</TD><TD>678</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2,G0S2,ELF3</TD></TR>
<TR><TD>1.408e-02</TD><TD>-4.26</TD><TD>GGGNNTTTCC_V$NFKB_Q6_01</TD><TD>MSigDB lists</TD><TD>GGGNNTTTCC_V$NFKB_Q6_01</TD><TD>129</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.440e-02</TD><TD>-4.24</TD><TD>Phenylalanine, tyrosine and tryptophan biosynthesis</TD><TD>KEGG pathways</TD><TD>hsa00400</TD><TD>5</TD><TD>1</TD><TD>6908</TD><TD>20</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.440e-02</TD><TD>-4.24</TD><TD>Phenylalanine, tyrosine and tryptophan biosynthesis</TD><TD>KEGG pathways</TD><TD>ko00400</TD><TD>5</TD><TD>1</TD><TD>6908</TD><TD>20</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.442e-02</TD><TD>-4.24</TD><TD>cellular response to nitrogen compound</TD><TD>biological process</TD><TD>GO:1901699</TD><TD>660</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,CSF2</TD></TR>
<TR><TD>1.444e-02</TD><TD>-4.24</TD><TD>lymphocyte activation</TD><TD>biological process</TD><TD>GO:0046649</TD><TD>355</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11,IL6</TD></TR>
<TR><TD>1.450e-02</TD><TD>-4.23</TD><TD>KRAS.KIDNEY_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>KRAS.KIDNEY_UP.V1_DN</TD><TD>131</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,IL6</TD></TR>
<TR><TD>1.451e-02</TD><TD>-4.23</TD><TD>positive regulation of macrophage chemotaxis</TD><TD>biological process</TD><TD>GO:0010759</TD><TD>10</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.451e-02</TD><TD>-4.23</TD><TD>positive regulation of oxidative stress-induced cell death</TD><TD>biological process</TD><TD>GO:1903209</TD><TD>10</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.451e-02</TD><TD>-4.23</TD><TD>regulation of germinal center formation</TD><TD>biological process</TD><TD>GO:0002634</TD><TD>10</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.451e-02</TD><TD>-4.23</TD><TD>response to peptidoglycan</TD><TD>biological process</TD><TD>GO:0032494</TD><TD>10</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.464e-02</TD><TD>-4.22</TD><TD>Validated targets of C-MYC transcriptional repression</TD><TD>Pathway Interaction DB</TD><TD>myc_represspathway</TD><TD>62</TD><TD>2</TD><TD>2227</TD><TD>7</TD>
<TD>CCL5,DKK1</TD></TR>
<TR><TD>1.467e-02</TD><TD>-4.22</TD><TD>regulation of primary metabolic process</TD><TD>biological process</TD><TD>GO:0080090</TD><TD>5688</TD><TD>14</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,PTGS2,CSF3,IL11,CCL20,CCL8,IL6,NFKBIZ,PIM2,CSF2,CCL5,DKK1,ELF3</TD></TR>
<TR><TD>1.480e-02</TD><TD>-4.21</TD><TD>MODULE_33</TD><TD>MSigDB lists</TD><TD>MODULE_33</TD><TD>371</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL20,ELF3</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>FAM160A2 (family with sequence similarity 160, member A2)</TD><TD>protein interactions</TD><TD>84067</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>ARHGAP29 (Rho GTPase activating protein 29)</TD><TD>protein interactions</TD><TD>9411</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>CBR3 (carbonyl reductase 3)</TD><TD>protein interactions</TD><TD>874</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>KRT82 (keratin 82, type II)</TD><TD>protein interactions</TD><TD>3888</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>LRRC8A (leucine rich repeat containing 8 family, member A)</TD><TD>protein interactions</TD><TD>56262</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>GPC4 (glypican 4)</TD><TD>protein interactions</TD><TD>2239</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>MON2 (MON2 homolog, regulator of endosome-to-Golgi trafficking)</TD><TD>protein interactions</TD><TD>23041</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>TIMP1 (TIMP metallopeptidase inhibitor 1)</TD><TD>protein interactions</TD><TD>7076</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.487e-02</TD><TD>-4.21</TD><TD>CCR10 (chemokine (C-C motif) receptor 10)</TD><TD>protein interactions</TD><TD>2826</TD><TD>10</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7</TD></TR>
<TR><TD>1.493e-02</TD><TD>-4.20</TD><TD>Pointed_dom</TD><TD>interpro domains</TD><TD>IPR003118</TD><TD>11</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.494e-02</TD><TD>-4.20</TD><TD>An_peroxidase</TD><TD>pfam domains</TD><TD>PF03098</TD><TD>10</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.494e-02</TD><TD>-4.20</TD><TD>Amino_oxidase</TD><TD>pfam domains</TD><TD>PF01593</TD><TD>10</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.514e-02</TD><TD>-4.19</TD><TD>ALK_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>ALK_DN.V1_UP</TD><TD>134</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,IL6</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>DORN_ADENOVIRUS_INFECTION_32HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_32HR_UP</TD><TD>11</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>HASEGAWA_TUMORIGENESIS_BY_RET_C634R</TD><TD>MSigDB lists</TD><TD>HASEGAWA_TUMORIGENESIS_BY_RET_C634R</TD><TD>11</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_6</TD><TD>MSigDB lists</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_6</TD><TD>11</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>MODULE_211</TD><TD>MSigDB lists</TD><TD>MODULE_211</TD><TD>11</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.538e-02</TD><TD>-4.17</TD><TD>ST_STAT3_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_STAT3_PATHWAY</TD><TD>11</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>cellular homeostasis</TD><TD>biological process</TD><TD>GO:0019725</TD><TD>673</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8,IL6</TD></TR>
<TR><TD>1.543e-02</TD><TD>-4.17</TD><TD>cellular response to organic cyclic compound</TD><TD>biological process</TD><TD>GO:0071407</TD><TD>364</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.551e-02</TD><TD>-4.17</TD><TD>response to alkaloid</TD><TD>biological process</TD><TD>GO:0043279</TD><TD>131</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>1.555e-02</TD><TD>-4.16</TD><TD>regulation of intracellular protein transport</TD><TD>biological process</TD><TD>GO:0033157</TD><TD>365</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>1.566e-02</TD><TD>-4.16</TD><TD>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</TD><TD>MSigDB lists</TD><TD>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</TD><TD>379</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5,CXCL6</TD></TR>
<TR><TD>1.581e-02</TD><TD>-4.15</TD><TD>POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS</TD><TD>MSigDB lists</TD><TD>POSITIVE_REGULATION_OF_BIOLOGICAL_PROCESS</TD><TD>702</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3,IL6,TNFSF13B</TD></TR>
<TR><TD>1.586e-02</TD><TD>-4.14</TD><TD>cell proliferation</TD><TD>biological process</TD><TD>GO:0008283</TD><TD>679</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,PIM2,IL6,TNFSF13B</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>alkaloid metabolic process</TD><TD>biological process</TD><TD>GO:0009820</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>CD4-positive or CD8-positive, alpha-beta T cell lineage commitment</TD><TD>biological process</TD><TD>GO:0043369</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>regulation of T-helper 2 cell differentiation</TD><TD>biological process</TD><TD>GO:0045628</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>L-phenylalanine catabolic process</TD><TD>biological process</TD><TD>GO:0006559</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>positive regulation of T cell chemotaxis</TD><TD>biological process</TD><TD>GO:0010820</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>negative regulation of pathway-restricted SMAD protein phosphorylation</TD><TD>biological process</TD><TD>GO:0060394</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>positive regulation of immunoglobulin secretion</TD><TD>biological process</TD><TD>GO:0051024</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process</TD><TD>biological process</TD><TD>GO:1902222</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>regulation of chronic inflammatory response</TD><TD>biological process</TD><TD>GO:0002676</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>positive regulation of sprouting angiogenesis</TD><TD>biological process</TD><TD>GO:1903672</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>negative regulation of gluconeogenesis</TD><TD>biological process</TD><TD>GO:0045721</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.595e-02</TD><TD>-4.14</TD><TD>alpha-beta T cell lineage commitment</TD><TD>biological process</TD><TD>GO:0002363</TD><TD>11</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</TD><TD>138</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,NFKBIZ</TD></TR>
<TR><TD>1.600e-02</TD><TD>-4.14</TD><TD>positive regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044089</TD><TD>369</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,MMP3,CSF2</TD></TR>
<TR><TD>1.618e-02</TD><TD>-4.12</TD><TD>Epithelial cell signaling in Helicobacter pylori infection</TD><TD>KEGG pathways</TD><TD>hsa05120</TD><TD>68</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CCL5</TD></TR>
<TR><TD>1.618e-02</TD><TD>-4.12</TD><TD>Epithelial cell signaling in Helicobacter pylori infection</TD><TD>KEGG pathways</TD><TD>ko05120</TD><TD>68</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CXCL1,CCL5</TD></TR>
<TR><TD>1.622e-02</TD><TD>-4.12</TD><TD>PEDRIOLI_MIR31_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>PEDRIOLI_MIR31_TARGETS_DN</TD><TD>384</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL2,CCL20</TD></TR>
<TR><TD>1.622e-02</TD><TD>-4.12</TD><TD>ZHANG_BREAST_CANCER_PROGENITORS_DN</TD><TD>MSigDB lists</TD><TD>ZHANG_BREAST_CANCER_PROGENITORS_DN</TD><TD>139</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,MMP3</TD></TR>
<TR><TD>1.626e-02</TD><TD>-4.12</TD><TD>MODULE_117</TD><TD>MSigDB lists</TD><TD>MODULE_117</TD><TD>708</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,IL11,CCL20,CCL8</TD></TR>
<TR><TD>1.628e-02</TD><TD>-4.12</TD><TD>Metalthion</TD><TD>interpro domains</TD><TD>IPR003019</TD><TD>12</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.628e-02</TD><TD>-4.12</TD><TD>Metalthion_vert</TD><TD>interpro domains</TD><TD>IPR000006</TD><TD>12</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.628e-02</TD><TD>-4.12</TD><TD>Metalthion_dom</TD><TD>interpro domains</TD><TD>IPR017854</TD><TD>12</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.628e-02</TD><TD>-4.12</TD><TD>Metalthion_dom_vert</TD><TD>interpro domains</TD><TD>IPR023587</TD><TD>12</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.630e-02</TD><TD>-4.12</TD><TD>Celecoxib Metabolism Pathway</TD><TD>SMPDB pathways</TD><TD>SMP00644</TD><TD>8</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.633e-02</TD><TD>-4.11</TD><TD>KUMAR_TARGETS_OF_MLL_AF9_FUSION</TD><TD>MSigDB lists</TD><TD>KUMAR_TARGETS_OF_MLL_AF9_FUSION</TD><TD>385</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5,CD83</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>TNFSF13 (tumor necrosis factor (ligand) superfamily, member 13)</TD><TD>protein interactions</TD><TD>8741</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>IL6R (interleukin 6 receptor)</TD><TD>protein interactions</TD><TD>3570</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>POTEI (POTE ankyrin domain family, member I)</TD><TD>protein interactions</TD><TD>653269</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>CSF2RA (colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage))</TD><TD>protein interactions</TD><TD>1438</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>TTC17 (tetratricopeptide repeat domain 17)</TD><TD>protein interactions</TD><TD>55761</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>TNFRSF13B (tumor necrosis factor receptor superfamily, member 13B)</TD><TD>protein interactions</TD><TD>23495</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>CHST12 (carbohydrate (chondroitin 4) sulfotransferase 12)</TD><TD>protein interactions</TD><TD>55501</TD><TD>11</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>MAPK1 (ERK2) activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-112411</TD><TD>9</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>IL6</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>EGFR Transactivation by Gastrin</TD><TD>REACTOME pathways</TD><TD>R-HSA-2179392</TD><TD>9</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>leukocyte activation involved in immune response</TD><TD>biological process</TD><TD>GO:0002366</TD><TD>135</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6</TD></TR>
<TR><TD>1.642e-02</TD><TD>-4.11</TD><TD>SAM_PNT</TD><TD>pfam domains</TD><TD>PF02198</TD><TD>11</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.644e-02</TD><TD>-4.11</TD><TD>BROWNE_HCMV_INFECTION_24HR_UP</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_24HR_UP</TD><TD>140</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CD83</TD></TR>
<TR><TD>1.644e-02</TD><TD>-4.11</TD><TD>BROWNE_HCMV_INFECTION_30MIN_DN</TD><TD>MSigDB lists</TD><TD>BROWNE_HCMV_INFECTION_30MIN_DN</TD><TD>140</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CXCL6</TD></TR>
<TR><TD>1.658e-02</TD><TD>-4.10</TD><TD>response to nutrient levels</TD><TD>biological process</TD><TD>GO:0031667</TD><TD>374</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.664e-02</TD><TD>-4.10</TD><TD>B cell activation</TD><TD>biological process</TD><TD>GO:0042113</TD><TD>136</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL11</TD></TR>
<TR><TD>1.664e-02</TD><TD>-4.10</TD><TD>regulation of lymphocyte differentiation</TD><TD>biological process</TD><TD>GO:0045619</TD><TD>136</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>1.667e-02</TD><TD>-4.09</TD><TD>VECCHI_GASTRIC_CANCER_EARLY_UP</TD><TD>MSigDB lists</TD><TD>VECCHI_GASTRIC_CANCER_EARLY_UP</TD><TD>388</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,MMP3,CXCL3</TD></TR>
<TR><TD>1.673e-02</TD><TD>-4.09</TD><TD>METALLOTHIONEIN_VRT</TD><TD>prosite domains</TD><TD>PS00203</TD><TD>10</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.673e-02</TD><TD>-4.09</TD><TD>PEROXIDASE_3</TD><TD>prosite domains</TD><TD>PS50292</TD><TD>10</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.677e-02</TD><TD>-4.09</TD><TD>LEI_HOXC8_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LEI_HOXC8_TARGETS_UP</TD><TD>12</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>1.677e-02</TD><TD>-4.09</TD><TD>chr3p12</TD><TD>MSigDB lists</TD><TD>chr3p12</TD><TD>12</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>1.677e-02</TD><TD>-4.09</TD><TD>DORN_ADENOVIRUS_INFECTION_24HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_24HR_UP</TD><TD>12</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.677e-02</TD><TD>-4.09</TD><TD>NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_CYTOKINE_BIOSYNTHETIC_PROCESS</TD><TD>12</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.688e-02</TD><TD>-4.08</TD><TD>cell activation involved in immune response</TD><TD>biological process</TD><TD>GO:0002263</TD><TD>137</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6</TD></TR>
<TR><TD>1.711e-02</TD><TD>-4.07</TD><TD>regulation of DNA replication</TD><TD>biological process</TD><TD>GO:0006275</TD><TD>138</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>1.711e-02</TD><TD>-4.07</TD><TD>SMITH_TERT_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SMITH_TERT_TARGETS_UP</TD><TD>143</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2</TD></TR>
<TR><TD>1.731e-02</TD><TD>-4.06</TD><TD>regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044087</TD><TD>697</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,MMP3,CSF2,DKK1</TD></TR>
<TR><TD>1.734e-02</TD><TD>-4.05</TD><TD>CELLULAR_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>CELLULAR_HOMEOSTASIS</TD><TD>144</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>1.734e-02</TD><TD>-4.05</TD><TD>RELA_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>RELA_DN.V1_UP</TD><TD>144</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2</TD></TR>
<TR><TD>1.734e-02</TD><TD>-4.05</TD><TD>BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE</TD><TD>MSigDB lists</TD><TD>BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE</TD><TD>144</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CD83</TD></TR>
<TR><TD>1.734e-02</TD><TD>-4.05</TD><TD>regulation of cell shape</TD><TD>biological process</TD><TD>GO:0008360</TD><TD>139</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL6</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>regulation of transmission of nerve impulse</TD><TD>biological process</TD><TD>GO:0051969</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>positive regulation of cellular response to oxidative stress</TD><TD>biological process</TD><TD>GO:1900409</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>cellular response to ATP</TD><TD>biological process</TD><TD>GO:0071318</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>negative regulation of skeletal muscle tissue development</TD><TD>biological process</TD><TD>GO:0048642</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>negative regulation of cell fate commitment</TD><TD>biological process</TD><TD>GO:0010454</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>negative regulation by host of viral transcription</TD><TD>biological process</TD><TD>GO:0043922</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>positive regulation of cell fate commitment</TD><TD>biological process</TD><TD>GO:0010455</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process</TD><TD>biological process</TD><TD>GO:1902221</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>cellular response to lipoprotein particle stimulus</TD><TD>biological process</TD><TD>GO:0071402</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>regulation of T cell chemotaxis</TD><TD>biological process</TD><TD>GO:0010819</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>L-phenylalanine metabolic process</TD><TD>biological process</TD><TD>GO:0006558</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>regulation of podosome assembly</TD><TD>biological process</TD><TD>GO:0071801</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>positive regulation of response to oxidative stress</TD><TD>biological process</TD><TD>GO:1902884</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.738e-02</TD><TD>-4.05</TD><TD>regulation of chemokine biosynthetic process</TD><TD>biological process</TD><TD>GO:0045073</TD><TD>12</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.748e-02</TD><TD>-4.05</TD><TD>MODULE_118</TD><TD>MSigDB lists</TD><TD>MODULE_118</TD><TD>395</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL1,CCL5</TD></TR>
<TR><TD>1.757e-02</TD><TD>-4.04</TD><TD>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</TD><TD>MSigDB lists</TD><TD>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</TD><TD>145</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL3</TD></TR>
<TR><TD>1.780e-02</TD><TD>-4.03</TD><TD>GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN</TD><TD>146</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,IL6</TD></TR>
<TR><TD>1.782e-02</TD><TD>-4.03</TD><TD>KITLG (KIT ligand)</TD><TD>protein interactions</TD><TD>4254</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>1.782e-02</TD><TD>-4.03</TD><TD>PF4 (platelet factor 4)</TD><TD>protein interactions</TD><TD>5196</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.782e-02</TD><TD>-4.03</TD><TD>AMIGO1 (adhesion molecule with Ig-like domain 1)</TD><TD>protein interactions</TD><TD>57463</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.782e-02</TD><TD>-4.03</TD><TD>FAM118A (family with sequence similarity 118, member A)</TD><TD>protein interactions</TD><TD>55007</TD><TD>12</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.790e-02</TD><TD>-4.02</TD><TD>Metallothio</TD><TD>pfam domains</TD><TD>PF00131</TD><TD>12</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.803e-02</TD><TD>-4.02</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN</TD><TD>147</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL6,DKK1</TD></TR>
<TR><TD>1.803e-02</TD><TD>-4.02</TD><TD>TSAI_RESPONSE_TO_IONIZING_RADIATION</TD><TD>MSigDB lists</TD><TD>TSAI_RESPONSE_TO_IONIZING_RADIATION</TD><TD>147</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CD83</TD></TR>
<TR><TD>1.803e-02</TD><TD>-4.02</TD><TD>regulation of response to wounding</TD><TD>biological process</TD><TD>GO:1903034</TD><TD>386</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.805e-02</TD><TD>-4.01</TD><TD>placenta development</TD><TD>biological process</TD><TD>GO:0001890</TD><TD>142</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>MAPK3 (ERK1) activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-110056</TD><TD>10</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>IL6</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>MODULE_470</TD><TD>MSigDB lists</TD><TD>MODULE_470</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>GLAND_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GLAND_DEVELOPMENT</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>NEGATIVE_REGULATION_OF_SECRETION</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_SECRETION</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>MSigDB lists</TD><TD>WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2</TD><TD>MSigDB lists</TD><TD>GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>MODULE_148</TD><TD>MSigDB lists</TD><TD>MODULE_148</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>WU_HBX_TARGETS_2_DN</TD><TD>MSigDB lists</TD><TD>WU_HBX_TARGETS_2_DN</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>WU_HBX_TARGETS_3_DN</TD><TD>MSigDB lists</TD><TD>WU_HBX_TARGETS_3_DN</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>MODULE_326</TD><TD>MSigDB lists</TD><TD>MODULE_326</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.815e-02</TD><TD>-4.01</TD><TD>BIOCARTA_GRANULOCYTES_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_GRANULOCYTES_PATHWAY</TD><TD>13</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3</TD></TR>
<TR><TD>1.817e-02</TD><TD>-4.01</TD><TD>FORTSCHEGGER_PHF8_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>FORTSCHEGGER_PHF8_TARGETS_DN</TD><TD>732</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5,IL6,DKK1</TD></TR>
<TR><TD>1.824e-02</TD><TD>-4.00</TD><TD>regulation of multicellular organismal process</TD><TD>biological process</TD><TD>GO:0051239</TD><TD>2431</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,CSF2,CCL20,IL6,DKK1,CD83</TD></TR>
<TR><TD>1.839e-02</TD><TD>-4.00</TD><TD>PNT</TD><TD>prosite domains</TD><TD>PS51433</TD><TD>11</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.865e-02</TD><TD>-3.98</TD><TD>positive regulation of defense response</TD><TD>biological process</TD><TD>GO:0031349</TD><TD>391</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>1.878e-02</TD><TD>-3.98</TD><TD>cellular response to inorganic substance</TD><TD>biological process</TD><TD>GO:0071241</TD><TD>145</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3,MT1F</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>cyclooxygenase pathway</TD><TD>biological process</TD><TD>GO:0019371</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>lipoxygenase pathway</TD><TD>biological process</TD><TD>GO:0019372</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>positive regulation of type 2 immune response</TD><TD>biological process</TD><TD>GO:0002830</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>mature B cell differentiation involved in immune response</TD><TD>biological process</TD><TD>GO:0002313</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>negative regulation of myeloid cell apoptotic process</TD><TD>biological process</TD><TD>GO:0033033</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>response to manganese ion</TD><TD>biological process</TD><TD>GO:0010042</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.882e-02</TD><TD>-3.97</TD><TD>positive regulation of nitric-oxide synthase biosynthetic process</TD><TD>biological process</TD><TD>GO:0051770</TD><TD>13</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>1.891e-02</TD><TD>-3.97</TD><TD>RIGGI_EWING_SARCOMA_PROGENITOR_UP</TD><TD>MSigDB lists</TD><TD>RIGGI_EWING_SARCOMA_PROGENITOR_UP</TD><TD>407</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,C15orf48,G0S2</TD></TR>
<TR><TD>1.896e-02</TD><TD>-3.97</TD><TD>NEGATIVE_REGULATION_OF_CELL_PROLIFERATION</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_CELL_PROLIFERATION</TD><TD>151</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>1.896e-02</TD><TD>-3.97</TD><TD>MULTI_ORGANISM_PROCESS</TD><TD>MSigDB lists</TD><TD>MULTI_ORGANISM_PROCESS</TD><TD>151</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>1.902e-02</TD><TD>-3.96</TD><TD>response to purine-containing compound</TD><TD>biological process</TD><TD>GO:0014074</TD><TD>146</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>1.919e-02</TD><TD>-3.95</TD><TD>GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP</TD><TD>152</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CCL20</TD></TR>
<TR><TD>1.929e-02</TD><TD>-3.95</TD><TD>ARSK (arylsulfatase family, member K)</TD><TD>protein interactions</TD><TD>153642</TD><TD>13</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.929e-02</TD><TD>-3.95</TD><TD>SEC62 (SEC62 homolog, preprotein translocation factor)</TD><TD>protein interactions</TD><TD>7095</TD><TD>13</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.929e-02</TD><TD>-3.95</TD><TD>BRAT1 (BRCA1-associated ATM activator 1)</TD><TD>protein interactions</TD><TD>221927</TD><TD>13</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>1.929e-02</TD><TD>-3.95</TD><TD>RBM45 (RNA binding motif protein 45)</TD><TD>protein interactions</TD><TD>129831</TD><TD>13</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>1.943e-02</TD><TD>-3.94</TD><TD>CHEMICAL_HOMEOSTASIS</TD><TD>MSigDB lists</TD><TD>CHEMICAL_HOMEOSTASIS</TD><TD>153</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>1.948e-02</TD><TD>-3.94</TD><TD>Pertussis</TD><TD>KEGG pathways</TD><TD>ko05133</TD><TD>75</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>1.948e-02</TD><TD>-3.94</TD><TD>Pertussis</TD><TD>KEGG pathways</TD><TD>hsa05133</TD><TD>75</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>1.949e-02</TD><TD>-3.94</TD><TD>positive regulation of catalytic activity</TD><TD>biological process</TD><TD>GO:0043085</TD><TD>1521</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CCL5,CSF2,CCL20,CCL8</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>MATZUK_OVULATION</TD><TD>MSigDB lists</TD><TD>MATZUK_OVULATION</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>ONGUSAHA_BRCA1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>ONGUSAHA_BRCA1_TARGETS_DN</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_UP</TD><TD>MSigDB lists</TD><TD>DORN_ADENOVIRUS_INFECTION_48HR_UP</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>REGULATION_OF_HORMONE_SECRETION</TD><TD>MSigDB lists</TD><TD>REGULATION_OF_HORMONE_SECRETION</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>TSUNODA_CISPLATIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>TSUNODA_CISPLATIN_RESISTANCE_UP</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>GILMORE_CORE_NFKB_PATHWAY</TD><TD>MSigDB lists</TD><TD>GILMORE_CORE_NFKB_PATHWAY</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>1.954e-02</TD><TD>-3.94</TD><TD>PIEPOLI_LGI1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>PIEPOLI_LGI1_TARGETS_DN</TD><TD>14</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>1.967e-02</TD><TD>-3.93</TD><TD>KIM_WT1_TARGETS_12HR_UP</TD><TD>MSigDB lists</TD><TD>KIM_WT1_TARGETS_12HR_UP</TD><TD>154</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,IL11</TD></TR>
<TR><TD>1.967e-02</TD><TD>-3.93</TD><TD>HALLMARK_UV_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>HALLMARK_UV_RESPONSE_UP</TD><TD>154</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,IL6</TD></TR>
<TR><TD>1.972e-02</TD><TD>-3.93</TD><TD>regulation of protein transport</TD><TD>biological process</TD><TD>GO:0051223</TD><TD>725</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,IL6</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>human chr13q32.3</TD><TD>chromosome location</TD><TD>human chr13q32.3</TD><TD>21</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>GPR183</TD></TR>
<TR><TD>1.995e-02</TD><TD>-3.91</TD><TD>Interleukin-6 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1059683</TD><TD>11</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>IL6</TD></TR>
<TR><TD>1.995e-02</TD><TD>-3.91</TD><TD>Nicotinate metabolism</TD><TD>REACTOME pathways</TD><TD>R-HSA-196807</TD><TD>11</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>PTGS2</TD></TR>
<TR><TD>1.995e-02</TD><TD>-3.91</TD><TD>Phenylalanine and tyrosine catabolism</TD><TD>REACTOME pathways</TD><TD>R-HSA-71182</TD><TD>11</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.007e-02</TD><TD>-3.91</TD><TD>response to steroid hormone</TD><TD>biological process</TD><TD>GO:0048545</TD><TD>402</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.007e-02</TD><TD>-3.91</TD><TD>response to extracellular stimulus</TD><TD>biological process</TD><TD>GO:0009991</TD><TD>402</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.015e-02</TD><TD>-3.90</TD><TD>CSR_EARLY_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>CSR_EARLY_UP.V1_UP</TD><TD>156</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2</TD></TR>
<TR><TD>2.015e-02</TD><TD>-3.90</TD><TD>HALLMARK_FATTY_ACID_METABOLISM</TD><TD>MSigDB lists</TD><TD>HALLMARK_FATTY_ACID_METABOLISM</TD><TD>156</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,G0S2</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>negative regulation of chemokine production</TD><TD>biological process</TD><TD>GO:0032682</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>extracellular negative regulation of signal transduction</TD><TD>biological process</TD><TD>GO:1900116</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>extracellular regulation of signal transduction</TD><TD>biological process</TD><TD>GO:1900115</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>cellular response to nitric oxide</TD><TD>biological process</TD><TD>GO:0071732</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>regulation of hydrogen peroxide metabolic process</TD><TD>biological process</TD><TD>GO:0010310</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.025e-02</TD><TD>-3.90</TD><TD>macrophage chemotaxis</TD><TD>biological process</TD><TD>GO:0048246</TD><TD>14</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.031e-02</TD><TD>-3.90</TD><TD>Pept_M10A_Zn_BS</TD><TD>interpro domains</TD><TD>IPR021158</TD><TD>15</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.040e-02</TD><TD>-3.89</TD><TD>GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP</TD><TD>157</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,C15orf48</TD></TR>
<TR><TD>2.040e-02</TD><TD>-3.89</TD><TD>AMIT_EGF_RESPONSE_480_HELA</TD><TD>MSigDB lists</TD><TD>AMIT_EGF_RESPONSE_480_HELA</TD><TD>157</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,MT1F</TD></TR>
<TR><TD>2.040e-02</TD><TD>-3.89</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP</TD><TD>157</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,NFKBIZ</TD></TR>
<TR><TD>2.051e-02</TD><TD>-3.89</TD><TD>response to ketone</TD><TD>biological process</TD><TD>GO:1901654</TD><TD>152</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>2.054e-02</TD><TD>-3.89</TD><TD>regulation of cellular biosynthetic process</TD><TD>biological process</TD><TD>GO:0031326</TD><TD>4091</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,CCL20,IL6,NFKBIZ,PIM2,CSF2,CCL5,DKK1,ELF3</TD></TR>
<TR><TD>2.073e-02</TD><TD>-3.88</TD><TD>protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030296</TD><TD>15</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.073e-02</TD><TD>-3.88</TD><TD>oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor</TD><TD>molecular function</TD><TD>GO:0016641</TD><TD>15</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>FBXO18 (F-box protein, helicase, 18)</TD><TD>protein interactions</TD><TD>84893</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PIM2</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>MFAP3 (microfibrillar associated protein 3)</TD><TD>protein interactions</TD><TD>4238</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>IGFBP7 (insulin like growth factor binding protein 7)</TD><TD>protein interactions</TD><TD>3490</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>FAM193B (family with sequence similarity 193, member B)</TD><TD>protein interactions</TD><TD>54540</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>TIMP3 (TIMP metallopeptidase inhibitor 3)</TD><TD>protein interactions</TD><TD>7078</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>TGFB3 (transforming growth factor beta 3)</TD><TD>protein interactions</TD><TD>7043</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>BTAF1 (BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa)</TD><TD>protein interactions</TD><TD>9044</TD><TD>14</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.077e-02</TD><TD>-3.87</TD><TD>positive regulation of epithelial cell proliferation</TD><TD>biological process</TD><TD>GO:0050679</TD><TD>153</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>2.086e-02</TD><TD>-3.87</TD><TD>response to insulin</TD><TD>biological process</TD><TD>GO:0032868</TD><TD>408</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN</TD><TD>MSigDB lists</TD><TD>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN</TD><TD>159</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL6</TD></TR>
<TR><TD>2.088e-02</TD><TD>-3.87</TD><TD>LIU_CMYB_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LIU_CMYB_TARGETS_UP</TD><TD>159</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,MT1F</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>OZANNE_AP1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>OZANNE_AP1_TARGETS_UP</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MARKS_HDAC_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>MARKS_HDAC_TARGETS_DN</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MODULE_431</TD><TD>MSigDB lists</TD><TD>MODULE_431</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN</TD><TD>MSigDB lists</TD><TD>MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>ZHAN_LATE_DIFFERENTIATION_GENES_DN</TD><TD>MSigDB lists</TD><TD>ZHAN_LATE_DIFFERENTIATION_GENES_DN</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>SANDERSON_PPARA_TARGETS</TD><TD>MSigDB lists</TD><TD>SANDERSON_PPARA_TARGETS</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MODULE_462</TD><TD>MSigDB lists</TD><TD>MODULE_462</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>BIOCARTA_TALL1_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_TALL1_PATHWAY</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MORPHOGENESIS_OF_AN_EPITHELIUM</TD><TD>MSigDB lists</TD><TD>MORPHOGENESIS_OF_AN_EPITHELIUM</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>2.092e-02</TD><TD>-3.87</TD><TD>MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH</TD><TD>MSigDB lists</TD><TD>MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH</TD><TD>15</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.113e-02</TD><TD>-3.86</TD><TD>SOLUBLE_FRACTION</TD><TD>MSigDB lists</TD><TD>SOLUBLE_FRACTION</TD><TD>160</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,TNFSF13B</TD></TR>
<TR><TD>2.113e-02</TD><TD>-3.86</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN</TD><TD>160</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CD83</TD></TR>
<TR><TD>2.138e-02</TD><TD>-3.85</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>161</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,C15orf48</TD></TR>
<TR><TD>2.140e-02</TD><TD>-3.84</TD><TD>regulation of multicellular organismal development</TD><TD>biological process</TD><TD>GO:2000026</TD><TD>1553</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,IL6,DKK1,CD83</TD></TR>
<TR><TD>2.148e-02</TD><TD>-3.84</TD><TD>SAM_PNT</TD><TD>smart domains</TD><TD>SM00251</TD><TD>11</TD><TD>1</TD><TD>9131</TD><TD>18</TD>
<TD>ELF3</TD></TR>
<TR><TD>2.149e-02</TD><TD>-3.84</TD><TD>NFKB1 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 1)</TD><TD>protein interactions</TD><TD>4790</TD><TD>152</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>NFKBIZ,ELF3</TD></TR>
<TR><TD>2.154e-02</TD><TD>-3.84</TD><TD>positive regulation of DNA metabolic process</TD><TD>biological process</TD><TD>GO:0051054</TD><TD>156</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>2.154e-02</TD><TD>-3.84</TD><TD>cellular metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0006875</TD><TD>413</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>granulocyte differentiation</TD><TD>biological process</TD><TD>GO:0030851</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>positive regulation of fatty acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0045723</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>positive regulation of actin cytoskeleton reorganization</TD><TD>biological process</TD><TD>GO:2000251</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>positive regulation of monocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0090026</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>response to yeast</TD><TD>biological process</TD><TD>GO:0001878</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>regulation of mononuclear cell migration</TD><TD>biological process</TD><TD>GO:0071675</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>cellular response to cadmium ion</TD><TD>biological process</TD><TD>GO:0071276</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MT1F</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>positive regulation of cell adhesion mediated by integrin</TD><TD>biological process</TD><TD>GO:0033630</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.168e-02</TD><TD>-3.83</TD><TD>positive regulation of macrophage derived foam cell differentiation</TD><TD>biological process</TD><TD>GO:0010744</TD><TD>15</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.179e-02</TD><TD>-3.83</TD><TD>regulation of extrinsic apoptotic signaling pathway</TD><TD>biological process</TD><TD>GO:2001236</TD><TD>157</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2,G0S2</TD></TR>
<TR><TD>2.180e-02</TD><TD>-3.83</TD><TD>cellular response to endogenous stimulus</TD><TD>biological process</TD><TD>GO:0071495</TD><TD>1133</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,MMP3,CSF2,IL6</TD></TR>
<TR><TD>2.181e-02</TD><TD>-3.83</TD><TD>response to drug</TD><TD>biological process</TD><TD>GO:0042493</TD><TD>415</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6</TD></TR>
<TR><TD>2.188e-02</TD><TD>-3.82</TD><TD>TAAYNRNNTCC_UNKNOWN</TD><TD>MSigDB lists</TD><TD>TAAYNRNNTCC_UNKNOWN</TD><TD>163</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2</TD></TR>
<TR><TD>2.202e-02</TD><TD>-3.82</TD><TD>MARTENS_TRETINOIN_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>MARTENS_TRETINOIN_RESPONSE_UP</TD><TD>776</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CXCL3,G0S2,ELF3</TD></TR>
<TR><TD>2.217e-02</TD><TD>-3.81</TD><TD>regulation of biosynthetic process</TD><TD>biological process</TD><TD>GO:0009889</TD><TD>4134</TD><TD>11</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,CCL20,IL6,NFKBIZ,PIM2,CSF2,CCL5,DKK1,ELF3</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>CSF2 (colony stimulating factor 2 (granulocyte-macrophage))</TD><TD>protein interactions</TD><TD>1437</TD><TD>15</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>IMPAD1 (inositol monophosphatase domain containing 1)</TD><TD>protein interactions</TD><TD>54928</TD><TD>15</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>IL3RA (interleukin 3 receptor, alpha (low affinity))</TD><TD>protein interactions</TD><TD>3563</TD><TD>15</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.223e-02</TD><TD>-3.81</TD><TD>BCAN (brevican)</TD><TD>protein interactions</TD><TD>63827</TD><TD>15</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>FINETTI_BREAST_CANCER_KINOME_GREEN</TD><TD>MSigDB lists</TD><TD>FINETTI_BREAST_CANCER_KINOME_GREEN</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>HAHTOLA_CTCL_PATHOGENESIS</TD><TD>MSigDB lists</TD><TD>HAHTOLA_CTCL_PATHOGENESIS</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>LY_AGING_MIDDLE_DN</TD><TD>MSigDB lists</TD><TD>LY_AGING_MIDDLE_DN</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>DORMOY_ELAVL1_TARGETS</TD><TD>MSigDB lists</TD><TD>DORMOY_ELAVL1_TARGETS</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>BIOCARTA_LAIR_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_LAIR_PATHWAY</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN</TD><TD>MSigDB lists</TD><TD>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN</TD><TD>16</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>Tyrosinemia Type 3 (TYRO3)</TD><TD>SMPDB pathways</TD><TD>SMP00370</TD><TD>11</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>Tyrosinemia Type 2 (or Richner-Hanhart syndrome)</TD><TD>SMPDB pathways</TD><TD>SMP00369</TD><TD>11</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>Phenylalanine and Tyrosine Metabolism</TD><TD>SMPDB pathways</TD><TD>SMP00008</TD><TD>11</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>Phenylketonuria</TD><TD>SMPDB pathways</TD><TD>SMP00206</TD><TD>11</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>165</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,G0S2</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE6269_E_COLI_VS_STREP_AUREUS_INF_PBMC_DN</TD><TD>165</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>2.263e-02</TD><TD>-3.79</TD><TD>GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP</TD><TD>166</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>2.284e-02</TD><TD>-3.78</TD><TD>leukocyte mediated immunity</TD><TD>biological process</TD><TD>GO:0002443</TD><TD>161</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CXCL6</TD></TR>
<TR><TD>2.289e-02</TD><TD>-3.78</TD><TD>GSE12366_NAIVE_VS_MEMORY_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE12366_NAIVE_VS_MEMORY_BCELL_UP</TD><TD>167</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>2.292e-02</TD><TD>-3.78</TD><TD>DELYS_THYROID_CANCER_UP</TD><TD>MSigDB lists</TD><TD>DELYS_THYROID_CANCER_UP</TD><TD>438</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,G0S2,ELF3</TD></TR>
<TR><TD>2.299e-02</TD><TD>-3.77</TD><TD>Hemopexin_CS</TD><TD>interpro domains</TD><TD>IPR018486</TD><TD>17</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>cellular response to reactive nitrogen species</TD><TD>biological process</TD><TD>GO:1902170</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>cellular response to zinc ion</TD><TD>biological process</TD><TD>GO:0071294</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MT1F</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>positive regulation of transforming growth factor beta production</TD><TD>biological process</TD><TD>GO:0071636</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>regulation of synaptic transmission, dopaminergic</TD><TD>biological process</TD><TD>GO:0032225</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>negative regulation of lipid storage</TD><TD>biological process</TD><TD>GO:0010888</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>regulation of cell migration involved in sprouting angiogenesis</TD><TD>biological process</TD><TD>GO:0090049</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>dendritic cell chemotaxis</TD><TD>biological process</TD><TD>GO:0002407</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>regulation of mesoderm development</TD><TD>biological process</TD><TD>GO:2000380</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>response to caffeine</TD><TD>biological process</TD><TD>GO:0031000</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.311e-02</TD><TD>-3.77</TD><TD>regulation of protein import into nucleus, translocation</TD><TD>biological process</TD><TD>GO:0033158</TD><TD>16</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>MSigDB lists</TD><TD>GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP</TD><TD>168</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>2.337e-02</TD><TD>-3.76</TD><TD>response to nutrient</TD><TD>biological process</TD><TD>GO:0007584</TD><TD>163</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>2.349e-02</TD><TD>-3.75</TD><TD>positive regulation of protein transport</TD><TD>biological process</TD><TD>GO:0051222</TD><TD>427</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>2.364e-02</TD><TD>-3.74</TD><TD>cellular response to acid chemical</TD><TD>biological process</TD><TD>GO:0071229</TD><TD>164</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,MMP3</TD></TR>
<TR><TD>2.366e-02</TD><TD>-3.74</TD><TD>GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>170</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,NFKBIZ</TD></TR>
<TR><TD>2.366e-02</TD><TD>-3.74</TD><TD>GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN</TD><TD>170</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F,CD83</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>MATTHEWS_AP1_TARGETS</TD><TD>MSigDB lists</TD><TD>MATTHEWS_AP1_TARGETS</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>BIOCARTA_IL10_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_IL10_PATHWAY</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</TD><TD>MSigDB lists</TD><TD>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>HORMONE_SECRETION</TD><TD>MSigDB lists</TD><TD>HORMONE_SECRETION</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>LIU_IL13_MEMORY_MODEL_UP</TD><TD>MSigDB lists</TD><TD>LIU_IL13_MEMORY_MODEL_UP</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>chr6p23</TD><TD>MSigDB lists</TD><TD>chr6p23</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CD83</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>HAHTOLA_MYCOSIS_FUNGOIDES_UP</TD><TD>MSigDB lists</TD><TD>HAHTOLA_MYCOSIS_FUNGOIDES_UP</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</TD><TD>MSigDB lists</TD><TD>ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>ZHENG_RESPONSE_TO_ARSENITE_DN</TD><TD>MSigDB lists</TD><TD>ZHENG_RESPONSE_TO_ARSENITE_DN</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN</TD><TD>MSigDB lists</TD><TD>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>KEGG_PHENYLALANINE_METABOLISM</TD><TD>MSigDB lists</TD><TD>KEGG_PHENYLALANINE_METABOLISM</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</TD><TD>MSigDB lists</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_5</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.368e-02</TD><TD>-3.74</TD><TD>NIELSEN_LEIOMYOSARCOMA_UP</TD><TD>MSigDB lists</TD><TD>NIELSEN_LEIOMYOSARCOMA_UP</TD><TD>17</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.369e-02</TD><TD>-3.74</TD><TD>ITGA7 (integrin alpha 7)</TD><TD>protein interactions</TD><TD>3679</TD><TD>16</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.369e-02</TD><TD>-3.74</TD><TD>OSBPL8 (oxysterol binding protein-like 8)</TD><TD>protein interactions</TD><TD>114882</TD><TD>16</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.392e-02</TD><TD>-3.73</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP</TD><TD>171</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,G0S2</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>JISON_SICKLE_CELL_DISEASE_DN</TD><TD>MSigDB lists</TD><TD>JISON_SICKLE_CELL_DISEASE_DN</TD><TD>172</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,MMP3</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN</TD><TD>172</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP</TD><TD>172</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CXCL6</TD></TR>
<TR><TD>2.433e-02</TD><TD>-3.72</TD><TD>Pept_M10A_stromelysin-type</TD><TD>interpro domains</TD><TD>IPR016293</TD><TD>18</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.433e-02</TD><TD>-3.72</TD><TD>TNF_dom</TD><TD>interpro domains</TD><TD>IPR006052</TD><TD>18</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.436e-02</TD><TD>-3.71</TD><TD>regulation of cytoplasmic transport</TD><TD>biological process</TD><TD>GO:1903649</TD><TD>433</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>2.439e-02</TD><TD>-3.71</TD><TD>enzyme activator activity</TD><TD>molecular function</TD><TD>GO:0008047</TD><TD>454</TD><TD>3</TD><TD>16491</TD><TD>23</TD>
<TD>CXCL1,CCL5,CCL8</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP</TD><TD>173</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>WNT_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>WNT_UP.V1_UP</TD><TD>173</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL6</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>MODULE_197</TD><TD>MSigDB lists</TD><TD>MODULE_197</TD><TD>173</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>OKUMURA_INFLAMMATORY_RESPONSE_LPS</TD><TD>MSigDB lists</TD><TD>OKUMURA_INFLAMMATORY_RESPONSE_LPS</TD><TD>173</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP</TD><TD>173</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CD83</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>regulation of cell fate specification</TD><TD>biological process</TD><TD>GO:0042659</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>chronic inflammatory response</TD><TD>biological process</TD><TD>GO:0002544</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>positive regulation of tyrosine phosphorylation of Stat5 protein</TD><TD>biological process</TD><TD>GO:0042523</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>negative regulation of cardiac muscle tissue development</TD><TD>biological process</TD><TD>GO:0055026</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>mature B cell differentiation</TD><TD>biological process</TD><TD>GO:0002335</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>response to hydroperoxide</TD><TD>biological process</TD><TD>GO:0033194</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>negative regulation of smooth muscle contraction</TD><TD>biological process</TD><TD>GO:0045986</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>branching involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060445</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>regulation of immunoglobulin secretion</TD><TD>biological process</TD><TD>GO:0051023</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>negative regulation of T cell apoptotic process</TD><TD>biological process</TD><TD>GO:0070233</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>regulation of nitric-oxide synthase biosynthetic process</TD><TD>biological process</TD><TD>GO:0051769</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>T cell lineage commitment</TD><TD>biological process</TD><TD>GO:0002360</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>positive regulation of T cell apoptotic process</TD><TD>biological process</TD><TD>GO:0070234</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>regulation of macrophage chemotaxis</TD><TD>biological process</TD><TD>GO:0010758</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>positive regulation of synaptic transmission, glutamatergic</TD><TD>biological process</TD><TD>GO:0051968</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.454e-02</TD><TD>-3.71</TD><TD>positive regulation of neurological system process</TD><TD>biological process</TD><TD>GO:0031646</TD><TD>17</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.482e-02</TD><TD>-3.70</TD><TD>low-density lipoprotein particle receptor binding</TD><TD>molecular function</TD><TD>GO:0050750</TD><TD>18</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.494e-02</TD><TD>-3.69</TD><TD>Glucocorticoid receptor regulatory network</TD><TD>Pathway Interaction DB</TD><TD>reg_gr_pathway</TD><TD>82</TD><TD>2</TD><TD>2227</TD><TD>7</TD>
<TD>CSF2,IL6</TD></TR>
<TR><TD>2.497e-02</TD><TD>-3.69</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>175</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL6</TD></TR>
<TR><TD>2.497e-02</TD><TD>-3.69</TD><TD>GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP</TD><TD>175</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,G0S2</TD></TR>
<TR><TD>2.497e-02</TD><TD>-3.69</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP</TD><TD>175</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,G0S2</TD></TR>
<TR><TD>2.497e-02</TD><TD>-3.69</TD><TD>GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP</TD><TD>175</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,ELF3</TD></TR>
<TR><TD>2.500e-02</TD><TD>-3.69</TD><TD>positive regulation of homeostatic process</TD><TD>biological process</TD><TD>GO:0032846</TD><TD>169</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>2.500e-02</TD><TD>-3.69</TD><TD>CYSTEINE_SWITCH</TD><TD>prosite domains</TD><TD>PS00546</TD><TD>15</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.505e-02</TD><TD>-3.69</TD><TD>BOWIE_RESPONSE_TO_TAMOXIFEN</TD><TD>MSigDB lists</TD><TD>BOWIE_RESPONSE_TO_TAMOXIFEN</TD><TD>18</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.505e-02</TD><TD>-3.69</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.110.10.10</TD><TD>23</TD><TD>1</TD><TD>9988</TD><TD>11</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.515e-02</TD><TD>-3.68</TD><TD>PIGR (polymeric immunoglobulin receptor)</TD><TD>protein interactions</TD><TD>5284</TD><TD>17</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.515e-02</TD><TD>-3.68</TD><TD>ACAN (aggrecan)</TD><TD>protein interactions</TD><TD>176</TD><TD>17</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.515e-02</TD><TD>-3.68</TD><TD>CUTC (cutC copper transporter)</TD><TD>protein interactions</TD><TD>51076</TD><TD>17</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PIM2</TD></TR>
<TR><TD>2.515e-02</TD><TD>-3.68</TD><TD>HOOK3 (hook microtubule-tethering protein 3)</TD><TD>protein interactions</TD><TD>84376</TD><TD>17</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.524e-02</TD><TD>-3.68</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN</TD><TD>176</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,TNFSF13B</TD></TR>
<TR><TD>2.524e-02</TD><TD>-3.68</TD><TD>JNK_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>JNK_DN.V1_DN</TD><TD>176</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,G0S2</TD></TR>
<TR><TD>2.526e-02</TD><TD>-3.68</TD><TD>TNF</TD><TD>pfam domains</TD><TD>PF00229</TD><TD>17</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.527e-02</TD><TD>-3.68</TD><TD>response to toxic substance</TD><TD>biological process</TD><TD>GO:0009636</TD><TD>170</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>2.527e-02</TD><TD>-3.68</TD><TD>negative regulation of secretion by cell</TD><TD>biological process</TD><TD>GO:1903531</TD><TD>170</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,IL6</TD></TR>
<TR><TD>2.532e-02</TD><TD>-3.68</TD><TD>Synthesis of Prostaglandins (PG) and Thromboxanes (TX)</TD><TD>REACTOME pathways</TD><TD>R-HSA-2162123</TD><TD>14</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.550e-02</TD><TD>-3.67</TD><TD>GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN</TD><TD>177</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,G0S2</TD></TR>
<TR><TD>2.550e-02</TD><TD>-3.67</TD><TD>GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP</TD><TD>177</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2</TD></TR>
<TR><TD>2.558e-02</TD><TD>-3.67</TD><TD>regulation of establishment of protein localization</TD><TD>biological process</TD><TD>GO:0070201</TD><TD>785</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,IL6</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>IL2_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>IL2_UP.V1_UP</TD><TD>178</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CXCL3</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP</TD><TD>178</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,C15orf48</TD></TR>
<TR><TD>2.577e-02</TD><TD>-3.66</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP</TD><TD>178</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,G0S2</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>defense response to protozoan</TD><TD>biological process</TD><TD>GO:0042832</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>ovulation</TD><TD>biological process</TD><TD>GO:0030728</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>muscle cell cellular homeostasis</TD><TD>biological process</TD><TD>GO:0046716</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>regulation of cardiac muscle cell differentiation</TD><TD>biological process</TD><TD>GO:2000725</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>positive regulation of T-helper cell differentiation</TD><TD>biological process</TD><TD>GO:0045624</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.597e-02</TD><TD>-3.65</TD><TD>cellular response to vitamin</TD><TD>biological process</TD><TD>GO:0071295</TD><TD>18</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.604e-02</TD><TD>-3.65</TD><TD>GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN</TD><TD>179</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL5</TD></TR>
<TR><TD>2.604e-02</TD><TD>-3.65</TD><TD>V$FREAC7_01</TD><TD>MSigDB lists</TD><TD>V$FREAC7_01</TD><TD>179</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CXCL2</TD></TR>
<TR><TD>2.604e-02</TD><TD>-3.65</TD><TD>GSE12366_GC_VS_NAIVE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE12366_GC_VS_NAIVE_BCELL_DN</TD><TD>179</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CD83</TD></TR>
<TR><TD>2.618e-02</TD><TD>-3.64</TD><TD>oxidoreductase activity, acting on the CH-NH2 group of donors</TD><TD>molecular function</TD><TD>GO:0016638</TD><TD>19</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN</TD><TD>180</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN</TD><TD>180</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PIM2</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP</TD><TD>180</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F,CXCL6</TD></TR>
<TR><TD>2.634e-02</TD><TD>-3.64</TD><TD>human chr15q21.1</TD><TD>chromosome location</TD><TD>human chr15q21.1</TD><TD>28</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>C15orf48</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>GENTLES_LEUKEMIC_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>GENTLES_LEUKEMIC_STEM_CELL_DN</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>GTCAACC,MIR-380-5P</TD><TD>MSigDB lists</TD><TD>GTCAACC,MIR-380-5P</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CD83</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>DE_YY1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>DE_YY1_TARGETS_UP</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>STREICHER_LSM1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>STREICHER_LSM1_TARGETS_DN</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>ABE_VEGFA_TARGETS</TD><TD>MSigDB lists</TD><TD>ABE_VEGFA_TARGETS</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN</TD><TD>MSigDB lists</TD><TD>ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>MODULE_191</TD><TD>MSigDB lists</TD><TD>MODULE_191</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>ZHANG_RESPONSE_TO_CANTHARIDIN_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_RESPONSE_TO_CANTHARIDIN_UP</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>MODULE_262</TD><TD>MSigDB lists</TD><TD>MODULE_262</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>SESTO_RESPONSE_TO_UV_C3</TD><TD>MSigDB lists</TD><TD>SESTO_RESPONSE_TO_UV_C3</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.643e-02</TD><TD>-3.63</TD><TD>MURAKAMI_UV_RESPONSE_24HR</TD><TD>MSigDB lists</TD><TD>MURAKAMI_UV_RESPONSE_24HR</TD><TD>19</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.658e-02</TD><TD>-3.63</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,G0S2</TD></TR>
<TR><TD>2.658e-02</TD><TD>-3.63</TD><TD>TGFB_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>TGFB_UP.V1_DN</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL2</TD></TR>
<TR><TD>2.658e-02</TD><TD>-3.63</TD><TD>GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,MT1F</TD></TR>
<TR><TD>2.658e-02</TD><TD>-3.63</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,ELF3</TD></TR>
<TR><TD>2.658e-02</TD><TD>-3.63</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN</TD><TD>MSigDB lists</TD><TD>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN</TD><TD>181</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CCL8</TD></TR>
<TR><TD>2.660e-02</TD><TD>-3.63</TD><TD>negative regulation of transport</TD><TD>biological process</TD><TD>GO:0051051</TD><TD>448</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL11,IL6</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</TD><TD>MSigDB lists</TD><TD>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</TD><TD>464</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2,CCL5</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>HBD (hemoglobin, delta)</TD><TD>protein interactions</TD><TD>3045</TD><TD>18</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>MMP1 (matrix metallopeptidase 1)</TD><TD>protein interactions</TD><TD>4312</TD><TD>18</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>SDC1 (syndecan 1)</TD><TD>protein interactions</TD><TD>6382</TD><TD>18</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>LRP5 (LDL receptor related protein 5)</TD><TD>protein interactions</TD><TD>4041</TD><TD>18</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.661e-02</TD><TD>-3.63</TD><TD>SEC63 (SEC63 homolog, protein translocation regulator)</TD><TD>protein interactions</TD><TD>11231</TD><TD>18</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.685e-02</TD><TD>-3.62</TD><TD>GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN</TD><TD>182</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,G0S2</TD></TR>
<TR><TD>2.685e-02</TD><TD>-3.62</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_DC_DN</TD><TD>182</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>C15orf48,IL6</TD></TR>
<TR><TD>2.685e-02</TD><TD>-3.62</TD><TD>GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN</TD><TD>182</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2</TD></TR>
<TR><TD>2.695e-02</TD><TD>-3.61</TD><TD>positive regulation of I-kappaB kinase/NF-kappaB signaling</TD><TD>biological process</TD><TD>GO:0043123</TD><TD>176</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,PIM2</TD></TR>
<TR><TD>2.697e-02</TD><TD>-3.61</TD><TD>response to organic cyclic compound</TD><TD>biological process</TD><TD>GO:0014070</TD><TD>798</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5,IL6,CD83</TD></TR>
<TR><TD>2.699e-02</TD><TD>-3.61</TD><TD>Peptidoglycan-bd-like</TD><TD>interpro domains</TD><TD>IPR002477</TD><TD>20</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.706e-02</TD><TD>-3.61</TD><TD>SENESE_HDAC3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SENESE_HDAC3_TARGETS_UP</TD><TD>467</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL20,CXCL3</TD></TR>
<TR><TD>2.711e-02</TD><TD>-3.61</TD><TD>Negative regulation of TCF-dependent signaling by WNT ligand antagonists</TD><TD>REACTOME pathways</TD><TD>R-HSA-3772470</TD><TD>15</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>DKK1</TD></TR>
<TR><TD>2.713e-02</TD><TD>-3.61</TD><TD>GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>MSigDB lists</TD><TD>GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP</TD><TD>183</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL6,TNFSF13B</TD></TR>
<TR><TD>2.713e-02</TD><TD>-3.61</TD><TD>GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP</TD><TD>183</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CXCL6</TD></TR>
<TR><TD>2.713e-02</TD><TD>-3.61</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN</TD><TD>183</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>2.724e-02</TD><TD>-3.60</TD><TD>response to reactive oxygen species</TD><TD>biological process</TD><TD>GO:0000302</TD><TD>177</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3,IL6</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>cellular response to fluid shear stress</TD><TD>biological process</TD><TD>GO:0071498</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>response to cholesterol</TD><TD>biological process</TD><TD>GO:0070723</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>response to lipoprotein particle</TD><TD>biological process</TD><TD>GO:0055094</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>response to auditory stimulus</TD><TD>biological process</TD><TD>GO:0010996</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>decidualization</TD><TD>biological process</TD><TD>GO:0046697</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.739e-02</TD><TD>-3.60</TD><TD>regulation of circadian sleep/wake cycle, sleep</TD><TD>biological process</TD><TD>GO:0045187</TD><TD>19</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>2.740e-02</TD><TD>-3.60</TD><TD>CYCLIN_D1_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>CYCLIN_D1_UP.V1_DN</TD><TD>184</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,MT1F</TD></TR>
<TR><TD>2.740e-02</TD><TD>-3.60</TD><TD>P53_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>P53_DN.V1_UP</TD><TD>184</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,DKK1</TD></TR>
<TR><TD>2.740e-02</TD><TD>-3.60</TD><TD>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</TD><TD>MSigDB lists</TD><TD>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</TD><TD>184</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,NFKBIZ</TD></TR>
<TR><TD>2.751e-02</TD><TD>-3.59</TD><TD>ZHENG_BOUND_BY_FOXP3</TD><TD>MSigDB lists</TD><TD>ZHENG_BOUND_BY_FOXP3</TD><TD>470</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,NFKBIZ,C15orf48</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE25087_FETAL_VS_ADULT_TCONV_UP</TD><TD>MSigDB lists</TD><TD>GSE25087_FETAL_VS_ADULT_TCONV_UP</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CXCL3</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,C15orf48</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CD83</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,C15orf48</TD></TR>
<TR><TD>2.768e-02</TD><TD>-3.59</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN</TD><TD>185</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>MURAKAMI_UV_RESPONSE_6HR_DN</TD><TD>MSigDB lists</TD><TD>MURAKAMI_UV_RESPONSE_6HR_DN</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>WOTTON_RUNX_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>WOTTON_RUNX_TARGETS_UP</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>MODULE_439</TD><TD>MSigDB lists</TD><TD>MODULE_439</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>HOMEOSTASIS_OF_NUMBER_OF_CELLS</TD><TD>MSigDB lists</TD><TD>HOMEOSTASIS_OF_NUMBER_OF_CELLS</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN</TD><TD>MSigDB lists</TD><TD>NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</TD><TD>MSigDB lists</TD><TD>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON</TD><TD>MSigDB lists</TD><TD>NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CD83</TD></TR>
<TR><TD>2.780e-02</TD><TD>-3.58</TD><TD>GESERICK_TERT_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>GESERICK_TERT_TARGETS_DN</TD><TD>20</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ</TD></TR>
<TR><TD>2.781e-02</TD><TD>-3.58</TD><TD>SWEET_LUNG_CANCER_KRAS_UP</TD><TD>MSigDB lists</TD><TD>SWEET_LUNG_CANCER_KRAS_UP</TD><TD>472</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,IL11,CSF2</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>CYCLIN_D1_KE_.V1_DN</TD><TD>MSigDB lists</TD><TD>CYCLIN_D1_KE_.V1_DN</TD><TD>186</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CXCL3</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP</TD><TD>186</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CCL5</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN</TD><TD>186</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE14000_UNSTIM_VS_4H_LPS_DC_DN</TD><TD>186</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL5</TD></TR>
<TR><TD>2.795e-02</TD><TD>-3.58</TD><TD>GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN</TD><TD>186</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>C15orf48,TNFSF13B</TD></TR>
<TR><TD>2.800e-02</TD><TD>-3.58</TD><TD>cellular cation homeostasis</TD><TD>biological process</TD><TD>GO:0030003</TD><TD>457</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>SDC4 (syndecan 4)</TD><TD>protein interactions</TD><TD>6385</TD><TD>19</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>TMEFF1 (transmembrane protein with EGF-like and two follistatin-like domains 1)</TD><TD>protein interactions</TD><TD>8577</TD><TD>19</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>ELMO1 (engulfment and cell motility 1)</TD><TD>protein interactions</TD><TD>9844</TD><TD>19</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>NID2 (nidogen 2 (osteonidogen))</TD><TD>protein interactions</TD><TD>22795</TD><TD>19</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>TSSK3 (testis-specific serine kinase 3)</TD><TD>protein interactions</TD><TD>81629</TD><TD>19</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>C15orf48</TD></TR>
<TR><TD>2.815e-02</TD><TD>-3.57</TD><TD>GEORGES_TARGETS_OF_MIR192_AND_MIR215</TD><TD>MSigDB lists</TD><TD>GEORGES_TARGETS_OF_MIR192_AND_MIR215</TD><TD>837</TD><TD>4</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,MT1F,CD83,TNFSF13B</TD></TR>
<TR><TD>2.818e-02</TD><TD>-3.57</TD><TD>regulation of cellular localization</TD><TD>biological process</TD><TD>GO:0060341</TD><TD>1211</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,CCL5,IL6</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDM_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CXCL6</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_UP</TD><TD>MSigDB lists</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_UP</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,MMP3</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,MT1F</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_DN</TD><TD>MSigDB lists</TD><TD>GSE13306_TREG_RA_VS_TCONV_RA_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL5</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PIM2</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN</TD><TD>MSigDB lists</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,G0S2</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>VEGF_A_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>VEGF_A_UP.V1_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,DKK1</TD></TR>
<TR><TD>2.823e-02</TD><TD>-3.57</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDM_DN</TD><TD>187</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>2.829e-02</TD><TD>-3.57</TD><TD>TNF_2</TD><TD>prosite domains</TD><TD>PS50049</TD><TD>17</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>2.829e-02</TD><TD>-3.57</TD><TD>HEMOPEXIN</TD><TD>prosite domains</TD><TD>PS00024</TD><TD>17</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.832e-02</TD><TD>-3.56</TD><TD>immune effector process</TD><TD>biological process</TD><TD>GO:0002252</TD><TD>459</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,IL6,CXCL6</TD></TR>
<TR><TD>2.838e-02</TD><TD>-3.56</TD><TD>regulation of myeloid cell differentiation</TD><TD>biological process</TD><TD>GO:0045637</TD><TD>181</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,CCL5</TD></TR>
<TR><TD>2.844e-02</TD><TD>-3.56</TD><TD>Canavan Disease</TD><TD>SMPDB pathways</TD><TD>SMP00175</TD><TD>14</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.844e-02</TD><TD>-3.56</TD><TD>Hypoacetylaspartia</TD><TD>SMPDB pathways</TD><TD>SMP00192</TD><TD>14</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.844e-02</TD><TD>-3.56</TD><TD>Aspartate Metabolism</TD><TD>SMPDB pathways</TD><TD>SMP00067</TD><TD>14</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,DKK1</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CD83</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,CD83</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,CXCL6</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE17721_12H_VS_24H_POLYIC_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_12H_VS_24H_POLYIC_BMDM_UP</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,IL6</TD></TR>
<TR><TD>2.851e-02</TD><TD>-3.56</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDM_DN</TD><TD>188</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CD83</TD></TR>
<TR><TD>2.857e-02</TD><TD>-3.56</TD><TD>RGAGGAARY_V$PU1_Q6</TD><TD>MSigDB lists</TD><TD>RGAGGAARY_V$PU1_Q6</TD><TD>477</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CSF3,CSF2</TD></TR>
<TR><TD>2.872e-02</TD><TD>-3.55</TD><TD>cellular process</TD><TD>biological process</TD><TD>GO:0009987</TD><TD>14182</TD><TD>24</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,IL4I1,CXCL2,CCL5,CSF2,DKK1,CD83,ELF3,GPR183,CSF3,PTGS2,MMP3,CCL8,IL6,G0S2,CXCL1,NFKBIZ,PIM2,MT1F</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE25087_FETAL_VS_ADULT_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE25087_FETAL_VS_ADULT_TREG_UP</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL3</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,MT1F</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_UP</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL7</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PTGS2</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE10325_CD4_TCELL_VS_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE10325_CD4_TCELL_VS_BCELL_UP</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,MT1F</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>GSE3982_EOSINOPHIL_VS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_DC_DN</TD><TD>189</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CD83</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>positive regulation of translational initiation</TD><TD>biological process</TD><TD>GO:0045948</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>regulation of tyrosine phosphorylation of Stat5 protein</TD><TD>biological process</TD><TD>GO:0042522</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>response to nitric oxide</TD><TD>biological process</TD><TD>GO:0071731</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>myeloid dendritic cell differentiation</TD><TD>biological process</TD><TD>GO:0043011</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>positive regulation of protein oligomerization</TD><TD>biological process</TD><TD>GO:0032461</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>regulation of monocyte chemotaxis</TD><TD>biological process</TD><TD>GO:0090025</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>prostanoid biosynthetic process</TD><TD>biological process</TD><TD>GO:0046457</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.881e-02</TD><TD>-3.55</TD><TD>prostaglandin biosynthetic process</TD><TD>biological process</TD><TD>GO:0001516</TD><TD>20</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP</TD><TD>MSigDB lists</TD><TD>GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,PTGS2</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CD83</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDM_DN</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CXCL3</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE17721_0.5H_VS_8H_CPG_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_8H_CPG_BMDM_DN</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL5</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_UP</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CCL5</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE17721_POLYIC_VS_CPG_2H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_CPG_2H_BMDM_DN</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CD83</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_ALL_VS_24H_PAM3CSK4_BMDM_DN</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,TNFSF13B</TD></TR>
<TR><TD>2.907e-02</TD><TD>-3.54</TD><TD>GSE14350_IL2RB_KO_VS_WT_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE14350_IL2RB_KO_VS_WT_TREG_UP</TD><TD>190</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,TNFSF13B</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</TD><TD>MSigDB lists</TD><TD>SEKI_INFLAMMATORY_RESPONSE_LPS_DN</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>KANNAN_TP53_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>KANNAN_TP53_TARGETS_DN</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>PID_S1P_S1P1_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_S1P_S1P1_PATHWAY</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>BIOCARTA_CYTOKINE_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_CYTOKINE_PATHWAY</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</TD><TD>MSigDB lists</TD><TD>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>2.917e-02</TD><TD>-3.53</TD><TD>MODULE_562</TD><TD>MSigDB lists</TD><TD>MODULE_562</TD><TD>21</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CCL8</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,MT1F</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_8H_BMDM_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CXCL6</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE360_L_DONOVANI_VS_T_GONDII_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_T_GONDII_DC_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CCL8</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE2826_WT_VS_BTK_KO_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE2826_WT_VS_BTK_KO_BCELL_UP</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CD83</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE10325_MYELOID_VS_LUPUS_MYELOID_DN</TD><TD>MSigDB lists</TD><TD>GSE10325_MYELOID_VS_LUPUS_MYELOID_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,MT1F</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE29618_MONOCYTE_VS_MDC_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_MONOCYTE_VS_MDC_UP</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,G0S2</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,PIM2</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CCL5</TD></TR>
<TR><TD>2.936e-02</TD><TD>-3.53</TD><TD>GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN</TD><TD>191</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,G0S2</TD></TR>
<TR><TD>2.953e-02</TD><TD>-3.52</TD><TD>TSHZ3 (teashirt zinc finger homeobox 3)</TD><TD>protein interactions</TD><TD>57616</TD><TD>20</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.953e-02</TD><TD>-3.52</TD><TD>CWC22 (CWC22 homolog, spliceosome-associated protein)</TD><TD>protein interactions</TD><TD>57703</TD><TD>20</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>2.955e-02</TD><TD>-3.52</TD><TD>homeostasis of number of cells</TD><TD>biological process</TD><TD>GO:0048872</TD><TD>185</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,TNFSF13B</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_PAM3CSK4_24H_BMDM_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CD83</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE17721_CTRL_VS_CPG_2H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_CPG_2H_BMDM_DN</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,ELF3</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE3982_EOSINOPHIL_VS_MAST_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_EOSINOPHIL_VS_MAST_CELL_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,MMP3</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CD83</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_POLYIC_24H_BMDM_DN</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,ELF3</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE5960_TH1_VS_ANERGIC_TH1_DN</TD><TD>MSigDB lists</TD><TD>GSE5960_TH1_VS_ANERGIC_TH1_DN</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CSF2</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP</TD><TD>MSigDB lists</TD><TD>GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,TNFSF13B</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE17721_CTRL_VS_CPG_12H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_CPG_12H_BMDM_DN</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CCL5</TD></TR>
<TR><TD>2.964e-02</TD><TD>-3.52</TD><TD>GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP</TD><TD>192</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CD83</TD></TR>
<TR><TD>2.966e-02</TD><TD>-3.52</TD><TD>PG_binding_1</TD><TD>pfam domains</TD><TD>PF01471</TD><TD>20</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE17721_12H_VS_24H_PAM3CSK4_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_12H_VS_24H_PAM3CSK4_BMDM_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CXCL6</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE3982_CTRL_VS_LPS_4H_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_CTRL_VS_LPS_4H_MAC_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,MT1F</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDM_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,TNFSF13B</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN</TD><TD>MSigDB lists</TD><TD>GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,ELF3</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE7852_TREG_VS_TCONV_LN_UP</TD><TD>MSigDB lists</TD><TD>GSE7852_TREG_VS_TCONV_LN_UP</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CD83</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDM_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PTGS2</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>GSE2826_WT_VS_XID_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE2826_WT_VS_XID_BCELL_UP</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1,CD83</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>VESICLE_MEDIATED_TRANSPORT</TD><TD>MSigDB lists</TD><TD>VESICLE_MEDIATED_TRANSPORT</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>2.992e-02</TD><TD>-3.51</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN</TD><TD>193</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL3</TD></TR>
<TR><TD>2.993e-02</TD><TD>-3.51</TD><TD>cellular ion homeostasis</TD><TD>biological process</TD><TD>GO:0006873</TD><TD>469</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>3.005e-02</TD><TD>-3.50</TD><TD>human chr16q13</TD><TD>chromosome location</TD><TD>human chr16q13</TD><TD>32</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>3.014e-02</TD><TD>-3.50</TD><TD>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</TD><TD>MSigDB lists</TD><TD>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</TD><TD>487</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,ELF3,DKK1</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,G0S2</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>ZWANG_EGF_INTERVAL_DN</TD><TD>MSigDB lists</TD><TD>ZWANG_EGF_INTERVAL_DN</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3,DKK1</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,IL6</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE7852_TREG_VS_TCONV_THYMUS_UP</TD><TD>MSigDB lists</TD><TD>GSE7852_TREG_VS_TCONV_THYMUS_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDM_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE20715_WT_VS_TLR4_KO_LUNG_UP</TD><TD>MSigDB lists</TD><TD>GSE20715_WT_VS_TLR4_KO_LUNG_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,TNFSF13B</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE17721_LPS_VS_POLYIC_1H_BMDM_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_LPS_VS_POLYIC_1H_BMDM_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL6</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE3982_MAC_VS_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_MAC_VS_BCELL_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP</TD><TD>MSigDB lists</TD><TD>GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CD83</TD></TR>
<TR><TD>3.021e-02</TD><TD>-3.50</TD><TD>GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_PAM3CSK4_2H_BMDM_DN</TD><TD>194</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF2</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>response to protozoan</TD><TD>biological process</TD><TD>GO:0001562</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>aromatic amino acid family catabolic process</TD><TD>biological process</TD><TD>GO:0009074</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>positive regulation of epithelial cell apoptotic process</TD><TD>biological process</TD><TD>GO:1904037</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>modulation by host of viral transcription</TD><TD>biological process</TD><TD>GO:0043921</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>negative regulation of peptidyl-serine phosphorylation</TD><TD>biological process</TD><TD>GO:0033137</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>positive regulation of lymphocyte apoptotic process</TD><TD>biological process</TD><TD>GO:0070230</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>dendritic cell migration</TD><TD>biological process</TD><TD>GO:0036336</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>regulation of circadian sleep/wake cycle</TD><TD>biological process</TD><TD>GO:0042749</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>response to salt stress</TD><TD>biological process</TD><TD>GO:0009651</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.023e-02</TD><TD>-3.50</TD><TD>modulation by host of symbiont transcription</TD><TD>biological process</TD><TD>GO:0052472</TD><TD>21</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.037e-02</TD><TD>-3.49</TD><TD>positive regulation of hydrolase activity</TD><TD>biological process</TD><TD>GO:0051345</TD><TD>828</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,PIM2</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GSE29618_BCELL_VS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE29618_BCELL_VS_MONOCYTE_DN</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CXCL2</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_FAT_TCONV_DN</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL3</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GSE7460_TCONV_VS_TREG_THYMUS_DN</TD><TD>MSigDB lists</TD><TD>GSE7460_TCONV_VS_TREG_THYMUS_DN</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CD83</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP</TD><TD>MSigDB lists</TD><TD>GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP</TD><TD>195</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CD83</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>BIOCARTA_IL6_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_IL6_PATHWAY</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>BIOCARTA_HER2_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_HER2_PATHWAY</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>REGULATION_OF_BLOOD_PRESSURE</TD><TD>MSigDB lists</TD><TD>REGULATION_OF_BLOOD_PRESSURE</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>WU_HBX_TARGETS_2_UP</TD><TD>MSigDB lists</TD><TD>WU_HBX_TARGETS_2_UP</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>MATZUK_IMPLANTATION_AND_UTERINE</TD><TD>MSigDB lists</TD><TD>MATZUK_IMPLANTATION_AND_UTERINE</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>NEWMAN_ERCC6_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>NEWMAN_ERCC6_TARGETS_UP</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>3.054e-02</TD><TD>-3.49</TD><TD>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN</TD><TD>MSigDB lists</TD><TD>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN</TD><TD>22</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>3.067e-02</TD><TD>-3.48</TD><TD>TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-5676594</TD><TD>17</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.074e-02</TD><TD>-3.48</TD><TD>response to mechanical stimulus</TD><TD>biological process</TD><TD>GO:0009612</TD><TD>189</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>3.097e-02</TD><TD>-3.47</TD><TD>human chr11q22.3</TD><TD>chromosome location</TD><TD>human chr11q22.3</TD><TD>33</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>ABHD16A (abhydrolase domain containing 16A)</TD><TD>protein interactions</TD><TD>7920</TD><TD>21</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>CAND2 (cullin-associated and neddylation-dissociated 2 (putative))</TD><TD>protein interactions</TD><TD>23066</TD><TD>21</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>Hemopexin-like_dom</TD><TD>interpro domains</TD><TD>IPR000585</TD><TD>23</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>Pept_M10_metallopeptidase</TD><TD>interpro domains</TD><TD>IPR001818</TD><TD>23</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>Hemopexin-like_repeat</TD><TD>interpro domains</TD><TD>IPR018487</TD><TD>23</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.098e-02</TD><TD>-3.47</TD><TD>Pept_M10A</TD><TD>interpro domains</TD><TD>IPR021190</TD><TD>23</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.104e-02</TD><TD>-3.47</TD><TD>response to estrogen</TD><TD>biological process</TD><TD>GO:0043627</TD><TD>190</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN</TD><TD>197</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CD83</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDM_DN</TD><TD>197</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CXCL3</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>GSE30083_SP2_VS_SP3_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE30083_SP2_VS_SP3_THYMOCYTE_UP</TD><TD>197</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CD83</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN</TD><TD>197</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,MT1F</TD></TR>
<TR><TD>3.107e-02</TD><TD>-3.47</TD><TD>GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP</TD><TD>197</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,CD83</TD></TR>
<TR><TD>3.110e-02</TD><TD>-3.47</TD><TD>ANPEROXIDASE</TD><TD>prints domains</TD><TD>PR00457</TD><TD>10</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.125e-02</TD><TD>-3.47</TD><TD>defense response to other organism</TD><TD>biological process</TD><TD>GO:0098542</TD><TD>477</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20,IL6,CXCL6</TD></TR>
<TR><TD>3.136e-02</TD><TD>-3.46</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN</TD><TD>MSigDB lists</TD><TD>GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN</TD><TD>198</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2,CXCL3</TD></TR>
<TR><TD>3.136e-02</TD><TD>-3.46</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP</TD><TD>198</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8,G0S2</TD></TR>
<TR><TD>3.136e-02</TD><TD>-3.46</TD><TD>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</TD><TD>MSigDB lists</TD><TD>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</TD><TD>198</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1,CXCL6</TD></TR>
<TR><TD>3.161e-02</TD><TD>-3.45</TD><TD>lipoprotein particle receptor binding</TD><TD>molecular function</TD><TD>GO:0070325</TD><TD>23</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.164e-02</TD><TD>-3.45</TD><TD>positive regulation of nucleobase-containing compound metabolic process</TD><TD>biological process</TD><TD>GO:0045935</TD><TD>1697</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,PIM2,CSF2,IL6,ELF3</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>T-helper cell differentiation</TD><TD>biological process</TD><TD>GO:0042093</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>CD4-positive, alpha-beta T cell differentiation involved in immune response</TD><TD>biological process</TD><TD>GO:0002294</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>response to sterol</TD><TD>biological process</TD><TD>GO:0036314</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>positive T cell selection</TD><TD>biological process</TD><TD>GO:0043368</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>cellular response to interleukin-6</TD><TD>biological process</TD><TD>GO:0071354</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>modulation of transcription in other organism involved in symbiotic interaction</TD><TD>biological process</TD><TD>GO:0052312</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>megakaryocyte differentiation</TD><TD>biological process</TD><TD>GO:0030219</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL11</TD></TR>
<TR><TD>3.165e-02</TD><TD>-3.45</TD><TD>neutrophil activation</TD><TD>biological process</TD><TD>GO:0042119</TD><TD>22</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>GRUETZMANN_PANCREATIC_CANCER_DN</TD><TD>MSigDB lists</TD><TD>GRUETZMANN_PANCREATIC_CANCER_DN</TD><TD>199</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL2</TD></TR>
<TR><TD>3.174e-02</TD><TD>-3.45</TD><TD>MODULE_16</TD><TD>MSigDB lists</TD><TD>MODULE_16</TD><TD>497</TD><TD>3</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,GPR183,CCL5</TD></TR>
<TR><TD>3.190e-02</TD><TD>-3.45</TD><TD>AZARE_STAT3_TARGETS</TD><TD>MSigDB lists</TD><TD>AZARE_STAT3_TARGETS</TD><TD>23</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.190e-02</TD><TD>-3.45</TD><TD>BIOCARTA_DC_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_DC_PATHWAY</TD><TD>23</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>3.190e-02</TD><TD>-3.45</TD><TD>OSADA_ASCL1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>OSADA_ASCL1_TARGETS_DN</TD><TD>23</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.190e-02</TD><TD>-3.45</TD><TD>NEGATIVE_REGULATION_OF_TRANSLATION</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_TRANSLATION</TD><TD>23</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.194e-02</TD><TD>-3.44</TD><TD>regulation of cellular ketone metabolic process</TD><TD>biological process</TD><TD>GO:0010565</TD><TD>193</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>3.195e-02</TD><TD>-3.44</TD><TD>GSE14350_IL2RB_KO_VS_WT_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE14350_IL2RB_KO_VS_WT_TREG_DN</TD><TD>200</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,CD83</TD></TR>
<TR><TD>3.198e-02</TD><TD>-3.44</TD><TD>regulation of hydrolase activity</TD><TD>biological process</TD><TD>GO:0051336</TD><TD>1252</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL20,CCL8,IL6</TD></TR>
<TR><TD>3.210e-02</TD><TD>-3.44</TD><TD>metal ion homeostasis</TD><TD>biological process</TD><TD>GO:0055065</TD><TD>482</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>3.225e-02</TD><TD>-3.43</TD><TD>negative regulation of secretion</TD><TD>biological process</TD><TD>GO:0051048</TD><TD>194</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL11,IL6</TD></TR>
<TR><TD>3.243e-02</TD><TD>-3.43</TD><TD>STAG1 (stromal antigen 1)</TD><TD>protein interactions</TD><TD>10274</TD><TD>22</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>3.254e-02</TD><TD>-3.43</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>202</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL6,DKK1</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>regulation of sprouting angiogenesis</TD><TD>biological process</TD><TD>GO:1903670</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>positive regulation of blood vessel endothelial cell migration</TD><TD>biological process</TD><TD>GO:0043536</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>negative regulation of muscle contraction</TD><TD>biological process</TD><TD>GO:0045932</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>leukocyte apoptotic process</TD><TD>biological process</TD><TD>GO:0071887</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>regulation of myeloid cell apoptotic process</TD><TD>biological process</TD><TD>GO:0033032</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.306e-02</TD><TD>-3.41</TD><TD>granulocyte activation</TD><TD>biological process</TD><TD>GO:0036230</TD><TD>23</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.327e-02</TD><TD>-3.40</TD><TD>WONG_ENDMETRIUM_CANCER_UP</TD><TD>MSigDB lists</TD><TD>WONG_ENDMETRIUM_CANCER_UP</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20</TD></TR>
<TR><TD>3.327e-02</TD><TD>-3.40</TD><TD>MURATA_VIRULENCE_OF_H_PILORI</TD><TD>MSigDB lists</TD><TD>MURATA_VIRULENCE_OF_H_PILORI</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>3.327e-02</TD><TD>-3.40</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP</TD><TD>MSigDB lists</TD><TD>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>3.327e-02</TD><TD>-3.40</TD><TD>HAHTOLA_CTCL_CUTANEOUS</TD><TD>MSigDB lists</TD><TD>HAHTOLA_CTCL_CUTANEOUS</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>3.327e-02</TD><TD>-3.40</TD><TD>TOMIDA_METASTASIS_UP</TD><TD>MSigDB lists</TD><TD>TOMIDA_METASTASIS_UP</TD><TD>24</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>3.374e-02</TD><TD>-3.39</TD><TD>human chr4q13.3</TD><TD>chromosome location</TD><TD>human chr4q13.3</TD><TD>36</TD><TD>1</TD><TD>26250</TD><TD>25</TD>
<TD>CXCL6</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>CCL5 (chemokine (C-C motif) ligand 5)</TD><TD>protein interactions</TD><TD>6352</TD><TD>23</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>MMP14 (matrix metallopeptidase 14 (membrane-inserted))</TD><TD>protein interactions</TD><TD>4323</TD><TD>23</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL7</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>SERPINE1 (serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1)</TD><TD>protein interactions</TD><TD>5054</TD><TD>23</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>CSF3R (colony stimulating factor 3 receptor)</TD><TD>protein interactions</TD><TD>1441</TD><TD>23</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF3</TD></TR>
<TR><TD>3.388e-02</TD><TD>-3.38</TD><TD>TGFBR3 (transforming growth factor beta receptor III)</TD><TD>protein interactions</TD><TD>7049</TD><TD>23</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>3.403e-02</TD><TD>-3.38</TD><TD>Peptidase_M10</TD><TD>pfam domains</TD><TD>PF00413</TD><TD>23</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.403e-02</TD><TD>-3.38</TD><TD>Hemopexin</TD><TD>pfam domains</TD><TD>PF00045</TD><TD>23</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.431e-02</TD><TD>-3.37</TD><TD>oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</TD><TD>molecular function</TD><TD>GO:0016702</TD><TD>25</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.431e-02</TD><TD>-3.37</TD><TD>chemoattractant activity</TD><TD>molecular function</TD><TD>GO:0042056</TD><TD>25</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>alpha-beta T cell activation involved in immune response</TD><TD>biological process</TD><TD>GO:0002287</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>alpha-beta T cell differentiation involved in immune response</TD><TD>biological process</TD><TD>GO:0002293</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>positive regulation of smooth muscle cell migration</TD><TD>biological process</TD><TD>GO:0014911</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>negative regulation of viral transcription</TD><TD>biological process</TD><TD>GO:0032897</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>cellular response to dexamethasone stimulus</TD><TD>biological process</TD><TD>GO:0071549</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>positive regulation of osteoclast differentiation</TD><TD>biological process</TD><TD>GO:0045672</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.448e-02</TD><TD>-3.37</TD><TD>myeloid dendritic cell activation</TD><TD>biological process</TD><TD>GO:0001773</TD><TD>24</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>KIM_WT1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>KIM_WT1_TARGETS_UP</TD><TD>209</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CD83</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>COLLER_MYC_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>COLLER_MYC_TARGETS_UP</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>KIM_HYPOXIA</TD><TD>MSigDB lists</TD><TD>KIM_HYPOXIA</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>VERRECCHIA_RESPONSE_TO_TGFB1_C2</TD><TD>MSigDB lists</TD><TD>VERRECCHIA_RESPONSE_TO_TGFB1_C2</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>WALLACE_JAK2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>WALLACE_JAK2_TARGETS_UP</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>PID_INTEGRIN_A9B1_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_INTEGRIN_A9B1_PATHWAY</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>MODULE_371</TD><TD>MSigDB lists</TD><TD>MODULE_371</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.463e-02</TD><TD>-3.36</TD><TD>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP</TD><TD>25</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>3.490e-02</TD><TD>-3.36</TD><TD>regulation of transport</TD><TD>biological process</TD><TD>GO:0051049</TD><TD>1736</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL11,CCL5,IL6,DKK1</TD></TR>
<TR><TD>3.493e-02</TD><TD>-3.35</TD><TD>TNF</TD><TD>smart domains</TD><TD>SM00207</TD><TD>18</TD><TD>1</TD><TD>9131</TD><TD>18</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.493e-02</TD><TD>-3.35</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>MSigDB lists</TD><TD>BOQUEST_STEM_CELL_DN</TD><TD>210</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,G0S2</TD></TR>
<TR><TD>3.525e-02</TD><TD>-3.35</TD><TD>regulation of transcription from RNA polymerase II promoter</TD><TD>biological process</TD><TD>GO:0006357</TD><TD>1740</TD><TD>6</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,NFKBIZ,IL6,DKK1,ELF3</TD></TR>
<TR><TD>3.533e-02</TD><TD>-3.34</TD><TD>VIMP (VCP-interacting membrane selenoprotein)</TD><TD>protein interactions</TD><TD>55829</TD><TD>24</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.566e-02</TD><TD>-3.33</TD><TD>oxidoreductase activity, acting on single donors with incorporation of molecular oxygen</TD><TD>molecular function</TD><TD>GO:0016701</TD><TD>26</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.576e-02</TD><TD>-3.33</TD><TD>Chagas disease (American trypanosomiasis)</TD><TD>KEGG pathways</TD><TD>ko05142</TD><TD>104</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>3.576e-02</TD><TD>-3.33</TD><TD>Chagas disease (American trypanosomiasis)</TD><TD>KEGG pathways</TD><TD>hsa05142</TD><TD>104</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>regulation of type 2 immune response</TD><TD>biological process</TD><TD>GO:0002828</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>negative regulation of embryonic development</TD><TD>biological process</TD><TD>GO:0045992</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>positive regulation of interleukin-10 production</TD><TD>biological process</TD><TD>GO:0032733</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CD83</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>B cell homeostasis</TD><TD>biological process</TD><TD>GO:0001782</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>response to vitamin D</TD><TD>biological process</TD><TD>GO:0033280</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.589e-02</TD><TD>-3.33</TD><TD>regulation of transforming growth factor beta production</TD><TD>biological process</TD><TD>GO:0071634</TD><TD>25</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.595e-02</TD><TD>-3.33</TD><TD>regulation of cellular protein localization</TD><TD>biological process</TD><TD>GO:1903827</TD><TD>504</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>regulation of calcium ion transport</TD><TD>biological process</TD><TD>GO:0051924</TD><TD>206</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP</TD><TD>MSigDB lists</TD><TD>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>CHIN_BREAST_CANCER_COPY_NUMBER_UP</TD><TD>MSigDB lists</TD><TD>CHIN_BREAST_CANCER_COPY_NUMBER_UP</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>CHOW_RASSF1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>CHOW_RASSF1_TARGETS_UP</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>MODULE_59</TD><TD>MSigDB lists</TD><TD>MODULE_59</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>PID_IL27_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_IL27_PATHWAY</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.599e-02</TD><TD>-3.32</TD><TD>CALCIUM_ION_TRANSPORT</TD><TD>MSigDB lists</TD><TD>CALCIUM_ION_TRANSPORT</TD><TD>26</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8</TD></TR>
<TR><TD>3.616e-02</TD><TD>-3.32</TD><TD>V$IK3_01</TD><TD>MSigDB lists</TD><TD>V$IK3_01</TD><TD>214</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20,CXCL6</TD></TR>
<TR><TD>3.623e-02</TD><TD>-3.32</TD><TD>regulation of molecular function</TD><TD>biological process</TD><TD>GO:0065009</TD><TD>2753</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CSF3,CCL20,CCL8,IL6,CXCL1,CSF2,CCL5</TD></TR>
<TR><TD>3.628e-02</TD><TD>-3.32</TD><TD>AT_hook_DNA-bd_motif</TD><TD>interpro domains</TD><TD>IPR017956</TD><TD>27</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>positive regulation of transport</TD><TD>biological process</TD><TD>GO:0051050</TD><TD>876</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,IL6</TD></TR>
<TR><TD>3.649e-02</TD><TD>-3.31</TD><TD>Etoposide Action Pathway</TD><TD>SMPDB pathways</TD><TD>SMP00442</TD><TD>18</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.649e-02</TD><TD>-3.31</TD><TD>Etoposide Metabolism Pathway</TD><TD>SMPDB pathways</TD><TD>SMP00601</TD><TD>18</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.678e-02</TD><TD>-3.30</TD><TD>RANBP6 (RAN binding protein 6)</TD><TD>protein interactions</TD><TD>26953</TD><TD>25</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.678e-02</TD><TD>-3.30</TD><TD>HOOK1 (hook microtubule-tethering protein 1)</TD><TD>protein interactions</TD><TD>51361</TD><TD>25</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.703e-02</TD><TD>-3.30</TD><TD>Toll-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>ko04620</TD><TD>106</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>3.703e-02</TD><TD>-3.30</TD><TD>Toll-like receptor signaling pathway</TD><TD>KEGG pathways</TD><TD>hsa04620</TD><TD>106</TD><TD>2</TD><TD>6908</TD><TD>20</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>3.711e-02</TD><TD>-3.29</TD><TD>chemical homeostasis</TD><TD>biological process</TD><TD>GO:0048878</TD><TD>882</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8,IL6</TD></TR>
<TR><TD>3.715e-02</TD><TD>-3.29</TD><TD>organ development</TD><TD>biological process</TD><TD>GO:0048513</TD><TD>2766</TD><TD>8</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,PTGS2,CSF3,IL11,IL6,CSF2,DKK1,ELF3</TD></TR>
<TR><TD>3.722e-02</TD><TD>-3.29</TD><TD>MTVERTEBRATE</TD><TD>prints domains</TD><TD>PR00860</TD><TD>12</TD><TD>1</TD><TD>4759</TD><TD>15</TD>
<TD>MT1F</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>response to morphine</TD><TD>biological process</TD><TD>GO:0043278</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>positive regulation of vascular endothelial growth factor production</TD><TD>biological process</TD><TD>GO:0010575</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>prostaglandin metabolic process</TD><TD>biological process</TD><TD>GO:0006693</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>negative regulation of endothelial cell apoptotic process</TD><TD>biological process</TD><TD>GO:2000352</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL11</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>response to lithium ion</TD><TD>biological process</TD><TD>GO:0010226</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>prostanoid metabolic process</TD><TD>biological process</TD><TD>GO:0006692</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.730e-02</TD><TD>-3.29</TD><TD>regulation of T-helper cell differentiation</TD><TD>biological process</TD><TD>GO:0045622</TD><TD>26</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</TD><TD>MSigDB lists</TD><TD>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>GENTILE_UV_LOW_DOSE_UP</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_LOW_DOSE_UP</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>ST_GRANULE_CELL_SURVIVAL_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_GRANULE_CELL_SURVIVAL_PATHWAY</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>HOEGERKORP_CD44_TARGETS_DIRECT_UP</TD><TD>MSigDB lists</TD><TD>HOEGERKORP_CD44_TARGETS_DIRECT_UP</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>REACTOME_IL_RECEPTOR_SHC_SIGNALING</TD><TD>MSigDB lists</TD><TD>REACTOME_IL_RECEPTOR_SHC_SIGNALING</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>MODULE_210</TD><TD>MSigDB lists</TD><TD>MODULE_210</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>METALLOENDOPEPTIDASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>METALLOENDOPEPTIDASE_ACTIVITY</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.735e-02</TD><TD>-3.29</TD><TD>MODULE_226</TD><TD>MSigDB lists</TD><TD>MODULE_226</TD><TD>27</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>3.771e-02</TD><TD>-3.28</TD><TD>MODULE_47</TD><TD>MSigDB lists</TD><TD>MODULE_47</TD><TD>219</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2,IL6</TD></TR>
<TR><TD>3.792e-02</TD><TD>-3.27</TD><TD>negative regulation of cytokine production</TD><TD>biological process</TD><TD>GO:0001818</TD><TD>212</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>3.802e-02</TD><TD>-3.27</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</TD><TD>MSigDB lists</TD><TD>PHONG_TNF_RESPONSE_VIA_P38_COMPLETE</TD><TD>220</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,PTGS2</TD></TR>
<TR><TD>3.809e-02</TD><TD>-3.27</TD><TD>HEMOPEXIN_2</TD><TD>prosite domains</TD><TD>PS51642</TD><TD>23</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.822e-02</TD><TD>-3.26</TD><TD>GRK6 (G protein-coupled receptor kinase 6)</TD><TD>protein interactions</TD><TD>2870</TD><TD>26</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>3.822e-02</TD><TD>-3.26</TD><TD>IPO8 (importin 8)</TD><TD>protein interactions</TD><TD>10526</TD><TD>26</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>3.836e-02</TD><TD>-3.26</TD><TD>phosphatidylinositol phospholipase C activity</TD><TD>molecular function</TD><TD>GO:0004435</TD><TD>28</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Cystathionine Beta-Synthase Deficiency</TD><TD>SMPDB pathways</TD><TD>SMP00177</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Glycine N-methyltransferase Deficiency</TD><TD>SMPDB pathways</TD><TD>SMP00222</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>S-Adenosylhomocysteine (SAH) Hydrolase Deficiency</TD><TD>SMPDB pathways</TD><TD>SMP00214</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Methionine Adenosyltransferase Deficiency</TD><TD>SMPDB pathways</TD><TD>SMP00221</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Methionine Metabolism</TD><TD>SMPDB pathways</TD><TD>SMP00033</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Hypermethioninemia</TD><TD>SMPDB pathways</TD><TD>SMP00341</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type</TD><TD>SMPDB pathways</TD><TD>SMP00570</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.850e-02</TD><TD>-3.26</TD><TD>Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)</TD><TD>SMPDB pathways</TD><TD>SMP00340</TD><TD>19</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>IL4I1</TD></TR>
<TR><TD>3.866e-02</TD><TD>-3.25</TD><TD>MEOX2 (mesenchyme homeobox 2)</TD><TD>protein interactions</TD><TD>4223</TD><TD>209</TD><TD>2</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2,MMP3</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>response to isoquinoline alkaloid</TD><TD>biological process</TD><TD>GO:0014072</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>negative regulation of striated muscle cell differentiation</TD><TD>biological process</TD><TD>GO:0051154</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>positive regulation of viral genome replication</TD><TD>biological process</TD><TD>GO:0045070</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>cellular response to ammonium ion</TD><TD>biological process</TD><TD>GO:0071242</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>response to interleukin-6</TD><TD>biological process</TD><TD>GO:0070741</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>3.870e-02</TD><TD>-3.25</TD><TD>positive regulation of NF-kappaB import into nucleus</TD><TD>biological process</TD><TD>GO:0042346</TD><TD>27</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>MA_PITUITARY_FETAL_VS_ADULT_UP</TD><TD>MSigDB lists</TD><TD>MA_PITUITARY_FETAL_VS_ADULT_UP</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>ABE_VEGFA_TARGETS_30MIN</TD><TD>MSigDB lists</TD><TD>ABE_VEGFA_TARGETS_30MIN</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>GNF2_SNRK</TD><TD>MSigDB lists</TD><TD>GNF2_SNRK</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</TD><TD>MSigDB lists</TD><TD>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>PID_WNT_SIGNALING_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_WNT_SIGNALING_PATHWAY</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>MODULE_281</TD><TD>MSigDB lists</TD><TD>MODULE_281</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL1</TD></TR>
<TR><TD>3.871e-02</TD><TD>-3.25</TD><TD>MORI_PLASMA_CELL_DN</TD><TD>MSigDB lists</TD><TD>MORI_PLASMA_CELL_DN</TD><TD>28</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CD83</TD></TR>
<TR><TD>3.891e-02</TD><TD>-3.25</TD><TD>Ets_dom</TD><TD>interpro domains</TD><TD>IPR000418</TD><TD>29</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>3.891e-02</TD><TD>-3.25</TD><TD>Peptidase_Metallo</TD><TD>interpro domains</TD><TD>IPR006026</TD><TD>29</TD><TD>1</TD><TD>18293</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>3.895e-02</TD><TD>-3.25</TD><TD>regulation of macromolecule metabolic process</TD><TD>biological process</TD><TD>GO:0060255</TD><TD>5698</TD><TD>13</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,CCL7,CSF3,IL11,CCL20,CCL8,IL6,NFKBIZ,PIM2,CSF2,CCL5,DKK1,ELF3</TD></TR>
<TR><TD>3.929e-02</TD><TD>-3.24</TD><TD>V$ATF1_Q6</TD><TD>MSigDB lists</TD><TD>V$ATF1_Q6</TD><TD>224</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2</TD></TR>
<TR><TD>3.929e-02</TD><TD>-3.24</TD><TD>UDAYAKUMAR_MED1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>UDAYAKUMAR_MED1_TARGETS_DN</TD><TD>224</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3,DKK1</TD></TR>
<TR><TD>3.959e-02</TD><TD>-3.23</TD><TD>regulation of macromolecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0010556</TD><TD>3904</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3,IL11,CCL20,IL6,NFKBIZ,PIM2,CSF2,CCL5,ELF3,DKK1</TD></TR>
<TR><TD>3.987e-02</TD><TD>-3.22</TD><TD>regulation of catalytic activity</TD><TD>biological process</TD><TD>GO:0050790</TD><TD>2284</TD><TD>7</TD><TD>16441</TD><TD>24</TD>
<TD>CXCL1,CCL7,CCL5,CSF2,CCL20,CCL8,IL6</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>TISSUE_REMODELING</TD><TD>MSigDB lists</TD><TD>TISSUE_REMODELING</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>NEGATIVE_REGULATION_OF_CELLULAR_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_CELLULAR_BIOSYNTHETIC_PROCESS</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>WILENSKY_RESPONSE_TO_DARAPLADIB</TD><TD>MSigDB lists</TD><TD>WILENSKY_RESPONSE_TO_DARAPLADIB</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX</TD><TD>MSigDB lists</TD><TD>REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>MODULE_500</TD><TD>MSigDB lists</TD><TD>MODULE_500</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING</TD><TD>MSigDB lists</TD><TD>GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>BIOCARTA_NKT_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_NKT_PATHWAY</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.006e-02</TD><TD>-3.22</TD><TD>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</TD><TD>29</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>macrophage activation</TD><TD>biological process</TD><TD>GO:0042116</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>regulation of macrophage derived foam cell differentiation</TD><TD>biological process</TD><TD>GO:0010743</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>T cell differentiation involved in immune response</TD><TD>biological process</TD><TD>GO:0002292</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>negative regulation of lymphocyte apoptotic process</TD><TD>biological process</TD><TD>GO:0070229</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>response to dexamethasone</TD><TD>biological process</TD><TD>GO:0071548</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.011e-02</TD><TD>-3.22</TD><TD>positive regulation of smooth muscle contraction</TD><TD>biological process</TD><TD>GO:0045987</TD><TD>28</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.036e-02</TD><TD>-3.21</TD><TD>regulation of protein localization</TD><TD>biological process</TD><TD>GO:0032880</TD><TD>906</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,CCL5,IL6</TD></TR>
<TR><TD>4.041e-02</TD><TD>-3.21</TD><TD>cell differentiation</TD><TD>biological process</TD><TD>GO:0030154</TD><TD>3353</TD><TD>9</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,PTGS2,CSF3,IL11,IL6,CSF2,CCL5,ELF3,DKK1</TD></TR>
<TR><TD>4.056e-02</TD><TD>-3.21</TD><TD>calcium ion transport</TD><TD>biological process</TD><TD>GO:0006816</TD><TD>220</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CCL8</TD></TR>
<TR><TD>4.057e-02</TD><TD>-3.20</TD><TD>V$POU6F1_01</TD><TD>MSigDB lists</TD><TD>V$POU6F1_01</TD><TD>228</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>GPR183,TNFSF13B</TD></TR>
<TR><TD>4.057e-02</TD><TD>-3.20</TD><TD>AFFAR_YY1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>AFFAR_YY1_TARGETS_DN</TD><TD>228</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7,CXCL6</TD></TR>
<TR><TD>4.104e-02</TD><TD>-3.19</TD><TD>tumor necrosis factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005164</TD><TD>30</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.104e-02</TD><TD>-3.19</TD><TD>phospholipase C activity</TD><TD>molecular function</TD><TD>GO:0004629</TD><TD>30</TD><TD>1</TD><TD>16491</TD><TD>23</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.110e-02</TD><TD>-3.19</TD><TD>SAAL1 (serum amyloid A-like 1)</TD><TD>protein interactions</TD><TD>113174</TD><TD>28</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.110e-02</TD><TD>-3.19</TD><TD>EIF2B4 (eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa)</TD><TD>protein interactions</TD><TD>8890</TD><TD>28</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.110e-02</TD><TD>-3.19</TD><TD>IGFBP3 (insulin like growth factor binding protein 3)</TD><TD>protein interactions</TD><TD>3486</TD><TD>28</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.128e-02</TD><TD>-3.19</TD><TD>RAF-independent MAPK1/3 activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-112409</TD><TD>23</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>IL6</TD></TR>
<TR><TD>4.128e-02</TD><TD>-3.19</TD><TD>Ets</TD><TD>pfam domains</TD><TD>PF00178</TD><TD>28</TD><TD>1</TD><TD>16629</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>HUNSBERGER_EXERCISE_REGULATED_GENES</TD><TD>MSigDB lists</TD><TD>HUNSBERGER_EXERCISE_REGULATED_GENES</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>LIANG_SILENCED_BY_METHYLATION_UP</TD><TD>MSigDB lists</TD><TD>LIANG_SILENCED_BY_METHYLATION_UP</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>HATADA_METHYLATED_IN_LUNG_CANCER_DN</TD><TD>MSigDB lists</TD><TD>HATADA_METHYLATED_IN_LUNG_CANCER_DN</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>ELF3</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</TD><TD>MSigDB lists</TD><TD>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>NEGATIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>NEGATIVE_REGULATION_OF_BIOSYNTHETIC_PROCESS</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>LI_PROSTATE_CANCER_EPIGENETIC</TD><TD>MSigDB lists</TD><TD>LI_PROSTATE_CANCER_EPIGENETIC</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.142e-02</TD><TD>-3.18</TD><TD>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</TD><TD>MSigDB lists</TD><TD>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</TD><TD>30</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>4.151e-02</TD><TD>-3.18</TD><TD>negative regulation of cytokine biosynthetic process</TD><TD>biological process</TD><TD>GO:0042036</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.151e-02</TD><TD>-3.18</TD><TD>regulation of interleukin-4 production</TD><TD>biological process</TD><TD>GO:0032673</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CD83</TD></TR>
<TR><TD>4.151e-02</TD><TD>-3.18</TD><TD>salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0007435</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.151e-02</TD><TD>-3.18</TD><TD>positive regulation of leukocyte apoptotic process</TD><TD>biological process</TD><TD>GO:2000108</TD><TD>29</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.154e-02</TD><TD>-3.18</TD><TD>homeostatic process</TD><TD>biological process</TD><TD>GO:0042592</TD><TD>1343</TD><TD>5</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8,IL6,TNFSF13B</TD></TR>
<TR><TD>4.154e-02</TD><TD>-3.18</TD><TD>V$HNF1_C</TD><TD>MSigDB lists</TD><TD>V$HNF1_C</TD><TD>231</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2,CSF3</TD></TR>
<TR><TD>4.186e-02</TD><TD>-3.17</TD><TD>V$LMO2COM_02</TD><TD>MSigDB lists</TD><TD>V$LMO2COM_02</TD><TD>232</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,TNFSF13B</TD></TR>
<TR><TD>4.196e-02</TD><TD>-3.17</TD><TD>cation homeostasis</TD><TD>biological process</TD><TD>GO:0055080</TD><TD>536</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.240e-02</TD><TD>-3.16</TD><TD>Selenium Pathway</TD><TD>WikiPathways</TD><TD>WP15</TD><TD>87</TD><TD>2</TD><TD>4455</TD><TD>17</TD>
<TD>PTGS2,IL6</TD></TR>
<TR><TD>4.252e-02</TD><TD>-3.16</TD><TD>KAYO_AGING_MUSCLE_UP</TD><TD>MSigDB lists</TD><TD>KAYO_AGING_MUSCLE_UP</TD><TD>234</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F,CD83</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>CXCL8 (chemokine (C-X-C motif) ligand 8)</TD><TD>protein interactions</TD><TD>3576</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>NCAPG (non-SMC condensin I complex subunit G)</TD><TD>protein interactions</TD><TD>64151</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>VAMP3 (vesicle associated membrane protein 3)</TD><TD>protein interactions</TD><TD>9341</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>CSF2RB (colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage))</TD><TD>protein interactions</TD><TD>1439</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.254e-02</TD><TD>-3.16</TD><TD>XPO4 (exportin 4)</TD><TD>protein interactions</TD><TD>64328</TD><TD>29</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>DI___TRI_VALENT_INORGANIC_CATION_TRANSPORT</TD><TD>MSigDB lists</TD><TD>DI___TRI_VALENT_INORGANIC_CATION_TRANSPORT</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL8</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>VANTVEER_BREAST_CANCER_BRCA1_UP</TD><TD>MSigDB lists</TD><TD>VANTVEER_BREAST_CANCER_BRCA1_UP</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.277e-02</TD><TD>-3.15</TD><TD>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</TD><TD>MSigDB lists</TD><TD>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</TD><TD>31</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.285e-02</TD><TD>-3.15</TD><TD>V$GATA4_Q3</TD><TD>MSigDB lists</TD><TD>V$GATA4_Q3</TD><TD>235</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CXCL6</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>maternal placenta development</TD><TD>biological process</TD><TD>GO:0001893</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>lipopolysaccharide-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0031663</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>regulation of actin cytoskeleton reorganization</TD><TD>biological process</TD><TD>GO:2000249</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF3</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>brown fat cell differentiation</TD><TD>biological process</TD><TD>GO:0050873</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>response to ATP</TD><TD>biological process</TD><TD>GO:0033198</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>aromatic amino acid family metabolic process</TD><TD>biological process</TD><TD>GO:0009072</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.292e-02</TD><TD>-3.15</TD><TD>regulation of collagen biosynthetic process</TD><TD>biological process</TD><TD>GO:0032965</TD><TD>30</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.301e-02</TD><TD>-3.15</TD><TD>external side of plasma membrane</TD><TD>cellular component</TD><TD>GO:0009897</TD><TD>233</TD><TD>2</TD><TD>17570</TD><TD>25</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>4.318e-02</TD><TD>-3.14</TD><TD>V$STAT5A_01</TD><TD>MSigDB lists</TD><TD>V$STAT5A_01</TD><TD>236</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CCL5</TD></TR>
<TR><TD>4.351e-02</TD><TD>-3.13</TD><TD>BLUM_RESPONSE_TO_SALIRASIB_UP</TD><TD>MSigDB lists</TD><TD>BLUM_RESPONSE_TO_SALIRASIB_UP</TD><TD>237</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL3,IL6</TD></TR>
<TR><TD>4.361e-02</TD><TD>-3.13</TD><TD>regulation of I-kappaB kinase/NF-kappaB signaling</TD><TD>biological process</TD><TD>GO:0043122</TD><TD>229</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,PIM2</TD></TR>
<TR><TD>4.398e-02</TD><TD>-3.12</TD><TD>PTGS2 (prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase))</TD><TD>protein interactions</TD><TD>5743</TD><TD>30</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.398e-02</TD><TD>-3.12</TD><TD>NF1 (neurofibromin 1)</TD><TD>protein interactions</TD><TD>4763</TD><TD>30</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</TD><TD>MSigDB lists</TD><TD>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>PID_SYNDECAN_4_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_SYNDECAN_4_PATHWAY</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM</TD><TD>MSigDB lists</TD><TD>KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>BAE_BRCA1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>BAE_BRCA1_TARGETS_DN</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>KORKOLA_CORRELATED_WITH_POU5F1</TD><TD>MSigDB lists</TD><TD>KORKOLA_CORRELATED_WITH_POU5F1</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>ABE_VEGFA_TARGETS_2HR</TD><TD>MSigDB lists</TD><TD>ABE_VEGFA_TARGETS_2HR</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>PID_SYNDECAN_2_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_SYNDECAN_2_PATHWAY</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>TSAI_RESPONSE_TO_RADIATION_THERAPY</TD><TD>MSigDB lists</TD><TD>TSAI_RESPONSE_TO_RADIATION_THERAPY</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.412e-02</TD><TD>-3.12</TD><TD>MODULE_131</TD><TD>MSigDB lists</TD><TD>MODULE_131</TD><TD>32</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL11</TD></TR>
<TR><TD>4.417e-02</TD><TD>-3.12</TD><TD>V$HLF_01</TD><TD>MSigDB lists</TD><TD>V$HLF_01</TD><TD>239</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CXCL6</TD></TR>
<TR><TD>4.419e-02</TD><TD>-3.12</TD><TD>TCR Signaling Pathway</TD><TD>WikiPathways</TD><TD>WP69</TD><TD>89</TD><TD>2</TD><TD>4455</TD><TD>17</TD>
<TD>IL6,CD83</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>positive regulation of interleukin-2 production</TD><TD>biological process</TD><TD>GO:0032743</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CD83</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>CD4-positive, alpha-beta T cell differentiation</TD><TD>biological process</TD><TD>GO:0043367</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>positive regulation of fatty acid metabolic process</TD><TD>biological process</TD><TD>GO:0045923</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>cellular response to nutrient</TD><TD>biological process</TD><TD>GO:0031670</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>positive regulation of tyrosine phosphorylation of Stat3 protein</TD><TD>biological process</TD><TD>GO:0042517</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.432e-02</TD><TD>-3.12</TD><TD>regulation of cell fate commitment</TD><TD>biological process</TD><TD>GO:0010453</TD><TD>31</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.442e-02</TD><TD>-3.11</TD><TD>HX</TD><TD>smart domains</TD><TD>SM00120</TD><TD>23</TD><TD>1</TD><TD>9131</TD><TD>18</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.451e-02</TD><TD>-3.11</TD><TD>Ibuprofen Metabolism Pathway</TD><TD>SMPDB pathways</TD><TD>SMP00590</TD><TD>22</TD><TD>1</TD><TD>978</TD><TD>2</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.480e-02</TD><TD>-3.11</TD><TD>TNFs bind their physiological receptors</TD><TD>REACTOME pathways</TD><TD>R-HSA-5669034</TD><TD>25</TD><TD>1</TD><TD>8202</TD><TD>15</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.484e-02</TD><TD>-3.10</TD><TD>V$HNF1_Q6</TD><TD>MSigDB lists</TD><TD>V$HNF1_Q6</TD><TD>241</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CXCL3</TD></TR>
<TR><TD>4.484e-02</TD><TD>-3.10</TD><TD>V$ETS1_B</TD><TD>MSigDB lists</TD><TD>V$ETS1_B</TD><TD>241</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,MMP3</TD></TR>
<TR><TD>4.495e-02</TD><TD>-3.10</TD><TD>cellular chemical homeostasis</TD><TD>biological process</TD><TD>GO:0055082</TD><TD>551</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.499e-02</TD><TD>-3.10</TD><TD>aging</TD><TD>biological process</TD><TD>GO:0007568</TD><TD>233</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,IL6</TD></TR>
<TR><TD>4.515e-02</TD><TD>-3.10</TD><TD>inorganic ion homeostasis</TD><TD>biological process</TD><TD>GO:0098771</TD><TD>552</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL7,CCL5,CCL8</TD></TR>
<TR><TD>4.517e-02</TD><TD>-3.10</TD><TD>V$CEBP_Q3</TD><TD>MSigDB lists</TD><TD>V$CEBP_Q3</TD><TD>242</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,CCL8</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>ELANE (elastase, neutrophil expressed)</TD><TD>protein interactions</TD><TD>1991</TD><TD>31</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>CSF3</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>NUP85 (nucleoporin 85kDa)</TD><TD>protein interactions</TD><TD>79902</TD><TD>31</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>HLA-DPB1 (major histocompatibility complex, class II, DP beta 1)</TD><TD>protein interactions</TD><TD>3115</TD><TD>31</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>TNFSF13B</TD></TR>
<TR><TD>4.541e-02</TD><TD>-3.09</TD><TD>EIF2B5 (eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa)</TD><TD>protein interactions</TD><TD>8893</TD><TD>31</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL7</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>TANG_SENESCENCE_TP53_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>TANG_SENESCENCE_TP53_TARGETS_UP</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</TD><TD>MSigDB lists</TD><TD>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>WESTON_VEGFA_TARGETS_12HR</TD><TD>MSigDB lists</TD><TD>WESTON_VEGFA_TARGETS_12HR</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.547e-02</TD><TD>-3.09</TD><TD>BURTON_ADIPOGENESIS_1</TD><TD>MSigDB lists</TD><TD>BURTON_ADIPOGENESIS_1</TD><TD>33</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.551e-02</TD><TD>-3.09</TD><TD>V$CEBPGAMMA_Q6</TD><TD>MSigDB lists</TD><TD>V$CEBPGAMMA_Q6</TD><TD>243</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,G0S2</TD></TR>
<TR><TD>4.556e-02</TD><TD>-3.09</TD><TD>protein phosphorylation</TD><TD>biological process</TD><TD>GO:0006468</TD><TD>942</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PIM2,CCL5,CSF2,CCL8</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>positive regulation of immunoglobulin production</TD><TD>biological process</TD><TD>GO:0002639</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>cellular response to alkaloid</TD><TD>biological process</TD><TD>GO:0071312</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>regulation of protein oligomerization</TD><TD>biological process</TD><TD>GO:0032459</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>MMP3</TD></TR>
<TR><TD>4.571e-02</TD><TD>-3.09</TD><TD>negative regulation of epithelial cell apoptotic process</TD><TD>biological process</TD><TD>GO:1904036</TD><TD>32</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL11</TD></TR>
<TR><TD>4.576e-02</TD><TD>-3.08</TD><TD>response to peptide hormone</TD><TD>biological process</TD><TD>GO:0043434</TD><TD>555</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6</TD></TR>
<TR><TD>4.585e-02</TD><TD>-3.08</TD><TD>V$AREB6_03</TD><TD>MSigDB lists</TD><TD>V$AREB6_03</TD><TD>244</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CCL20</TD></TR>
<TR><TD>4.618e-02</TD><TD>-3.08</TD><TD>V$CEBPB_02</TD><TD>MSigDB lists</TD><TD>V$CEBPB_02</TD><TD>245</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>NFKBIZ,G0S2</TD></TR>
<TR><TD>4.619e-02</TD><TD>-3.08</TD><TD>ETS_DOMAIN_3</TD><TD>prosite domains</TD><TD>PS50061</TD><TD>28</TD><TD>1</TD><TD>11866</TD><TD>20</TD>
<TD>ELF3</TD></TR>
<TR><TD>4.652e-02</TD><TD>-3.07</TD><TD>V$OCT_Q6</TD><TD>MSigDB lists</TD><TD>V$OCT_Q6</TD><TD>246</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.652e-02</TD><TD>-3.07</TD><TD>V$OCT_C</TD><TD>MSigDB lists</TD><TD>V$OCT_C</TD><TD>246</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.652e-02</TD><TD>-3.07</TD><TD>V$GATA_C</TD><TD>MSigDB lists</TD><TD>V$GATA_C</TD><TD>246</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,CSF2</TD></TR>
<TR><TD>4.661e-02</TD><TD>-3.07</TD><TD>regulation of immune response</TD><TD>biological process</TD><TD>GO:0050776</TD><TD>949</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5,CSF2,IL6,TNFSF13B</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>ST_WNT_BETA_CATENIN_PATHWAY</TD><TD>MSigDB lists</TD><TD>ST_WNT_BETA_CATENIN_PATHWAY</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>chr7p21</TD><TD>MSigDB lists</TD><TD>chr7p21</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>KEGG_CYSTEINE_AND_METHIONINE_METABOLISM</TD><TD>MSigDB lists</TD><TD>KEGG_CYSTEINE_AND_METHIONINE_METABOLISM</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>HAN_JNK_SINGALING_UP</TD><TD>MSigDB lists</TD><TD>HAN_JNK_SINGALING_UP</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>BIOCARTA_IL1R_PATHWAY</TD><TD>MSigDB lists</TD><TD>BIOCARTA_IL1R_PATHWAY</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</TD><TD>MSigDB lists</TD><TD>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CCL20</TD></TR>
<TR><TD>4.681e-02</TD><TD>-3.06</TD><TD>MEIOTIC_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>MEIOTIC_CELL_CYCLE</TD><TD>34</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.686e-02</TD><TD>-3.06</TD><TD>V$STAT6_02</TD><TD>MSigDB lists</TD><TD>V$STAT6_02</TD><TD>247</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,CSF2</TD></TR>
<TR><TD>4.691e-02</TD><TD>-3.06</TD><TD>system development</TD><TD>biological process</TD><TD>GO:0048731</TD><TD>4011</TD><TD>10</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183,PTGS2,CSF3,IL11,IL6,CXCL1,CSF2,CCL5,ELF3,DKK1</TD></TR>
<TR><TD>4.695e-02</TD><TD>-3.06</TD><TD>breast-carcinoma-ductal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-ductal_carcinoma</TD><TD>15563</TD><TD>23</TD><TD>17775</TD><TD>23</TD>
<TD>CCL7,IL11,CCL20,CXCL3,CXCL6,TNFSF13B,IL4I1,CXCL2,CSF2,CD83,ELF3,DKK1,GPR183,PTGS2,CSF3,MMP3,C15orf48,G0S2,CCL8,IL6,CXCL1,NFKBIZ,MT1F</TD></TR>
<TR><TD>4.711e-02</TD><TD>-3.06</TD><TD>dendritic cell differentiation</TD><TD>biological process</TD><TD>GO:0097028</TD><TD>33</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.711e-02</TD><TD>-3.06</TD><TD>positive regulation of vasoconstriction</TD><TD>biological process</TD><TD>GO:0045907</TD><TD>33</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.711e-02</TD><TD>-3.06</TD><TD>salivary gland development</TD><TD>biological process</TD><TD>GO:0007431</TD><TD>33</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.720e-02</TD><TD>-3.05</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</TD><TD>MSigDB lists</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</TD><TD>248</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>MMP3,G0S2</TD></TR>
<TR><TD>4.720e-02</TD><TD>-3.05</TD><TD>V$CREL_01</TD><TD>MSigDB lists</TD><TD>V$CREL_01</TD><TD>248</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,CCL20</TD></TR>
<TR><TD>4.755e-02</TD><TD>-3.05</TD><TD>V$OSF2_Q6</TD><TD>MSigDB lists</TD><TD>V$OSF2_Q6</TD><TD>249</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,DKK1</TD></TR>
<TR><TD>4.755e-02</TD><TD>-3.05</TD><TD>V$OCT1_01</TD><TD>MSigDB lists</TD><TD>V$OCT1_01</TD><TD>249</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.789e-02</TD><TD>-3.04</TD><TD>RACCACAR_V$AML_Q6</TD><TD>MSigDB lists</TD><TD>RACCACAR_V$AML_Q6</TD><TD>250</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF2,DKK1</TD></TR>
<TR><TD>4.815e-02</TD><TD>-3.03</TD><TD>Phenylalanine metabolism</TD><TD>KEGG pathways</TD><TD>ko00360</TD><TD>17</TD><TD>1</TD><TD>6908</TD><TD>20</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.815e-02</TD><TD>-3.03</TD><TD>Phenylalanine metabolism</TD><TD>KEGG pathways</TD><TD>hsa00360</TD><TD>17</TD><TD>1</TD><TD>6908</TD><TD>20</TD>
<TD>IL4I1</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>VARELA_ZMPSTE24_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>VARELA_ZMPSTE24_TARGETS_DN</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>G0S2</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>POSITIVE_REGULATION_OF_TRANSLATION</TD><TD>MSigDB lists</TD><TD>POSITIVE_REGULATION_OF_TRANSLATION</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</TD><TD>MSigDB lists</TD><TD>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>WANG_METHYLATED_IN_BREAST_CANCER</TD><TD>MSigDB lists</TD><TD>WANG_METHYLATED_IN_BREAST_CANCER</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.816e-02</TD><TD>-3.03</TD><TD>chr16q13</TD><TD>MSigDB lists</TD><TD>chr16q13</TD><TD>35</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>MT1F</TD></TR>
<TR><TD>4.823e-02</TD><TD>-3.03</TD><TD>V$OCT1_B</TD><TD>MSigDB lists</TD><TD>V$OCT1_B</TD><TD>251</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.823e-02</TD><TD>-3.03</TD><TD>V$OCT1_Q6</TD><TD>MSigDB lists</TD><TD>V$OCT1_Q6</TD><TD>251</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.827e-02</TD><TD>-3.03</TD><TD>ELF3 (E74-like factor 3 (ets domain transcription factor, epithelial-specific ))</TD><TD>protein interactions</TD><TD>1999</TD><TD>33</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>ELF3</TD></TR>
<TR><TD>4.846e-02</TD><TD>-3.03</TD><TD>regulation of intracellular transport</TD><TD>biological process</TD><TD>GO:0032386</TD><TD>568</TD><TD>3</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CSF3,IL6</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>B cell activation involved in immune response</TD><TD>biological process</TD><TD>GO:0002312</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>CD4-positive, alpha-beta T cell activation</TD><TD>biological process</TD><TD>GO:0035710</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>regulation of receptor internalization</TD><TD>biological process</TD><TD>GO:0002090</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>organ or tissue specific immune response</TD><TD>biological process</TD><TD>GO:0002251</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>regulation of collagen metabolic process</TD><TD>biological process</TD><TD>GO:0010712</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>regulation of fatty acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0042304</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>negative regulation of signal transduction in absence of ligand</TD><TD>biological process</TD><TD>GO:1901099</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>negative regulation of striated muscle tissue development</TD><TD>biological process</TD><TD>GO:0045843</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>face morphogenesis</TD><TD>biological process</TD><TD>GO:0060325</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>positive regulation of interleukin-1 production</TD><TD>biological process</TD><TD>GO:0032732</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL20</TD></TR>
<TR><TD>4.850e-02</TD><TD>-3.03</TD><TD>negative regulation of extrinsic apoptotic signaling pathway in absence of ligand</TD><TD>biological process</TD><TD>GO:2001240</TD><TD>34</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CSF2</TD></TR>
<TR><TD>4.858e-02</TD><TD>-3.02</TD><TD>V$OCT1_Q5_01</TD><TD>MSigDB lists</TD><TD>V$OCT1_Q5_01</TD><TD>252</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CSF3,PIM2</TD></TR>
<TR><TD>4.858e-02</TD><TD>-3.02</TD><TD>V$AP1_Q4_01</TD><TD>MSigDB lists</TD><TD>V$AP1_Q4_01</TD><TD>252</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>IL11,CSF3</TD></TR>
<TR><TD>4.923e-02</TD><TD>-3.01</TD><TD>cellular response to external stimulus</TD><TD>biological process</TD><TD>GO:0071496</TD><TD>245</TD><TD>2</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,CCL5</TD></TR>
<TR><TD>4.923e-02</TD><TD>-3.01</TD><TD>protein kinase activity</TD><TD>molecular function</TD><TD>GO:0004672</TD><TD>599</TD><TD>3</TD><TD>16491</TD><TD>23</TD>
<TD>PIM2,CCL5,CCL8</TD></TR>
<TR><TD>4.927e-02</TD><TD>-3.01</TD><TD>QI_PLASMACYTOMA_UP</TD><TD>MSigDB lists</TD><TD>QI_PLASMACYTOMA_UP</TD><TD>254</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>CCL5,TNFSF13B</TD></TR>
<TR><TD>4.938e-02</TD><TD>-3.01</TD><TD>negative regulation of multicellular organismal process</TD><TD>biological process</TD><TD>GO:0051241</TD><TD>967</TD><TD>4</TD><TD>16441</TD><TD>24</TD>
<TD>PTGS2,IL6,DKK1,CD83</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>PID_FRA_PATHWAY</TD><TD>MSigDB lists</TD><TD>PID_FRA_PATHWAY</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>IL6</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>HUANG_FOXA2_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HUANG_FOXA2_TARGETS_DN</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL2</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>HALLMARK_ANGIOGENESIS</TD><TD>MSigDB lists</TD><TD>HALLMARK_ANGIOGENESIS</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>CXCL6</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2</TD></TR>
<TR><TD>4.950e-02</TD><TD>-3.01</TD><TD>ZHAN_MULTIPLE_MYELOMA_MF_DN</TD><TD>MSigDB lists</TD><TD>ZHAN_MULTIPLE_MYELOMA_MF_DN</TD><TD>36</TD><TD>1</TD><TD>17758</TD><TD>25</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.962e-02</TD><TD>-3.00</TD><TD>V$AP1_Q2</TD><TD>MSigDB lists</TD><TD>V$AP1_Q2</TD><TD>255</TD><TD>2</TD><TD>17758</TD><TD>25</TD>
<TD>PIM2,IL6</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>LRP6 (LDL receptor related protein 6)</TD><TD>protein interactions</TD><TD>4040</TD><TD>34</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>DKK1</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>STAG2 (stromal antigen 2)</TD><TD>protein interactions</TD><TD>10735</TD><TD>34</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>GPR183</TD></TR>
<TR><TD>4.970e-02</TD><TD>-3.00</TD><TD>ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase)</TD><TD>protein interactions</TD><TD>27</TD><TD>34</TD><TD>1</TD><TD>16036</TD><TD>24</TD>
<TD>C15orf48</TD></TR>
<TR><TD>4.989e-02</TD><TD>-3.00</TD><TD>positive chemotaxis</TD><TD>biological process</TD><TD>GO:0050918</TD><TD>35</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>CCL5</TD></TR>
<TR><TD>4.989e-02</TD><TD>-3.00</TD><TD>regulation of multicellular organismal metabolic process</TD><TD>biological process</TD><TD>GO:0044246</TD><TD>35</TD><TD>1</TD><TD>16441</TD><TD>24</TD>
<TD>IL6</TD></TR>
</TABLE>
</BODY></HTML>
